data_2lbt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.991 0.9 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.404 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.53 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.53 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.505 ' O ' HG21 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.495 ' HA ' ' NZ ' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.495 ' HZ1' ' HB2' ' A' ' 248' ' ' LYS . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.415 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.415 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.497 ' O ' HG13 ' A' ' 280' ' ' ILE . 23.1 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.416 HG21 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.416 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 314' ' ' GLY . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 307' ' ' ALA . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 326' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.55 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.526 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.537 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.6 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.422 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.432 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.4 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.65 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.426 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.671 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.433 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.433 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.516 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 . . . . . 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.413 HD13 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 239' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.571 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 262' ' ' ASP . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.43 HG21 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.43 ' OD1' HG21 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG23 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 248' ' ' LYS . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.517 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.504 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.462 HD22 ' ND2' ' A' ' 309' ' ' ASN . 4.3 p-10 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.461 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.459 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.462 ' ND2' HD22 ' A' ' 263' ' ' ASN . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.54 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.589 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.565 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.423 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.423 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 83.1 m-20 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.444 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.426 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.518 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.405 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.578 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.465 HG21 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.465 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.579 0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.515 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.418 ' O ' HD21 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.422 ' O ' HG21 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 236' ' ' ALA . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.402 ' HB ' HG21 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.437 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.444 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.444 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.421 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.549 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.412 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.515 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.515 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.482 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 215' ' ' ILE . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 211' ' ' LEU . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.472 HG11 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.425 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.48 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.432 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 0.1 OUTLIER -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.572 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.426 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.471 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.486 ' O ' ' HD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.423 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.418 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG21 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 5.0 p-10 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.428 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 262' ' ' ASP . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.465 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.604 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.404 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.408 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.496 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.451 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 243' ' ' VAL . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.541 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.485 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.471 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.529 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 225' ' ' PHE . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.428 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.428 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.43 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.627 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.627 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.435 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.476 ' O ' HG21 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.525 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.572 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.55 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HA ' HG23 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.442 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.435 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 212' ' ' GLN . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.575 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.439 -0.999 0 CA-C-O 120.583 0.23 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.431 HG23 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.518 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.411 ' HB ' HG21 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.406 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.456 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.525 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.549 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.498 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.456 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.575 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.445 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.64 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.499 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.64 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.532 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.446 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.446 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.481 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.481 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.468 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.424 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 299' ' ' GLY . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.7 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HA ' HG23 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.514 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.524 HD13 ' NH1' ' A' ' 320' ' ' ARG . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.412 ' HB3' HD12 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.524 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.474 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.44 HG13 ' CB ' ' A' ' 211' ' ' LEU . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.45 HG11 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 243' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HE ' HG11 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.62 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.437 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.419 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 47.8 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.496 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.452 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.62 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.456 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.477 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.485 ' HB3' ' HZ1' ' A' ' 248' ' ' LYS . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.447 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.483 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.449 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.49 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.49 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.514 -0.426 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HZ3' ' HB2' ' A' ' 248' ' ' LYS . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 323' ' ' ILE . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.475 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.672 ' OD2' HG21 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.672 HG21 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.55 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.475 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.438 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.533 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.527 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 243' ' ' VAL . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.504 ' HB3' ' HZ3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.472 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.488 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.444 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.502 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.405 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.437 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.666 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.54 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.485 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.44 HG21 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.443 ' ND2' ' HH ' ' A' ' 260' ' ' TYR . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.412 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -108.79 151.07 26.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.863 0.363 . . . . 0.0 110.828 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.93 149.66 38.03 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.77 94.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.779 2.319 . . . . 0.0 111.792 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.05 142.92 52.45 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.957 2.438 . . . . 0.0 112.644 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.72 158.6 52.74 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 130.71 32.13 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.72 2.28 . . . . 0.0 112.422 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.45 166.62 28.29 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.258 . . . . 0.0 112.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -130.12 -55.32 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 42.9 m -88.8 -167.74 1.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.96 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -64.73 138.22 39.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.891 -1.147 . . . . 0.0 111.885 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 -53.61 2.78 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.232 . . . . 0.0 112.35 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.2 m -140.43 134.1 30.29 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.44 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.01 -34.08 61.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.161 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -172.63 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.404 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 -119.08 159.32 24.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 178.48 -156.59 19.47 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.349 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.45 -112.14 0.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.851 0.46 . . . . 0.0 110.046 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.06 -9.38 52.31 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.062 0.458 . . . . 0.0 111.401 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.7 -38.94 3.15 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.868 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.16 22.46 5.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.394 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p -137.86 152.44 49.06 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.028 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.53 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.53 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.505 ' O ' HG21 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.495 ' HA ' ' NZ ' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.495 ' HZ1' ' HB2' ' A' ' 248' ' ' LYS . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.415 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.415 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.497 ' O ' HG13 ' A' ' 280' ' ' ILE . 23.1 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.416 HG21 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.416 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 314' ' ' GLY . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 307' ' ' ALA . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 326' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.26 110.64 12.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.666 0.233 . . . . 0.0 110.667 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -70.15 124.91 91.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.911 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 29.4 Cg_exo -62.29 139.44 77.5 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.581 2.187 . . . . 0.0 111.885 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.22 140.39 88.6 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.574 2.182 . . . . 0.0 111.85 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -115.33 141.26 16.87 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.584 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.78 155.25 55.41 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.732 2.288 . . . . 0.0 111.98 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.56 170.55 6.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.826 2.351 . . . . 0.0 112.777 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -110.98 -13.65 14.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.963 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.4 m -145.21 179.69 7.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.189 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -83.49 173.36 51.36 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.827 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.43 -16.84 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.881 2.387 . . . . 0.0 112.108 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.8 m -123.97 136.27 54.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 110.991 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.73 -17.81 0.47 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.688 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -114.59 11.06 16.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.55 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -116.83 160.31 21.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.55 -172.35 40.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.35 -98.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.29 0.636 . . . . 0.0 110.923 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.57 -47.2 76.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.918 0.389 . . . . 0.0 111.69 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.28 -36.5 4.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.791 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.31 19.23 15.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.722 0.772 . . . . 0.0 109.302 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m -143.21 156.19 44.7 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.756 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.526 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.537 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.6 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.422 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.432 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.4 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.65 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.426 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -97.79 -164.12 1.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.442 0.163 . . . . 0.0 110.703 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.52 113.84 53.14 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.89 111.24 2.93 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.419 2.079 . . . . 0.0 110.873 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.27 129.58 14.15 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.003 1.802 . . . . 0.0 112.422 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.86 -150.99 5.57 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.6 145.92 59.57 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.857 2.371 . . . . 0.0 111.17 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.47 136.19 61.92 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.522 2.148 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.88 -42.3 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.008 0.433 . . . . 0.0 110.063 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 28.4 m -83.02 104.64 13.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.876 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 122.57 114.69 2.23 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.575 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.79 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.8 m -139.9 134.64 31.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -95.83 -85.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -134.37 87.01 2.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.671 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.433 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.433 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.516 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 -98.12 178.3 5.13 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.7 156.07 26.86 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.263 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.77 -146.12 0.25 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.897 0.479 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.87 -23.98 8.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.197 0.599 . . . . 0.0 111.985 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.01 38.07 6.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.634 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -102.87 -22.24 13.89 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t -137.31 153.61 50.25 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.763 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.413 HD13 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 239' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.571 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 262' ' ' ASP . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.43 HG21 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.43 ' OD1' HG21 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -81.36 104.75 12.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.803 0.335 . . . . 0.0 110.517 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.22 138.93 30.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.47 117.75 4.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.701 2.267 . . . . 0.0 111.927 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.02 170.3 20.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.426 2.084 . . . . 0.0 111.6 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -158.32 -163.69 13.17 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.75 128.04 23.32 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.404 2.069 . . . . 0.0 111.072 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.55 128.19 29.02 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.184 1.922 . . . . 0.0 111.222 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -176.78 -51.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.189 0.519 . . . . 0.0 109.916 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.3 t -137.41 170.65 15.72 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.008 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 138.01 -174.23 22.0 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.65 117.25 4.05 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.786 2.324 . . . . 0.0 111.599 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -148.01 136.46 21.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.535 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.47 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.4 8.8 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG23 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.13 164.85 13.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.7 -160.84 18.94 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.255 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.1 m120 56.96 -107.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.982 0.513 . . . . 0.0 111.61 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.09 -14.54 61.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 98.27 -32.48 6.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.476 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -103.47 16.8 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.733 0.778 . . . . 0.0 109.107 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -124.61 144.3 50.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.99 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 248' ' ' LYS . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.517 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.504 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.462 HD22 ' ND2' ' A' ' 309' ' ' ASN . 4.3 p-10 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.461 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.459 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.462 ' ND2' HD22 ' A' ' 263' ' ' ASN . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.54 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.589 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -124.1 113.6 18.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.69 128.69 53.55 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.27 142.27 94.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.575 2.183 . . . . 0.0 112.415 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.31 172.85 13.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.555 2.17 . . . . 0.0 111.569 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.51 -177.52 38.54 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.058 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.58 154.81 40.1 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.591 2.194 . . . . 0.0 111.882 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.73 146.41 72.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.667 2.245 . . . . 0.0 111.571 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 57.57 77.76 0.26 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.8 m -79.87 110.33 15.14 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.95 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.11 171.74 25.18 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.87 150.26 30.17 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.32 2.013 . . . . 0.0 111.699 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.8 m -94.5 136.05 35.24 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 110.859 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.79 -2.83 4.71 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.282 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -120.91 9.99 10.76 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.734 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.99 150.19 36.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 228' ' ' ASP . . . 168.29 -152.27 20.16 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 29.9 t30 70.98 -46.83 0.65 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.158 0.479 . . . . 0.0 111.948 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 226' ' ' GLY . 14.4 t70 -134.56 -52.19 0.81 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.32 1.17 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 111.83 -2.441 . . . . 0.0 110.367 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 18.33 3.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.501 0.667 . . . . 0.0 109.699 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m -151.89 171.85 17.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.242 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.565 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.423 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.423 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 83.1 m-20 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.444 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.426 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.518 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.405 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.34 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 139.49 46.7 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.04 62.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.123 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.73 141.53 5.49 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.717 2.278 . . . . 0.0 112.24 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.15 137.47 56.88 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.509 2.139 . . . . 0.0 111.057 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.15 179.19 22.43 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.801 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.54 132.28 23.35 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.95 159.7 37.04 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.329 2.019 . . . . 0.0 110.329 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -79.64 167.95 20.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.593 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.4 m -69.95 169.87 12.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -179.86 -70.72 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.9 179.99 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.549 2.166 . . . . 0.0 110.369 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.6 m -110.78 142.97 42.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.904 0.383 . . . . 0.0 111.373 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.73 -20.35 12.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.494 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.38 25.1 9.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.578 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 -119.97 171.5 8.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.89 -152.37 21.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.784 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 t30 58.73 -109.44 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.403 0.681 . . . . 0.0 110.552 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.22 -18.96 64.09 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.621 0.724 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 100.88 -40.32 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.858 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 277' ' ' ARG . . . -97.75 18.63 15.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m -125.1 150.19 47.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.339 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.465 HG21 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.465 ' OD1' HG21 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -131.73 173.76 10.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.85 141.41 22.73 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.556 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.41 158.59 39.89 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.517 2.144 . . . . 0.0 111.227 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.0 148.12 40.15 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.758 2.305 . . . . 0.0 111.83 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -106.65 -174.46 23.07 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.965 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.84 149.88 43.33 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.568 2.179 . . . . 0.0 111.917 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.47 169.81 21.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.652 2.234 . . . . 0.0 111.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.07 -31.53 70.09 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 110.814 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 46.8 t -84.28 139.29 32.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.946 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -138.4 -83.64 0.11 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.59 114.76 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.482 2.122 . . . . 0.0 110.533 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.402 ' CB ' ' HB2' ' A' ' 211' ' ' LEU . 75.9 m -95.11 139.2 31.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.981 0.42 . . . . 0.0 111.414 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.64 -45.22 10.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -127.16 45.73 2.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.515 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 -117.91 179.45 4.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -154.11 -170.02 19.58 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.712 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 229' ' ' GLY . 16.5 m120 59.03 -163.9 0.21 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.96 19.58 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.387 0.613 . . . . 0.0 111.927 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 227' ' ' ASN . . . 79.86 31.3 40.18 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 121.225 -0.512 . . . . 0.0 114.349 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.494 ' HA ' ' NH2' ' A' ' 277' ' ' ARG . . . -97.29 -17.28 19.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m -155.2 175.36 13.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.418 ' O ' HD21 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.422 ' O ' HG21 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 236' ' ' ALA . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.402 ' HB ' HG21 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.494 ' NH2' ' HA ' ' A' ' 230' ' ' ALA . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.437 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.153 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.31 151.09 33.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.93 0.395 . . . . 0.0 110.598 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.71 130.19 47.91 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.976 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.5 132.25 21.77 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.21 1.94 . . . . 0.0 111.602 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.88 145.61 83.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.779 2.319 . . . . 0.0 111.678 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.47 -151.11 9.35 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.207 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.29 126.02 8.86 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.246 1.964 . . . . 0.0 111.416 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.41 168.13 24.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.512 2.142 . . . . 0.0 112.199 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -117.98 144.83 45.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.0 t -120.55 136.4 54.8 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.288 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.89 2.49 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.62 124.58 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.374 2.05 . . . . 0.0 111.702 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.25 136.08 41.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.774 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.68 -59.24 2.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -158.59 98.89 1.55 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.444 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 -103.6 -175.82 2.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -149.0 178.91 26.24 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.458 -1.354 . . . . 0.0 113.193 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -52.6 -27.59 17.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.835 0.854 . . . . 0.0 113.173 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 231' ' ' SER . 5.2 m-20 -50.84 -20.07 1.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.26 -87.32 0.53 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.512 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.2 13.86 28.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.253 0.549 . . . . 0.0 110.384 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 228' ' ' ASP . 15.4 m -105.77 122.39 45.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.444 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.421 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.549 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.412 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.515 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.515 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.482 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -92.01 112.88 24.99 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.27 117.15 59.47 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.592 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.1 159.93 23.66 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.167 . . . . 0.0 111.45 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.57 139.23 82.46 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.595 2.196 . . . . 0.0 111.35 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.65 11.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.183 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 147.77 85.96 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.389 2.059 . . . . 0.0 111.385 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.42 159.26 54.36 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.326 2.017 . . . . 0.0 111.412 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -94.75 71.07 3.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.2 m -65.67 100.22 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.7 73.91 0.56 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.446 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.54 94.28 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.377 2.051 . . . . 0.0 110.516 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.6 m -127.03 136.49 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.143 0.497 . . . . 0.0 111.742 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.99 26.4 0.63 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.99 12.79 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.721 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 215' ' ' ILE . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 211' ' ' LEU . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -123.56 163.69 20.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -160.62 -170.2 24.9 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.537 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 59.8 -95.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.406 1.082 . . . . 0.0 112.007 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -93.79 0.83 56.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 111.01 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.9 83.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.661 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.2 6.5 10.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t -110.88 130.17 55.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.472 HG11 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.425 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.48 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.432 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 0.1 OUTLIER -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.572 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.426 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.471 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.486 ' O ' ' HD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.423 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.17 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -138.58 143.07 39.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.81 158.17 84.14 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.25 141.1 32.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.554 2.169 . . . . 0.0 112.249 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.51 167.27 5.18 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.955 2.437 . . . . 0.0 112.186 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -116.17 139.46 15.32 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.585 -0.816 . . . . 0.0 111.874 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 149.61 43.34 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.298 1.999 . . . . 0.0 111.31 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.02 166.4 23.07 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.527 2.151 . . . . 0.0 111.963 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.52 -126.72 0.27 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 t -100.45 -155.73 0.52 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.29 -70.65 0.02 OUTLIER Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.5 156.74 40.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.326 2.017 . . . . 0.0 110.934 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -94.93 135.48 36.39 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.225 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.3 -176.79 5.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 67.5 7.56 5.68 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.542 0.737 . . . . 0.0 112.485 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.418 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 -128.46 -178.49 4.59 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.44 -134.89 1.87 Allowed Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.349 -1.405 . . . . 0.0 113.437 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -84.94 47.09 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.194 0.997 . . . . 0.0 109.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.62 -49.21 3.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.997 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.82 -58.39 4.52 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.214 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -98.94 10.81 40.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t -159.67 -172.07 3.54 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG21 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 5.0 p-10 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.428 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 262' ' ' ASP . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.465 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.604 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.404 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.408 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.496 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.55 153.97 41.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -89.07 147.33 38.35 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.914 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.75 121.38 9.92 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.75 156.79 59.61 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.727 2.285 . . . . 0.0 112.01 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 167.01 -151.03 18.64 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 32.6 Cg_exo -62.33 126.25 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.18 1.92 . . . . 0.0 110.345 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 17.3 Cg_exo -66.77 128.46 18.96 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.12 1.88 . . . . 0.0 112.443 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.77 27.95 8.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.597 . . . . 0.0 109.79 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 6.7 m -71.97 -175.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.126 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -130.84 69.16 0.54 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.637 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.28 162.68 39.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.724 2.283 . . . . 0.0 112.208 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.1 p -95.22 -179.57 4.84 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.11 160.35 34.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.032 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 68.03 4.09 3.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.239 0.616 . . . . 0.0 112.341 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.451 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 -109.58 142.37 40.78 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.55 -122.8 0.64 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 33.2 t30 67.16 -58.43 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.329 0.652 . . . . 0.0 111.201 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.63 -45.28 0.98 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 155.86 -47.84 0.49 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.823 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.23 -61.68 1.89 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.847 -0.676 . . . . 0.0 112.062 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m -66.91 -178.09 0.71 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 243' ' ' VAL . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.541 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.485 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.471 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.529 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 225' ' ' PHE . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.428 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.428 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.43 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.627 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.627 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -140.6 153.0 45.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.684 0.278 . . . . 0.0 110.425 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.69 119.86 65.59 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.099 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.19 142.33 21.47 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.377 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 149.42 49.46 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.716 2.278 . . . . 0.0 111.686 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.81 -152.75 7.62 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.26 150.86 42.7 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.352 2.035 . . . . 0.0 112.035 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.53 163.22 34.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.591 2.194 . . . . 0.0 111.455 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.08 -54.48 42.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.187 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 252' ' ' ASP . 49.5 m -71.46 115.36 10.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.001 0.429 . . . . 0.0 110.867 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -148.99 175.04 28.42 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.836 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.02 129.97 29.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.839 2.36 . . . . 0.0 111.791 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 11.0 t -147.7 134.77 20.35 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.39 -71.46 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.77 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -160.83 99.01 1.23 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.435 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.39 160.01 18.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.82 32.82 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.068 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 66.7 t30 56.89 -102.89 0.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.159 0.983 . . . . 0.0 111.591 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.11 -30.49 71.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.13 0.49 . . . . 0.0 111.176 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.71 -41.12 2.25 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.7 17.98 10.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.909 0.862 . . . . 0.0 108.986 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p -126.79 143.41 51.26 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.476 ' O ' HG21 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 205' ' ' SER . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.525 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.572 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.55 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HA ' HG23 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.442 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.435 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 212' ' ' GLN . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -150.35 170.77 18.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.35 137.38 19.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.057 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.95 135.31 65.84 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.452 2.102 . . . . 0.0 111.374 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.08 147.42 91.58 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.874 2.383 . . . . 0.0 112.593 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.67 -178.21 40.06 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.062 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.44 145.45 98.68 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.791 2.327 . . . . 0.0 111.936 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.12 161.13 9.27 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.727 2.285 . . . . 0.0 111.346 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -116.2 -4.24 11.94 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.952 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 p -161.66 157.47 24.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -78.01 129.64 9.59 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.243 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.86 -46.22 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.48 2.12 . . . . 0.0 113.096 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.94 136.79 38.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.35 -22.34 0.68 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.121 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.23 14.86 13.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.575 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 -96.65 176.93 5.83 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.34 -145.5 13.19 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.348 -1.406 . . . . 0.0 113.011 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.6 t30 58.03 -101.06 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.08 -46.29 74.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.105 0.479 . . . . 0.0 110.679 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 126.41 -39.9 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.293 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.6 15.37 14.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.353 0.596 . . . . 0.0 110.675 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p -144.56 167.28 22.89 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.431 HG23 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.518 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.411 ' HB ' HG21 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.406 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.456 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.525 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.549 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.498 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.456 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.575 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.262 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -79.33 138.67 37.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.831 0.316 . . . . 0.0 110.271 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.07 136.86 46.65 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.28 111.46 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.787 2.325 . . . . 0.0 111.772 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.65 145.04 86.19 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.013 2.476 . . . . 0.0 112.464 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.41 172.16 50.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.408 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.23 162.06 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.087 2.525 . . . . 0.0 112.105 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.52 171.5 9.35 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.964 2.443 . . . . 0.0 111.925 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -128.79 92.12 3.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.5 m -152.57 102.0 2.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.997 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 144.44 62.85 0.02 OUTLIER Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.655 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.06 -29.09 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.197 1.931 . . . . 0.0 111.75 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.7 t -147.83 135.24 20.66 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -169.06 149.07 4.18 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.999 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.84 30.13 19.7 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 -91.76 169.52 10.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.39 -131.17 1.34 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.302 -1.427 . . . . 0.0 114.285 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -46.19 -67.01 0.32 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.117 0.967 . . . . 0.0 112.738 -175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.58 -18.2 0.13 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.21 -68.18 1.14 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.364 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 19.64 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.948 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.4 m -148.65 160.47 43.11 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.445 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.64 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.499 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.64 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.532 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.446 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.446 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.481 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.481 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -125.61 -162.53 1.12 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.13 142.23 35.84 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.62 141.52 80.05 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.271 1.981 . . . . 0.0 111.124 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.75 131.3 16.18 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.833 2.356 . . . . 0.0 112.081 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.75 -151.26 19.19 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.94 137.65 8.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.68 2.253 . . . . 0.0 111.889 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.9 146.99 94.42 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.858 2.372 . . . . 0.0 111.911 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.18 154.14 20.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.761 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.1 m -69.4 145.74 52.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.428 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.72 162.07 28.03 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.13 -29.53 81.09 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.648 2.232 . . . . 0.0 112.639 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.0 t -97.42 142.93 28.68 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.768 0.318 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 -178.65 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 61.52 7.68 1.92 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.468 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 -115.0 162.13 17.4 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 157.43 102.26 0.19 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.559 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -162.57 -138.54 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.28 -50.45 62.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 109.676 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.25 -107.96 0.24 Allowed Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.117 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.72 54.12 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.2 p -54.37 167.86 0.29 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.424 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 299' ' ' GLY . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.7 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HA ' HG23 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.514 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.524 HD13 ' NH1' ' A' ' 320' ' ' ARG . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.412 ' HB3' HD12 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.524 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.474 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.44 HG13 ' CB ' ' A' ' 211' ' ' LEU . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -83.4 147.49 27.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.775 0.322 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -81.43 126.76 75.55 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.321 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.7 123.02 11.88 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.63 2.22 . . . . 0.0 111.535 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.94 139.72 86.42 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.687 2.258 . . . . 0.0 111.516 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.13 -150.28 9.18 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 126.32 21.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.423 2.082 . . . . 0.0 111.189 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.5 139.07 74.29 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.359 2.04 . . . . 0.0 112.041 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.39 -27.65 56.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.15 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.2 p -58.58 124.23 18.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.947 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -81.17 178.96 53.79 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.732 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.13 150.68 72.0 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.004 2.469 . . . . 0.0 112.155 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.417 ' SG ' ' HB1' ' A' ' 253' ' ' ALA . 0.1 OUTLIER -98.03 161.26 13.81 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.28 140.8 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 53.94 19.86 2.16 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.45 HG11 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -115.61 153.16 31.76 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 228' ' ' ASP . . . -179.18 -169.59 39.91 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t30 71.82 -38.23 0.41 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.441 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 226' ' ' GLY . 20.1 t70 -135.3 -50.75 0.75 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 123.023 1.392 . . . . 0.0 108.038 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 128.27 -42.04 1.5 Allowed Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 112.131 -2.304 . . . . 0.0 109.211 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.5 21.22 10.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m -125.91 143.55 51.03 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 243' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HE ' HG11 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' SG ' ' A' ' 208' ' ' CYS . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.62 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.437 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.419 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 47.8 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.496 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.452 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.62 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -114.77 175.9 5.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 142.7 92.25 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.619 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.18 136.35 51.33 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.742 2.295 . . . . 0.0 112.102 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.9 154.78 43.27 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.542 2.161 . . . . 0.0 111.518 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.16 -150.36 16.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.717 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.52 164.37 29.01 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.772 2.315 . . . . 0.0 111.396 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.74 156.87 8.42 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.764 2.31 . . . . 0.0 111.951 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' HA ' ' NH2' ' A' ' 254' ' ' ARG . . . -112.82 -104.47 0.4 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.305 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.0 m -56.79 98.46 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.991 0.424 . . . . 0.0 111.06 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -110.77 -85.18 1.57 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.182 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 -7.47 19.91 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.741 2.294 . . . . 0.0 111.7 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.2 t -147.69 139.16 23.77 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.62 -177.94 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.366 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.22 12.41 7.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.636 0.775 . . . . 0.0 112.232 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.456 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 -122.56 169.77 10.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 173.01 -119.8 0.78 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 55.51 -132.82 1.67 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.556 0.342 . . . . 0.0 110.102 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -78.24 -32.76 49.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.16 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.27 -60.66 0.27 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.938 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.77 33.6 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m -139.57 154.55 47.64 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.477 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.485 ' HB3' ' HZ1' ' A' ' 248' ' ' LYS . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.447 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.483 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.449 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.49 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.49 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.42 ' C ' ' HB3' ' A' ' 204' ' ' ALA . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.241 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 110.601 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.78 149.93 97.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.514 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.92 143.2 99.64 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.68 164.28 29.76 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.551 2.168 . . . . 0.0 111.486 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.17 167.66 36.23 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.209 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 126.67 23.06 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.553 2.168 . . . . 0.0 111.575 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.86 129.28 17.52 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.147 2.565 . . . . 0.0 112.113 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 66.27 111.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.038 0.836 . . . . 0.0 111.341 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.7 m -67.87 119.68 12.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.996 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 207' ' ' PRO . . . -92.57 133.1 11.57 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.349 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 206' ' ' GLY . 13.6 Cg_exo -70.14 159.0 54.68 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 86.2 m -128.05 154.73 45.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.175 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.96 6.21 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.39 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -115.74 21.98 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -125.58 163.85 21.84 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . 174.39 101.69 0.15 Allowed Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.76 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 4.1 t-20 172.04 -106.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.403 0.681 . . . . 0.0 109.644 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -98.05 -4.18 36.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.742 0.305 . . . . 0.0 111.288 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 106.35 -19.74 36.42 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.906 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.08 -0.09 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.311 0.577 . . . . 0.0 110.282 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m -116.3 136.5 52.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.688 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HZ3' ' HB2' ' A' ' 248' ' ' LYS . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 323' ' ' ILE . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.475 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.672 ' OD2' HG21 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.672 HG21 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.55 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.475 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.438 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -88.48 160.78 17.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.622 0.248 . . . . 0.0 110.523 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.71 153.72 39.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.73 157.94 58.71 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.46 165.04 18.71 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.636 2.224 . . . . 0.0 111.356 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.01 177.61 21.82 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.084 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 131.93 28.66 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.715 2.277 . . . . 0.0 111.666 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.62 128.44 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.664 2.242 . . . . 0.0 111.841 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.52 140.46 29.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.4 m -116.95 160.61 20.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.565 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.19 161.24 14.85 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.37 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.3 2.0 . . . . 0.0 111.639 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 79.7 m -145.82 174.2 11.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.48 145.61 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.05 26.24 13.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.533 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.527 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 -109.21 157.03 19.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . -178.75 110.3 0.29 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.719 -176.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 60.3 t30 170.39 -108.32 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -91.93 4.36 53.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.65 -18.39 57.5 Favored Glycine 0 CA--C 1.495 -1.18 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.956 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.74 -76.46 0.09 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.58 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p -91.67 -169.6 2.34 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 243' ' ' VAL . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.504 ' HB3' ' HZ3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.472 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.488 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.444 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.502 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.405 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.437 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.25 119.48 8.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.45 55.98 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.465 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.23 153.78 50.72 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.6 2.2 . . . . 0.0 110.956 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.37 172.32 11.43 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 170.5 32.46 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.39 155.78 36.72 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.401 2.067 . . . . 0.0 111.932 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.03 170.61 12.68 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.86 2.374 . . . . 0.0 111.777 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.67 65.78 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.287 0.565 . . . . 0.0 111.718 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -157.49 163.98 37.89 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 165.23 -150.93 19.38 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.489 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.87 177.92 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.845 2.363 . . . . 0.0 112.169 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.66 134.99 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.814 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.16 173.52 16.59 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 59.67 24.06 12.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.441 0.696 . . . . 0.0 112.509 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -123.25 167.09 14.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.54 -159.05 20.83 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.58 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 55.51 -102.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.446 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.33 -28.04 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 111.44 -31.14 7.36 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.26 14.42 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t -111.44 137.25 49.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.193 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.666 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.54 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.485 ' O ' HG21 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.44 HG21 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.443 ' ND2' ' HH ' ' A' ' 260' ' ' TYR . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.412 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.991 0.9 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.42 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.527 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.511 ' HA ' ' HZ2' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 245' ' ' ASP . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.441 ' HB ' HG23 ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.464 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.419 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 280' ' ' ILE . 98.5 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HA ' HG21 ' A' ' 297' ' ' THR . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 321' ' ' VAL . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.412 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.423 HD12 ' HA2' ' A' ' 292' ' ' GLY . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 281' ' ' VAL . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG21 ' A' ' 239' ' ' ILE . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 236' ' ' ALA . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.436 ' HE ' HG13 ' A' ' 218' ' ' VAL . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.548 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.533 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.9 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.439 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.439 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 263' ' ' ASN . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.477 HG23 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.477 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.41 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.426 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.654 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 317' ' ' LYS . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.448 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 . . . . . 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 236' ' ' ALA . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.419 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 215' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 249' ' ' ALA . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 246' ' ' LYS . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.576 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.421 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' HG21 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.576 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.595 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 236' ' ' ALA . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.491 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.505 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.505 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 299' ' ' GLY . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 321' ' ' VAL . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.544 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 281' ' ' VAL . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.408 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.436 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 277' ' ' ARG . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.531 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.426 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.487 HG23 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.487 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.562 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.579 0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 281' ' ' VAL . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.406 ' OD2' ' HB ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.46 ' HB3' HD22 ' A' ' 309' ' ' ASN . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.406 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 297' ' ' THR . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 279' ' ' LYS . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.46 HD22 ' HB3' ' A' ' 263' ' ' ASN . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.458 HG23 ' HB ' ' A' ' 256' ' ' THR . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.445 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.443 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.451 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.551 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 320' ' ' ARG . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.9 t30 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.631 ' HB3' HG11 ' A' ' 325' ' ' VAL . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 243' ' ' VAL . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.454 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 24.1 p-10 -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.579 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.553 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.402 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.553 HH21 HD13 ' A' ' 306' ' ' ILE . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 236' ' ' ALA . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 232' ' ' LEU . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p30 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.508 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 277' ' ' ARG . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG21 ' A' ' 297' ' ' THR . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 277' ' ' ARG . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.441 HG21 HG11 ' A' ' 321' ' ' VAL . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.441 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 281' ' ' VAL . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 214' ' ' ALA . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG21 ' A' ' 239' ' ' ILE . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 243' ' ' VAL . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.494 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.556 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.455 HD21 ' HE ' ' A' ' 277' ' ' ARG . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.419 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.455 ' HE ' HD21 ' A' ' 273' ' ' LEU . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.415 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.503 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.628 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.628 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.609 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 236' ' ' ALA . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.479 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.494 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.552 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.559 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.417 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.422 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.1 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.456 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.437 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.44 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 211' ' ' LEU . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.587 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.439 -0.999 0 CA-C-O 120.583 0.23 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 232' ' ' LEU . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.418 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.519 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.461 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.553 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 261' ' ' THR . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.533 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 256' ' ' THR . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 239' ' ' ILE . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.493 HG21 HD23 ' A' ' 273' ' ' LEU . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.44 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.662 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.662 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 261' ' ' THR . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.462 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 297' ' ' THR . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 279' ' ' LYS . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 303' ' ' VAL . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.486 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.486 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.492 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.492 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.554 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 211' ' ' LEU . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.465 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 321' ' ' VAL . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 269' ' ' ILE . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 266' ' ' SER . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 280' ' ' ILE . 52.5 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' HG21 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.508 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 259' ' ' GLY . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.475 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 255' ' ' VAL . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.531 ' HB3' HG11 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.502 HG13 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 236' ' ' ALA . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.403 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 218' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HE ' HG13 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.497 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.551 HG22 ' HB1' ' A' ' 278' ' ' ALA . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.61 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.451 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 55.2 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.551 ' HB1' HG22 ' A' ' 257' ' ' ILE . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 321' ' ' VAL . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.427 HG21 ' HB ' ' A' ' 281' ' ' VAL . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.467 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 266' ' ' SER . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.525 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 319' ' ' ARG . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.525 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.514 -0.426 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 47.1 m-85 . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.473 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.685 ' OD2' HG22 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.685 HG22 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.563 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' A' ' 297' ' ' THR . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 279' ' ' LYS . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.44 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' A' ' 306' ' ' ILE . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.473 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.443 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.45 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 56.6 t30 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.442 ' HA ' HG21 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 236' ' ' ALA . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.439 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.402 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.435 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 281' ' ' VAL . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 236' ' ' ALA . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.476 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.453 HG22 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.675 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.545 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.58 ' HA3' HD13 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -108.79 151.07 26.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.863 0.363 . . . . 0.0 110.828 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.93 149.66 38.03 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.77 94.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.779 2.319 . . . . 0.0 111.792 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.05 142.92 52.45 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.957 2.438 . . . . 0.0 112.644 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.72 158.6 52.74 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 130.71 32.13 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.72 2.28 . . . . 0.0 112.422 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.45 166.62 28.29 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.258 . . . . 0.0 112.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -130.12 -55.32 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 42.9 m -88.8 -167.74 1.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.96 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -64.73 138.22 39.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.891 -1.147 . . . . 0.0 111.885 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 -53.61 2.78 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.232 . . . . 0.0 112.35 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.2 m -140.43 134.1 30.29 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.44 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.01 -34.08 61.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.161 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -172.63 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.42 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 -119.08 159.32 24.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 178.48 -156.59 19.47 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.349 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.45 -112.14 0.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.851 0.46 . . . . 0.0 110.046 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.06 -9.38 52.31 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.062 0.458 . . . . 0.0 111.401 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.7 -38.94 3.15 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.868 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.16 22.46 5.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.394 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p -137.86 152.44 49.06 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.028 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.527 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.511 ' HA ' ' HZ2' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 245' ' ' ASP . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.441 ' HB ' HG23 ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.464 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.419 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 280' ' ' ILE . 98.5 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HA ' HG21 ' A' ' 297' ' ' THR . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 321' ' ' VAL . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.412 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.423 HD12 ' HA2' ' A' ' 292' ' ' GLY . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 281' ' ' VAL . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.26 110.64 12.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.666 0.233 . . . . 0.0 110.667 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -70.15 124.91 91.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.911 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 29.4 Cg_exo -62.29 139.44 77.5 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.581 2.187 . . . . 0.0 111.885 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.22 140.39 88.6 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.574 2.182 . . . . 0.0 111.85 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -115.33 141.26 16.87 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.584 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.78 155.25 55.41 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.732 2.288 . . . . 0.0 111.98 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.56 170.55 6.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.826 2.351 . . . . 0.0 112.777 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -110.98 -13.65 14.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.963 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.4 m -145.21 179.69 7.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.189 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -83.49 173.36 51.36 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.827 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.43 -16.84 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.881 2.387 . . . . 0.0 112.108 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.8 m -123.97 136.27 54.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 110.991 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.73 -17.81 0.47 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.688 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -114.59 11.06 16.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG21 ' A' ' 239' ' ' ILE . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -116.83 160.31 21.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.55 -172.35 40.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.35 -98.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.29 0.636 . . . . 0.0 110.923 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.57 -47.2 76.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.918 0.389 . . . . 0.0 111.69 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.28 -36.5 4.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.791 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.31 19.23 15.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.722 0.772 . . . . 0.0 109.302 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m -143.21 156.19 44.7 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.756 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 236' ' ' ALA . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.436 ' HE ' HG13 ' A' ' 218' ' ' VAL . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.548 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.533 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.9 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.439 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.439 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 263' ' ' ASN . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.477 HG23 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.477 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.41 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.426 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.654 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 317' ' ' LYS . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -97.79 -164.12 1.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.442 0.163 . . . . 0.0 110.703 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.52 113.84 53.14 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 4.7 Cg_exo -78.89 111.24 2.93 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.419 2.079 . . . . 0.0 110.873 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 5.7 Cg_exo -73.27 129.58 14.15 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.003 1.802 . . . . 0.0 112.422 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.86 -150.99 5.57 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.6 145.92 59.57 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.857 2.371 . . . . 0.0 111.17 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.47 136.19 61.92 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.522 2.148 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.88 -42.3 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.008 0.433 . . . . 0.0 110.063 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 28.4 m -83.02 104.64 13.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.876 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 122.57 114.69 2.23 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.575 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.79 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.8 m -139.9 134.64 31.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -95.83 -85.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -134.37 87.01 2.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.448 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 -98.12 178.3 5.13 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.7 156.07 26.86 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.263 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.77 -146.12 0.25 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.897 0.479 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.87 -23.98 8.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.197 0.599 . . . . 0.0 111.985 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.01 38.07 6.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.634 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -102.87 -22.24 13.89 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t -137.31 153.61 50.25 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.763 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 236' ' ' ALA . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.419 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 215' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 249' ' ' ALA . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 246' ' ' LYS . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.576 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.421 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' HG21 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.576 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -81.36 104.75 12.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.803 0.335 . . . . 0.0 110.517 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.22 138.93 30.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.47 117.75 4.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.701 2.267 . . . . 0.0 111.927 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.02 170.3 20.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.426 2.084 . . . . 0.0 111.6 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -158.32 -163.69 13.17 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 203' ' ' PRO . 35.0 Cg_exo -61.75 128.04 23.32 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.404 2.069 . . . . 0.0 111.072 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 202' ' ' PRO . 12.0 Cg_endo -56.55 128.19 29.02 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.184 1.922 . . . . 0.0 111.222 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 251' ' ' PRO . . . -176.78 -51.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.189 0.519 . . . . 0.0 109.916 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.3 t -137.41 170.65 15.72 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.008 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 138.01 -174.23 22.0 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.65 117.25 4.05 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.786 2.324 . . . . 0.0 111.599 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -148.01 136.46 21.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.535 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.47 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.4 8.8 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.595 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.13 164.85 13.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.7 -160.84 18.94 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.255 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.1 m120 56.96 -107.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.982 0.513 . . . . 0.0 111.61 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.09 -14.54 61.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 98.27 -32.48 6.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.476 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -103.47 16.8 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.733 0.778 . . . . 0.0 109.107 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -124.61 144.3 50.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.99 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 236' ' ' ALA . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 204' ' ' ALA . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.491 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.505 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.505 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 299' ' ' GLY . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 321' ' ' VAL . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.544 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 281' ' ' VAL . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -124.1 113.6 18.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.69 128.69 53.55 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.27 142.27 94.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.575 2.183 . . . . 0.0 112.415 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.31 172.85 13.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.555 2.17 . . . . 0.0 111.569 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.51 -177.52 38.54 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.058 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.58 154.81 40.1 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.591 2.194 . . . . 0.0 111.882 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.73 146.41 72.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.667 2.245 . . . . 0.0 111.571 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 57.57 77.76 0.26 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.8 m -79.87 110.33 15.14 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.95 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.11 171.74 25.18 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.87 150.26 30.17 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.32 2.013 . . . . 0.0 111.699 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.8 m -94.5 136.05 35.24 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 110.859 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.79 -2.83 4.71 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.282 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -120.91 9.99 10.76 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.734 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.99 150.19 36.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 168.29 -152.27 20.16 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 29.9 t30 70.98 -46.83 0.65 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.158 0.479 . . . . 0.0 111.948 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.56 -52.19 0.81 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.32 1.17 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 111.83 -2.441 . . . . 0.0 110.367 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 18.33 3.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.501 0.667 . . . . 0.0 109.699 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m -151.89 171.85 17.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.242 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.408 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.436 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 277' ' ' ARG . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.531 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.34 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 139.49 46.7 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.04 62.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.123 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.73 141.53 5.49 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.717 2.278 . . . . 0.0 112.24 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.15 137.47 56.88 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.509 2.139 . . . . 0.0 111.057 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.15 179.19 22.43 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.801 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 54.0 Cg_endo -69.54 132.28 23.35 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 29.2 Cg_exo -62.95 159.7 37.04 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.329 2.019 . . . . 0.0 110.329 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -79.64 167.95 20.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.593 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.4 m -69.95 169.87 12.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -179.86 -70.72 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.9 179.99 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.549 2.166 . . . . 0.0 110.369 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.6 m -110.78 142.97 42.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.904 0.383 . . . . 0.0 111.373 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.73 -20.35 12.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.494 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.38 25.1 9.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 -119.97 171.5 8.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.89 -152.37 21.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.784 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 t30 58.73 -109.44 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.403 0.681 . . . . 0.0 110.552 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.22 -18.96 64.09 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.621 0.724 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 100.88 -40.32 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.858 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.411 ' HA ' ' NH1' ' A' ' 277' ' ' ARG . . . -97.75 18.63 15.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m -125.1 150.19 47.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.339 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.426 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.487 HG23 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.487 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.562 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -131.73 173.76 10.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.85 141.41 22.73 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.556 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.41 158.59 39.89 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.517 2.144 . . . . 0.0 111.227 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.0 148.12 40.15 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.758 2.305 . . . . 0.0 111.83 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -106.65 -174.46 23.07 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.965 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.84 149.88 43.33 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.568 2.179 . . . . 0.0 111.917 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.47 169.81 21.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.652 2.234 . . . . 0.0 111.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.07 -31.53 70.09 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 110.814 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 46.8 t -84.28 139.29 32.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.946 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -138.4 -83.64 0.11 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.59 114.76 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.482 2.122 . . . . 0.0 110.533 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 211' ' ' LEU . 75.9 m -95.11 139.2 31.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.981 0.42 . . . . 0.0 111.414 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.64 -45.22 10.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -127.16 45.73 2.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 -117.91 179.45 4.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -154.11 -170.02 19.58 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.712 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.49 ' C ' ' H ' ' A' ' 229' ' ' GLY . 16.5 m120 59.03 -163.9 0.21 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.96 19.58 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.387 0.613 . . . . 0.0 111.927 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 227' ' ' ASN . . . 79.86 31.3 40.18 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 121.225 -0.512 . . . . 0.0 114.349 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.502 ' HA ' ' NH2' ' A' ' 277' ' ' ARG . . . -97.29 -17.28 19.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m -155.2 175.36 13.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 281' ' ' VAL . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.406 ' OD2' ' HB ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.46 ' HB3' HD22 ' A' ' 309' ' ' ASN . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.406 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.502 ' NH2' ' HA ' ' A' ' 230' ' ' ALA . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 297' ' ' THR . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 279' ' ' LYS . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.46 HD22 ' HB3' ' A' ' 263' ' ' ASN . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.458 HG23 ' HB ' ' A' ' 256' ' ' THR . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.153 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.31 151.09 33.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.93 0.395 . . . . 0.0 110.598 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.71 130.19 47.91 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.976 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 41.7 Cg_endo -70.5 132.25 21.77 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.21 1.94 . . . . 0.0 111.602 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 47.8 Cg_exo -56.88 145.61 83.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.779 2.319 . . . . 0.0 111.678 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.47 -151.11 9.35 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.207 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.29 126.02 8.86 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.246 1.964 . . . . 0.0 111.416 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.41 168.13 24.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.512 2.142 . . . . 0.0 112.199 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -117.98 144.83 45.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.0 t -120.55 136.4 54.8 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.288 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.89 2.49 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.62 124.58 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.374 2.05 . . . . 0.0 111.702 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.25 136.08 41.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.774 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.68 -59.24 2.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -158.59 98.89 1.55 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.445 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 -103.6 -175.82 2.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -149.0 178.91 26.24 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.458 -1.354 . . . . 0.0 113.193 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -52.6 -27.59 17.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.835 0.854 . . . . 0.0 113.173 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' SER . 5.2 m-20 -50.84 -20.07 1.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.26 -87.32 0.53 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.512 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.2 13.86 28.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.253 0.549 . . . . 0.0 110.384 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 228' ' ' ASP . 15.4 m -105.77 122.39 45.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.443 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.451 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.551 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 320' ' ' ARG . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.9 t30 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.01 112.88 24.99 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.27 117.15 59.47 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.592 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.1 159.93 23.66 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.167 . . . . 0.0 111.45 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.57 139.23 82.46 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.595 2.196 . . . . 0.0 111.35 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.65 11.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.183 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 147.77 85.96 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.389 2.059 . . . . 0.0 111.385 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.42 159.26 54.36 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.326 2.017 . . . . 0.0 111.412 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -94.75 71.07 3.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.2 m -65.67 100.22 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.7 73.91 0.56 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.446 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.54 94.28 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.377 2.051 . . . . 0.0 110.516 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.6 m -127.03 136.49 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.143 0.497 . . . . 0.0 111.742 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.99 26.4 0.63 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.99 12.79 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.721 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.631 ' HB3' HG11 ' A' ' 325' ' ' VAL . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 243' ' ' VAL . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -123.56 163.69 20.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -160.62 -170.2 24.9 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.537 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 59.8 -95.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.406 1.082 . . . . 0.0 112.007 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -93.79 0.83 56.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 111.01 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.9 83.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.661 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.2 6.5 10.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t -110.88 130.17 55.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.454 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 24.1 p-10 -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.579 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.553 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.402 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.553 HH21 HD13 ' A' ' 306' ' ' ILE . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.17 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -138.58 143.07 39.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.81 158.17 84.14 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.25 141.1 32.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.554 2.169 . . . . 0.0 112.249 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.51 167.27 5.18 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.955 2.437 . . . . 0.0 112.186 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -116.17 139.46 15.32 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.585 -0.816 . . . . 0.0 111.874 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 149.61 43.34 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.298 1.999 . . . . 0.0 111.31 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.02 166.4 23.07 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.527 2.151 . . . . 0.0 111.963 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.52 -126.72 0.27 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 t -100.45 -155.73 0.52 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.29 -70.65 0.02 OUTLIER Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.5 156.74 40.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.326 2.017 . . . . 0.0 110.934 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -94.93 135.48 36.39 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.225 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.3 -176.79 5.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 67.5 7.56 5.68 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.542 0.737 . . . . 0.0 112.485 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 -128.46 -178.49 4.59 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.44 -134.89 1.87 Allowed Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.349 -1.405 . . . . 0.0 113.437 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.94 47.09 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.194 0.997 . . . . 0.0 109.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.62 -49.21 3.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.997 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.82 -58.39 4.52 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.214 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -98.94 10.81 40.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t -159.67 -172.07 3.54 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 236' ' ' ALA . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 232' ' ' LEU . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p30 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.508 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 277' ' ' ARG . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG21 ' A' ' 297' ' ' THR . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 277' ' ' ARG . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.441 HG21 HG11 ' A' ' 321' ' ' VAL . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.441 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 281' ' ' VAL . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.55 153.97 41.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -89.07 147.33 38.35 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.914 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.75 121.38 9.92 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.75 156.79 59.61 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.727 2.285 . . . . 0.0 112.01 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 167.01 -151.03 18.64 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 32.6 Cg_exo -62.33 126.25 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.18 1.92 . . . . 0.0 110.345 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 17.3 Cg_exo -66.77 128.46 18.96 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.12 1.88 . . . . 0.0 112.443 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.77 27.95 8.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.597 . . . . 0.0 109.79 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 6.7 m -71.97 -175.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.126 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -130.84 69.16 0.54 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.637 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.28 162.68 39.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.724 2.283 . . . . 0.0 112.208 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.1 p -95.22 -179.57 4.84 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.11 160.35 34.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.032 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 68.03 4.09 3.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.239 0.616 . . . . 0.0 112.341 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 214' ' ' ALA . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG21 ' A' ' 239' ' ' ILE . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 -109.58 142.37 40.78 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.55 -122.8 0.64 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 33.2 t30 67.16 -58.43 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.329 0.652 . . . . 0.0 111.201 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.63 -45.28 0.98 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 155.86 -47.84 0.49 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.823 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.23 -61.68 1.89 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.847 -0.676 . . . . 0.0 112.062 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m -66.91 -178.09 0.71 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 243' ' ' VAL . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.494 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.556 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.455 HD21 ' HE ' ' A' ' 277' ' ' ARG . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.419 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.455 ' HE ' HD21 ' A' ' 273' ' ' LEU . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.415 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.503 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.628 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.628 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -140.6 153.0 45.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.684 0.278 . . . . 0.0 110.425 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.69 119.86 65.59 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.099 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.19 142.33 21.47 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.377 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 149.42 49.46 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.716 2.278 . . . . 0.0 111.686 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.81 -152.75 7.62 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.26 150.86 42.7 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.352 2.035 . . . . 0.0 112.035 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.53 163.22 34.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.591 2.194 . . . . 0.0 111.455 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.08 -54.48 42.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.187 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 252' ' ' ASP . 49.5 m -71.46 115.36 10.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.001 0.429 . . . . 0.0 110.867 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -148.99 175.04 28.42 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.836 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.02 129.97 29.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.839 2.36 . . . . 0.0 111.791 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 11.0 t -147.7 134.77 20.35 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.39 -71.46 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.77 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -160.83 99.01 1.23 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.609 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.39 160.01 18.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.82 32.82 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.068 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 66.7 t30 56.89 -102.89 0.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.159 0.983 . . . . 0.0 111.591 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.11 -30.49 71.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.13 0.49 . . . . 0.0 111.176 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.71 -41.12 2.25 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.7 17.98 10.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.909 0.862 . . . . 0.0 108.986 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p -126.79 143.41 51.26 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 236' ' ' ALA . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.479 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 205' ' ' SER . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.494 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.552 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.559 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.417 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.422 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.1 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.456 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.437 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.44 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 211' ' ' LEU . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -150.35 170.77 18.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.35 137.38 19.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.057 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.95 135.31 65.84 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.452 2.102 . . . . 0.0 111.374 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.08 147.42 91.58 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.874 2.383 . . . . 0.0 112.593 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.67 -178.21 40.06 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.062 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.44 145.45 98.68 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.791 2.327 . . . . 0.0 111.936 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.12 161.13 9.27 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.727 2.285 . . . . 0.0 111.346 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -116.2 -4.24 11.94 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.952 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 p -161.66 157.47 24.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -78.01 129.64 9.59 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.243 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.86 -46.22 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.48 2.12 . . . . 0.0 113.096 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.94 136.79 38.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.35 -22.34 0.68 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.121 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.23 14.86 13.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.587 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 -96.65 176.93 5.83 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.34 -145.5 13.19 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.348 -1.406 . . . . 0.0 113.011 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 228' ' ' ASP . 4.6 t30 58.03 -101.06 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 227' ' ' ASN . 12.7 t70 -67.08 -46.29 74.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.105 0.479 . . . . 0.0 110.679 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 126.41 -39.9 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.293 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.6 15.37 14.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.353 0.596 . . . . 0.0 110.675 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p -144.56 167.28 22.89 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 232' ' ' LEU . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.418 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.519 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.461 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.553 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 261' ' ' THR . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.533 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 256' ' ' THR . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.262 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -79.33 138.67 37.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.831 0.316 . . . . 0.0 110.271 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.07 136.86 46.65 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 12.3 Cg_endo -56.28 111.46 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.787 2.325 . . . . 0.0 111.772 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 23.5 Cg_exo -64.65 145.04 86.19 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.013 2.476 . . . . 0.0 112.464 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.41 172.16 50.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.408 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.23 162.06 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.087 2.525 . . . . 0.0 112.105 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.52 171.5 9.35 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.964 2.443 . . . . 0.0 111.925 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -128.79 92.12 3.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.5 m -152.57 102.0 2.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.997 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.486 ' H ' ' HD3' ' A' ' 207' ' ' PRO . . . 144.44 62.85 0.02 OUTLIER Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.655 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.486 ' HD3' ' H ' ' A' ' 206' ' ' GLY . 94.5 Cg_endo -82.06 -29.09 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.197 1.931 . . . . 0.0 111.75 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.7 t -147.83 135.24 20.66 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -169.06 149.07 4.18 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.999 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.84 30.13 19.7 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 239' ' ' ILE . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 -91.76 169.52 10.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.39 -131.17 1.34 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.302 -1.427 . . . . 0.0 114.285 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -46.19 -67.01 0.32 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.117 0.967 . . . . 0.0 112.738 -175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 231' ' ' SER . 3.6 m-20 -47.58 -18.2 0.13 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.21 -68.18 1.14 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.364 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 19.64 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.948 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 228' ' ' ASP . 60.4 m -148.65 160.47 43.11 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.493 HG21 HD23 ' A' ' 273' ' ' LEU . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.44 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.662 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.662 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 261' ' ' THR . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.462 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 297' ' ' THR . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 279' ' ' LYS . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 303' ' ' VAL . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.486 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.486 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.492 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.492 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.554 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 211' ' ' LEU . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -125.61 -162.53 1.12 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.13 142.23 35.84 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.62 141.52 80.05 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.271 1.981 . . . . 0.0 111.124 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.75 131.3 16.18 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.833 2.356 . . . . 0.0 112.081 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.75 -151.26 19.19 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 93.2 Cg_endo -82.94 137.65 8.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.68 2.253 . . . . 0.0 111.889 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 32.3 Cg_exo -59.9 146.99 94.42 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.858 2.372 . . . . 0.0 111.911 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.18 154.14 20.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.761 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.1 m -69.4 145.74 52.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.428 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.72 162.07 28.03 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.13 -29.53 81.09 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.648 2.232 . . . . 0.0 112.639 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.0 t -97.42 142.93 28.68 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.768 0.318 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 -178.65 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 61.52 7.68 1.92 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.465 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 -115.0 162.13 17.4 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 157.43 102.26 0.19 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.559 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.41 ' HB3' ' OG ' ' A' ' 231' ' ' SER . 5.7 t-20 -162.57 -138.54 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.28 -50.45 62.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 109.676 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.25 -107.96 0.24 Allowed Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.117 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.72 54.12 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 227' ' ' ASN . 5.2 p -54.37 167.86 0.29 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 321' ' ' VAL . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 269' ' ' ILE . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 266' ' ' SER . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 280' ' ' ILE . 52.5 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' HG21 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.508 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 259' ' ' GLY . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.475 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 255' ' ' VAL . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -83.4 147.49 27.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.775 0.322 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -81.43 126.76 75.55 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.321 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 37.0 Cg_exo -61.7 123.02 11.88 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.63 2.22 . . . . 0.0 111.535 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 34.2 Cg_exo -60.94 139.72 86.42 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.687 2.258 . . . . 0.0 111.516 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.13 -150.28 9.18 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 126.32 21.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.423 2.082 . . . . 0.0 111.189 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.5 139.07 74.29 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.359 2.04 . . . . 0.0 112.041 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.39 -27.65 56.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.15 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.2 p -58.58 124.23 18.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.947 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -81.17 178.96 53.79 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.732 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.13 150.68 72.0 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.004 2.469 . . . . 0.0 112.155 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 0.1 OUTLIER -98.03 161.26 13.81 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.28 140.8 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 53.94 19.86 2.16 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.531 ' HB3' HG11 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.502 HG13 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -115.61 153.16 31.76 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -179.18 -169.59 39.91 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t30 71.82 -38.23 0.41 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.441 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.3 -50.75 0.75 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 123.023 1.392 . . . . 0.0 108.038 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 128.27 -42.04 1.5 Allowed Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 112.131 -2.304 . . . . 0.0 109.211 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.5 21.22 10.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m -125.91 143.55 51.03 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 236' ' ' ALA . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.403 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 218' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HE ' HG13 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.497 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.551 HG22 ' HB1' ' A' ' 278' ' ' ALA . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.61 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.451 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 55.2 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.551 ' HB1' HG22 ' A' ' 257' ' ' ILE . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 321' ' ' VAL . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -114.77 175.9 5.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 142.7 92.25 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.619 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.18 136.35 51.33 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.742 2.295 . . . . 0.0 112.102 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.9 154.78 43.27 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.542 2.161 . . . . 0.0 111.518 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.16 -150.36 16.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.717 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.52 164.37 29.01 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.772 2.315 . . . . 0.0 111.396 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.74 156.87 8.42 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.764 2.31 . . . . 0.0 111.951 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.437 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -112.82 -104.47 0.4 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.305 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.0 m -56.79 98.46 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.991 0.424 . . . . 0.0 111.06 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -110.77 -85.18 1.57 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.182 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 -7.47 19.91 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.741 2.294 . . . . 0.0 111.7 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.2 t -147.69 139.16 23.77 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.62 -177.94 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.366 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.22 12.41 7.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.636 0.775 . . . . 0.0 112.232 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 -122.56 169.77 10.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 173.01 -119.8 0.78 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 55.51 -132.82 1.67 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.556 0.342 . . . . 0.0 110.102 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -78.24 -32.76 49.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.16 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.27 -60.66 0.27 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.938 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.77 33.6 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m -139.57 154.55 47.64 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.427 HG21 ' HB ' ' A' ' 281' ' ' VAL . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.467 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 266' ' ' SER . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.525 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 319' ' ' ARG . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.525 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.437 ' C ' ' HB1' ' A' ' 204' ' ' ALA . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.241 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 110.601 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.78 149.93 97.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.514 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.92 143.2 99.64 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.68 164.28 29.76 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.551 2.168 . . . . 0.0 111.486 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.17 167.66 36.23 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.209 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 126.67 23.06 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.553 2.168 . . . . 0.0 111.575 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.86 129.28 17.52 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.147 2.565 . . . . 0.0 112.113 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 66.27 111.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.038 0.836 . . . . 0.0 111.341 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.7 m -67.87 119.68 12.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.996 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 207' ' ' PRO . . . -92.57 133.1 11.57 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.349 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 206' ' ' GLY . 13.6 Cg_exo -70.14 159.0 54.68 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 86.2 m -128.05 154.73 45.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.175 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.96 6.21 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.39 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -115.74 21.98 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 47.1 m-85 -125.58 163.85 21.84 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . 174.39 101.69 0.15 Allowed Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.76 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 4.1 t-20 172.04 -106.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.403 0.681 . . . . 0.0 109.644 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -98.05 -4.18 36.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.742 0.305 . . . . 0.0 111.288 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 106.35 -19.74 36.42 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.906 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.08 -0.09 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.311 0.577 . . . . 0.0 110.282 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m -116.3 136.5 52.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.688 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.473 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.685 ' OD2' HG22 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.685 HG22 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.563 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' A' ' 297' ' ' THR . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 279' ' ' LYS . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.44 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' A' ' 306' ' ' ILE . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.473 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.443 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.45 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 56.6 t30 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -88.48 160.78 17.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.622 0.248 . . . . 0.0 110.523 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.71 153.72 39.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.73 157.94 58.71 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.46 165.04 18.71 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.636 2.224 . . . . 0.0 111.356 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.01 177.61 21.82 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.084 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 36.8 Cg_endo -65.97 131.93 28.66 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.715 2.277 . . . . 0.0 111.666 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 50.6 Cg_exo -54.62 128.44 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.664 2.242 . . . . 0.0 111.841 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.52 140.46 29.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.4 m -116.95 160.61 20.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.565 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.19 161.24 14.85 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.37 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.3 2.0 . . . . 0.0 111.639 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 79.7 m -145.82 174.2 11.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.48 145.61 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.05 26.24 13.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.442 ' HA ' HG21 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 -109.21 157.03 19.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . -178.75 110.3 0.29 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.719 -176.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 60.3 t30 170.39 -108.32 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -91.93 4.36 53.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.65 -18.39 57.5 Favored Glycine 0 CA--C 1.495 -1.18 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.956 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.74 -76.46 0.09 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.58 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p -91.67 -169.6 2.34 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 236' ' ' ALA . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.439 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.402 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.435 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 281' ' ' VAL . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -146.25 119.48 8.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.45 55.98 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.465 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.23 153.78 50.72 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.6 2.2 . . . . 0.0 110.956 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.37 172.32 11.43 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 170.5 32.46 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.39 155.78 36.72 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.401 2.067 . . . . 0.0 111.932 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.03 170.61 12.68 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.86 2.374 . . . . 0.0 111.777 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.67 65.78 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.287 0.565 . . . . 0.0 111.718 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -157.49 163.98 37.89 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 165.23 -150.93 19.38 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.489 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.87 177.92 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.845 2.363 . . . . 0.0 112.169 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.66 134.99 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.814 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.16 173.52 16.59 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 59.67 24.06 12.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.441 0.696 . . . . 0.0 112.509 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -123.25 167.09 14.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.54 -159.05 20.83 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.58 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 55.51 -102.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.446 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.33 -28.04 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 111.44 -31.14 7.36 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.26 14.42 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t -111.44 137.25 49.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.193 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 236' ' ' ALA . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.476 ' N ' ' HD3' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.453 HG22 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.675 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.545 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.58 ' HA3' HD13 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.991 0.9 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.42 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.527 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.511 ' HA ' ' HZ2' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 245' ' ' ASP . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.441 ' HB ' HG23 ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.464 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.419 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 280' ' ' ILE . 23.1 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HA ' HG21 ' A' ' 297' ' ' THR . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 321' ' ' VAL . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.412 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.423 HD12 ' HA2' ' A' ' 292' ' ' GLY . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 281' ' ' VAL . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.454 ' C ' HD22 ' A' ' 326' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG21 ' A' ' 239' ' ' ILE . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 236' ' ' ALA . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.436 ' HE ' HG13 ' A' ' 218' ' ' VAL . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.548 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.533 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.6 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.439 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.439 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 263' ' ' ASN . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.477 HG23 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.477 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.41 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.426 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.654 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 317' ' ' LYS . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.448 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 . . . . . 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 236' ' ' ALA . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.419 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 215' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 249' ' ' ALA . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 246' ' ' LYS . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.576 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.421 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' HG21 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.576 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.595 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 236' ' ' ALA . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.498 HD21 ' ND2' ' A' ' 309' ' ' ASN . 4.3 p-10 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.505 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.505 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 299' ' ' GLY . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 321' ' ' VAL . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.498 ' ND2' HD21 ' A' ' 263' ' ' ASN . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.544 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 281' ' ' VAL . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.408 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.485 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 83.1 m-20 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.436 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 277' ' ' ARG . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.531 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.426 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.487 HG23 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.487 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.562 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 120.579 0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 281' ' ' VAL . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.406 ' OD2' ' HB ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.46 ' HB3' HD22 ' A' ' 309' ' ' ASN . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.406 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 297' ' ' THR . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 279' ' ' LYS . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.46 HD22 ' HB3' ' A' ' 263' ' ' ASN . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.458 HG23 ' HB ' ' A' ' 256' ' ' THR . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.445 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.443 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.451 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.551 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 320' ' ' ARG . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.631 ' HB3' HG11 ' A' ' 325' ' ' VAL . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 243' ' ' VAL . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.454 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 0.1 OUTLIER -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.579 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.452 ' HE ' ' HA ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.553 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.402 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.553 HH21 HD13 ' A' ' 306' ' ' ILE . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 236' ' ' ALA . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 232' ' ' LEU . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 5.0 p-10 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.508 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 277' ' ' ARG . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG21 ' A' ' 297' ' ' THR . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 277' ' ' ARG . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.441 HG21 HG11 ' A' ' 321' ' ' VAL . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.441 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 281' ' ' VAL . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 214' ' ' ALA . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG21 ' A' ' 239' ' ' ILE . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.494 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.556 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.455 HD21 ' HE ' ' A' ' 277' ' ' ARG . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.419 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.455 ' HE ' HD21 ' A' ' 273' ' ' LEU . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.415 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.503 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.628 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.628 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.609 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 236' ' ' ALA . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.479 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.494 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.559 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.434 HD22 ' HB2' ' A' ' 302' ' ' SER . 14.2 t-20 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.417 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.422 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.456 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.434 ' HB2' HD22 ' A' ' 263' ' ' ASN . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.437 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.44 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 211' ' ' LEU . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.587 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.439 -0.999 0 CA-C-O 120.583 0.23 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 232' ' ' LEU . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.418 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.519 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.461 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.553 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 261' ' ' THR . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.533 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 256' ' ' THR . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 HE21 HG23 ' A' ' 325' ' ' VAL . 7.1 tp-100 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 239' ' ' ILE . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.493 HG21 HD23 ' A' ' 273' ' ' LEU . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.44 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.662 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.662 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 261' ' ' THR . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.462 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.479 HH21 HD21 ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 297' ' ' THR . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 279' ' ' LYS . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 303' ' ' VAL . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.486 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.486 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.492 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.492 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.554 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.555 HG23 HE21 ' A' ' 212' ' ' GLN . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.465 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 321' ' ' VAL . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 269' ' ' ILE . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 266' ' ' SER . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.7 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' HG21 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.508 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 259' ' ' GLY . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.475 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 255' ' ' VAL . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.531 ' HB3' HG11 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.502 HG13 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 236' ' ' ALA . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.403 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 218' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HE ' HG13 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.551 HG22 ' HB1' ' A' ' 278' ' ' ALA . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.61 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.451 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 47.8 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.551 ' HB1' HG22 ' A' ' 257' ' ' ILE . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 321' ' ' VAL . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.427 HG21 ' HB ' ' A' ' 281' ' ' VAL . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.467 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 266' ' ' SER . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.525 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 319' ' ' ARG . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.525 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.514 -0.426 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 47.1 m-85 . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.473 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.685 ' OD2' HG22 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.685 HG22 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.563 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' A' ' 297' ' ' THR . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 279' ' ' LYS . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.44 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' A' ' 306' ' ' ILE . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.473 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.443 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.45 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.442 ' HA ' HG21 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 236' ' ' ALA . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.439 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.402 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.435 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 281' ' ' VAL . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 236' ' ' ALA . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.453 HG22 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.675 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.545 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.58 ' HA3' HD13 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -108.79 151.07 26.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.863 0.363 . . . . 0.0 110.828 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.93 149.66 38.03 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.77 94.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.779 2.319 . . . . 0.0 111.792 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.05 142.92 52.45 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.957 2.438 . . . . 0.0 112.644 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.72 158.6 52.74 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 130.71 32.13 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.72 2.28 . . . . 0.0 112.422 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.45 166.62 28.29 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.258 . . . . 0.0 112.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -130.12 -55.32 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 42.9 m -88.8 -167.74 1.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.96 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -64.73 138.22 39.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.891 -1.147 . . . . 0.0 111.885 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 -53.61 2.78 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.232 . . . . 0.0 112.35 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.2 m -140.43 134.1 30.29 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.44 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.01 -34.08 61.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.161 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -172.63 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 215' ' ' ILE . 37.9 tp -54.2 -22.0 10.35 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.552 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -54.86 -40.44 69.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.496 0.188 . . . . 0.0 110.754 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 55.2 m -62.63 -25.33 68.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.802 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.53 -36.14 19.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 211' ' ' LEU . 44.8 mm -69.89 -51.24 42.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.87 -31.88 73.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.005 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.85 81.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.956 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.8 t -75.26 -47.33 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.42 ' HA ' ' CG2' ' A' ' 239' ' ' ILE . 32.5 p -66.11 -40.91 91.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.569 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.9 4.04 53.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.02 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.48 -159.28 31.52 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.45 170.57 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.598 2.199 . . . . 0.0 111.36 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 45.9 mm -91.5 116.01 31.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.32 150.56 23.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 12.5 m-85 -119.08 159.32 24.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 178.48 -156.59 19.47 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.349 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.45 -112.14 0.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.851 0.46 . . . . 0.0 110.046 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.06 -9.38 52.31 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.062 0.458 . . . . 0.0 111.401 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.7 -38.94 3.15 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.868 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.16 22.46 5.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.394 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.9 p -137.86 152.44 49.06 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.028 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -88.27 168.05 13.05 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.6 pt -69.09 143.85 94.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.433 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.12 -35.93 43.87 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.283 2.656 . . . . 0.0 113.016 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.29 -23.93 61.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.554 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.2 70.2 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.112 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.527 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 96.8 m-85 -58.31 -40.97 83.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.506 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.14 -47.48 85.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.973 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 243' ' ' VAL . 65.6 mt -67.28 -37.76 79.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.425 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.31 -40.06 93.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.743 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -59.09 -35.68 73.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.166 0.508 . . . . 0.0 110.357 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -71.19 -31.22 67.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.483 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 239' ' ' ILE . 98.9 t -71.68 -43.2 70.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.032 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.9 71.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.282 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.511 ' HA ' ' HZ2' ' A' ' 248' ' ' LYS . 32.7 t70 -58.77 -45.61 89.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.701 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -68.42 -34.41 75.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.628 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 55.4 mt -64.41 -41.12 96.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.908 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 245' ' ' ASP . 10.3 mtmp? -65.83 -34.93 79.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 110.595 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.87 -14.66 61.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.355 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 2.1 t -139.1 73.65 37.84 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.69 -8.58 23.41 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.126 2.551 . . . . 0.0 113.177 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.04 -0.99 57.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.003 0.43 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.65 143.76 30.44 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.264 0.554 . . . . 0.0 112.043 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -109.45 144.05 38.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.9 142.4 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.284 0.564 . . . . 0.0 112.126 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.441 ' HB ' HG23 ' A' ' 324' ' ' VAL . 99.7 m -109.06 120.46 42.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -105.97 104.39 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.1 OUTLIER -104.65 126.48 51.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.449 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.45 144.39 17.2 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.281 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -131.09 151.69 51.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.037 0.446 . . . . 0.0 109.988 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -145.63 169.56 18.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.75 162.13 21.83 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.641 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.69 22.93 1.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.928 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.9 m -72.58 -49.72 30.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.81 -178.42 52.39 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.484 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.464 ' HB2' HG13 ' A' ' 269' ' ' ILE . 54.5 m -71.07 135.32 47.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.503 0.192 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.72 -37.45 76.17 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.84 -15.19 64.26 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.77 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 266' ' ' SER . 5.4 mt -101.83 -33.19 3.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.738 0.78 . . . . 0.0 110.084 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.419 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -62.97 -44.85 94.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.705 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 79.7 mt -57.57 -57.29 26.35 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.8 Cg_endo -57.0 -34.02 96.8 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.542 1.495 . . . . 0.0 111.519 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.35 -54.31 26.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.977 0.417 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.3 p -51.44 -43.14 61.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.53 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.9 89.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.956 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 280' ' ' ILE . 23.1 mt-30 -67.68 -48.34 66.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.549 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -57.2 -40.83 78.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.54 97.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.398 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HA ' HG21 ' A' ' 297' ' ' THR . 40.2 ttmt -61.63 -36.84 81.9 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.505 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 276' ' ' GLN . 70.0 mt -57.16 -43.37 81.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 321' ' ' VAL . 78.0 t -66.44 -45.3 89.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.54 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.85 -42.78 90.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.712 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.57 -46.01 90.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.412 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 48.7 t80 -62.31 -37.83 87.07 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.463 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.95 -38.75 92.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.318 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 282' ' ' ALA . 84.8 t -60.92 -34.23 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.375 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.53 -13.45 62.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.386 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 1.4 mpt_? -97.57 1.36 48.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.918 0.389 . . . . 0.0 111.008 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.44 -2.75 39.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.812 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 37.3 t -74.48 136.23 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.769 0.319 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.99 108.68 4.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -64.21 -16.79 60.64 Favored Glycine 0 C--N 1.322 -0.226 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.131 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -77.95 -16.78 57.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.954 0.407 . . . . 0.0 111.13 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -102.85 10.14 38.54 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.624 0.726 . . . . 0.0 109.111 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.423 HD12 ' HA2' ' A' ' 292' ' ' GLY . 60.9 mt -111.68 121.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.987 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -104.39 140.71 37.52 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.5 p -118.16 126.79 52.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.93 134.22 67.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -112.94 117.41 4.27 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 3.2 mp -106.79 -4.22 19.58 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.166 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.52 -123.9 30.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.423 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.1 p -114.64 91.89 3.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.3 m -109.04 -40.69 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.1 p-10 -145.44 100.13 4.45 Favored Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 121.49 0.662 . . . . 0.0 111.629 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.68 156.06 49.19 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.751 2.301 . . . . 0.0 110.834 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.62 -17.78 3.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -133.16 167.57 20.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.931 0.396 . . . . 0.0 111.475 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.0 m -65.59 121.57 15.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.48 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -77.54 -9.23 58.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.95 -20.22 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.17 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.7 p -119.89 140.52 29.81 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.713 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.11 -22.84 74.91 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.392 2.061 . . . . 0.0 110.756 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -70.37 -51.46 29.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.577 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.24 93.81 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.57 -34.9 59.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.619 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.96 -19.58 64.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.746 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -87.34 -34.56 18.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.136 0.493 . . . . 0.0 109.776 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.44 -23.93 67.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.791 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 15.3 ptp180 -102.72 98.6 8.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.49 170.5 17.28 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.51 -174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 281' ' ' VAL . 25.7 t -126.25 139.61 51.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 24.8 tt0 -127.06 145.61 50.66 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.287 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.9 mt -117.1 111.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.223 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 256' ' ' THR . 35.9 m -115.66 146.17 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.108 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.26 126.07 40.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.863 0.363 . . . . 0.0 110.14 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.454 ' C ' HD22 ' A' ' 326' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.982 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.26 110.64 12.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.666 0.233 . . . . 0.0 110.667 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -70.15 124.91 91.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.911 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 29.4 Cg_exo -62.29 139.44 77.5 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.581 2.187 . . . . 0.0 111.885 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.22 140.39 88.6 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.574 2.182 . . . . 0.0 111.85 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -115.33 141.26 16.87 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.584 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.78 155.25 55.41 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.732 2.288 . . . . 0.0 111.98 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.56 170.55 6.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.826 2.351 . . . . 0.0 112.777 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -110.98 -13.65 14.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.963 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.4 m -145.21 179.69 7.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.189 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -83.49 173.36 51.36 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.827 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.43 -16.84 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.881 2.387 . . . . 0.0 112.108 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.8 m -123.97 136.27 54.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 110.991 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.73 -17.81 0.47 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.688 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -114.59 11.06 16.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.034 0.445 . . . . 0.0 110.02 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 215' ' ' ILE . 28.1 tp -58.12 -28.32 64.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.192 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.87 -41.7 96.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 0.0 110.371 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -63.02 -19.91 64.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.345 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.45 -37.78 12.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -68.99 -52.2 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.041 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -63.5 -24.84 67.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.01 -32.68 59.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.893 0.378 . . . . 0.0 110.744 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 214' ' ' ALA . 65.9 t -71.01 -41.99 76.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.156 0.503 . . . . 0.0 109.759 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.426 ' HA ' HG21 ' A' ' 239' ' ' ILE . 45.8 p -73.75 -36.26 65.1 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.853 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.58 4.44 61.21 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.68 16.53 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -89.99 171.05 4.05 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.456 2.104 . . . . 0.0 110.667 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.1 mm -76.08 114.93 16.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.78 143.07 31.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.17 0.51 . . . . 0.0 111.273 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -116.83 160.31 21.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.64 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.55 -172.35 40.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.35 -98.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.29 0.636 . . . . 0.0 110.923 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.57 -47.2 76.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.918 0.389 . . . . 0.0 111.69 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.28 -36.5 4.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.791 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.31 19.23 15.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.722 0.772 . . . . 0.0 109.302 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 m -143.21 156.19 44.7 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.756 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -96.33 168.55 10.5 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.639 0.257 . . . . 0.0 110.677 -177.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 236' ' ' ALA . 33.2 pt -79.46 149.77 72.47 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.68 -27.07 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.32 2.68 . . . . 0.0 113.05 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.6 -26.68 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 239' ' ' ILE . . . -72.72 -39.06 67.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -57.68 -41.84 82.38 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.08 -43.89 87.25 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.25 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 236' ' ' ALA . 77.8 mt -57.92 -51.25 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.996 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 76.4 mt -53.95 -44.6 70.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -55.17 -40.48 70.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.811 0.339 . . . . 0.0 110.987 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.436 ' HE ' HG13 ' A' ' 218' ' ' VAL . 38.8 mtm-85 -75.94 -35.22 59.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.248 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 239' ' ' ILE . 81.5 t -63.35 -43.81 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.154 0.502 . . . . 0.0 109.968 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.21 73.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.551 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.27 -39.38 86.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.556 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.42 -38.01 77.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.127 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 56.6 mt -64.55 -39.8 94.42 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.512 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -59.89 -36.65 77.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.202 0.525 . . . . 0.0 110.318 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.35 69.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.399 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 39.9 t -136.9 83.7 27.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.5 -7.32 19.41 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.673 2.248 . . . . 0.0 112.447 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.4 -4.91 59.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.31 0.576 . . . . 0.0 110.131 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -95.85 149.23 21.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.813 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -114.96 146.28 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.73 133.06 70.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.154 0.502 . . . . 0.0 112.031 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 30.1 m -97.39 117.94 32.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.31 101.98 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.8 p-10 -106.46 124.09 49.07 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.469 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -91.92 155.31 23.02 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.958 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.18 172.0 13.64 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -173.03 178.07 2.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -94.51 142.23 27.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.548 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 55.5 t30 -79.38 17.1 0.88 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.928 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 5.7 m -65.6 -45.11 84.45 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.72 -91.35 0.04 OUTLIER Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.205 -0.521 . . . . 0.0 114.146 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.8 m -154.99 131.27 10.36 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.23 -49.49 52.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.77 -5.71 57.68 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.0 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.5 mm -108.55 -37.56 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.187 0.518 . . . . 0.0 110.483 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 82.6 m-20 -64.06 -45.92 86.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.528 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.533 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 68.2 mt -61.78 -52.4 68.99 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 36.3 Cg_exo -60.14 -32.19 94.26 Favored 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 121.353 1.369 . . . . 0.0 111.201 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.44 -55.13 14.88 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.525 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.7 p -48.29 -39.25 21.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.391 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.11 83.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.158 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.6 mt-30 -61.08 -50.33 73.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.903 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.95 93.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.458 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.39 -41.04 96.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.26 -45.05 93.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.538 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 70.7 t -64.39 -44.05 97.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.445 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.36 -50.26 73.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.12 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.92 -35.6 80.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.679 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.61 -37.0 81.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 110.716 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 91.9 mt -65.07 -37.47 87.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 109.956 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.7 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.398 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.42 -28.91 70.01 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.588 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.08 -3.49 52.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.144 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.67 -1.77 39.23 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.897 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 48.2 t -69.94 135.27 28.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.439 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -76.15 131.82 39.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.256 0.55 . . . . 0.0 112.026 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.74 -13.72 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.79 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -78.77 -19.23 52.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.534 . . . . 0.0 110.695 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.439 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 23.4 m170 -100.57 1.6 41.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.408 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.6 mt -114.9 122.07 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.165 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -112.71 139.58 48.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.632 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 41.6 p -119.35 127.93 53.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.697 0.284 . . . . 0.0 110.919 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 61.0 t -129.88 139.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.863 0.363 . . . . 0.0 111.038 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.52 122.94 6.42 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 -13.22 14.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.293 0.546 . . . . 0.0 112.161 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.22 -114.53 6.9 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 263' ' ' ASN . 14.8 m -132.53 107.08 8.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.477 HG23 ' OD1' ' A' ' 304' ' ' ASN . 10.0 m -115.98 -33.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 111.602 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.477 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.2 p-10 -154.21 97.47 2.61 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.877 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.41 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 29.1 Cg_endo -66.86 154.46 74.49 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.468 2.112 . . . . 0.0 112.322 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.08 -17.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.035 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.426 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -136.79 162.45 33.18 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.991 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.654 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 6.1 m -59.92 123.47 17.16 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.824 0.703 . . . . 0.0 111.807 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -79.92 -7.71 58.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.367 0.603 . . . . 0.0 110.918 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.27 -23.07 60.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.145 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.7 p -111.34 148.14 38.14 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.182 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.63 -33.09 96.12 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 110.682 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.92 -49.75 76.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.21 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -67.41 -40.91 91.45 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.121 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.48 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.448 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 317' ' ' LYS . 20.6 tptt -74.31 -29.43 61.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.37 0.605 . . . . 0.0 109.697 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 49.2 m-80 -76.09 -15.96 60.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.753 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -87.69 89.31 7.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -153.03 173.41 15.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.939 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 51.6 t -133.73 140.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.91 141.19 50.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.721 0.296 . . . . 0.0 110.374 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.08 109.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 256' ' ' THR . 28.9 m -115.62 146.44 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.125 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.11 128.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.882 0.372 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.536 -179.082 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -97.79 -164.12 1.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.442 0.163 . . . . 0.0 110.703 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.52 113.84 53.14 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 4.7 Cg_exo -78.89 111.24 2.93 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.419 2.079 . . . . 0.0 110.873 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 5.7 Cg_exo -73.27 129.58 14.15 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.003 1.802 . . . . 0.0 112.422 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.86 -150.99 5.57 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.6 145.92 59.57 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.857 2.371 . . . . 0.0 111.17 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.47 136.19 61.92 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.522 2.148 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.88 -42.3 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.008 0.433 . . . . 0.0 110.063 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 28.4 m -83.02 104.64 13.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.876 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 122.57 114.69 2.23 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.575 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.79 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.8 m -139.9 134.64 31.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -95.83 -85.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -134.37 87.01 2.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.189 0.519 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.9 OUTLIER -61.46 -42.68 99.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.87 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.448 ' HG3' ' ND2' ' A' ' 216' ' ' ASN . 26.5 tp60 -59.83 -42.55 93.81 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.927 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -67.33 -28.62 68.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.009 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.1 65.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 211' ' ' LEU . 35.3 mm -74.47 -49.92 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 212' ' ' GLN . 93.8 m-20 -54.4 -46.86 73.21 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.957 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.55 77.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.951 0.405 . . . . 0.0 111.457 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -47.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.496 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.1 p -73.68 -43.59 58.91 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.16 71.64 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.659 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.28 -150.79 20.79 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.762 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.28 169.65 7.17 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.794 2.329 . . . . 0.0 111.066 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.7 mm -81.16 114.71 22.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.89 121.03 31.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.34 0.59 . . . . 0.0 112.577 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 33.3 m-85 -98.12 178.3 5.13 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.7 156.07 26.86 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.263 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.77 -146.12 0.25 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.897 0.479 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.87 -23.98 8.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.197 0.599 . . . . 0.0 111.985 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.01 38.07 6.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.634 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -102.87 -22.24 13.89 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.5 t -137.31 153.61 50.25 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.763 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.5 mp -85.1 170.68 12.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 236' ' ' ALA . 35.0 pt -73.72 145.74 84.77 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -50.04 -37.36 47.32 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.143 2.562 . . . . 0.0 113.522 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -71.17 -27.56 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.419 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.46 -45.23 95.13 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -55.5 -42.28 74.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.21 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.51 98.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.76 -49.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.196 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 281' ' ' VAL . 3.7 mm? -51.01 -49.29 60.74 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.239 0.616 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -49.41 -44.56 45.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.274 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 71.3 mtt180 -71.69 -36.87 70.71 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 110.626 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 215' ' ' ILE . 76.4 t -58.91 -48.94 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.017 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.22 -29.61 70.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 34.7 t70 -63.06 -42.29 99.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.302 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 249' ' ' ALA . 33.3 mmtp -68.07 -36.09 79.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.032 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.8 -34.13 77.21 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 93.6 mttt -61.63 -30.95 71.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.217 0.532 . . . . 0.0 110.551 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 246' ' ' LYS . . . -67.52 -28.15 67.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.644 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.6 t -147.92 83.47 7.36 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.13 -3.97 14.6 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.575 2.184 . . . . 0.0 111.597 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.83 -4.47 58.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.48 142.07 31.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.841 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -102.43 134.47 45.69 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.08 134.34 61.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.3 0.571 . . . . 0.0 111.886 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 87.3 m -103.82 112.93 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.187 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.88 100.26 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.15 123.67 49.08 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.67 150.33 19.7 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.089 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.53 149.39 52.53 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.013 0.435 . . . . 0.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -141.06 174.98 10.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.576 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 19.5 t70 -93.18 144.25 25.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.62 26.5 0.39 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.308 0.575 . . . . 0.0 110.548 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.0 t -62.38 -42.25 99.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.207 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -100.11 -152.53 26.64 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.797 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.421 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 46.3 m -69.32 128.28 36.03 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.31 -37.55 83.64 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.99 -8.2 57.74 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.841 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 47.9 mm -102.71 -32.79 3.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.589 0.709 . . . . 0.0 109.208 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.08 -44.67 88.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.62 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.31 -55.97 33.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 16.7 Cg_endo -60.95 -32.74 92.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.385 1.39 . . . . 0.0 111.246 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -38.22 90.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.553 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -38.24 76.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.58 98.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.696 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 77.6 mt-30 -51.93 -57.15 10.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.362 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 277' ' ' ARG . 2.6 mpt_? -62.01 -38.83 90.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.994 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.17 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.402 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' HG21 ' A' ' 297' ' ' THR . 62.8 tttm -60.44 -32.45 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.647 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.86 -39.7 78.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.113 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 240' ' ' LEU . 72.2 t -69.3 -46.41 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.773 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -49.03 75.85 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.5 -39.49 83.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.49 -39.88 88.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.449 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.1 -40.88 95.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 0.0 110.566 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 282' ' ' ALA . 92.0 t -60.92 -33.01 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.55 65.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.444 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -82.77 -2.92 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.514 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.97 2.36 51.97 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.282 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.01 131.51 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.983 0.391 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.26 114.41 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.086 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.32 -20.17 60.59 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.315 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.62 -23.66 66.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.471 . . . . 0.0 111.034 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -105.92 9.58 32.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.143 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.51 117.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.319 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -113.76 141.42 47.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.212 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -120.36 126.29 50.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.63 133.52 68.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.02 108.48 2.73 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.0 -3.4 32.24 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.65 -121.22 19.32 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.981 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 10.1 m -119.56 95.57 4.84 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 120.949 0.404 . . . . 0.0 109.991 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 13.0 m -116.99 -39.86 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.477 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -142.42 91.6 7.62 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.519 0.676 . . . . 0.0 110.857 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.37 165.19 27.91 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.062 2.508 . . . . 0.0 111.716 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 36.9 pt -115.88 -6.52 11.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 120.991 0.424 . . . . 0.0 110.497 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -143.93 167.15 23.02 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.271 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 13.7 m -70.72 133.73 46.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -83.45 -8.24 59.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.528 0.68 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.45 -15.27 55.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.675 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 22.5 p -108.27 130.91 22.17 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.47 -44.75 35.04 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.815 2.343 . . . . 0.0 111.898 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -65.89 -34.09 77.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.716 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.61 -39.02 35.92 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.576 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.42 -38.48 71.64 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 123.131 0.572 . . . . 0.0 110.318 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.4 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.463 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 40.3 mttt -76.36 -26.78 56.05 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -72.77 -11.39 60.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.772 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.04 89.75 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -154.45 175.24 13.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.171 0.51 . . . . 0.0 111.191 -174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 53.2 t -134.28 141.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -124.93 126.1 44.96 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.68 0.276 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -95.43 115.76 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.446 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 76.0 t -113.65 128.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.777 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.43 136.24 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.314 -0.966 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.947 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -81.36 104.75 12.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.803 0.335 . . . . 0.0 110.517 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.22 138.93 30.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.47 117.75 4.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.701 2.267 . . . . 0.0 111.927 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.02 170.3 20.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.426 2.084 . . . . 0.0 111.6 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -158.32 -163.69 13.17 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 203' ' ' PRO . 35.0 Cg_exo -61.75 128.04 23.32 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.404 2.069 . . . . 0.0 111.072 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 202' ' ' PRO . 12.0 Cg_endo -56.55 128.19 29.02 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.184 1.922 . . . . 0.0 111.222 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 251' ' ' PRO . . . -176.78 -51.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.189 0.519 . . . . 0.0 109.916 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.3 t -137.41 170.65 15.72 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.008 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 138.01 -174.23 22.0 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.65 117.25 4.05 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.786 2.324 . . . . 0.0 111.599 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -148.01 136.46 21.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.535 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.47 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.4 8.8 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.9 tp -62.89 -30.56 71.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.582 0.23 . . . . 0.0 111.037 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.595 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -62.08 -39.72 93.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.637 0.256 . . . . 0.0 110.644 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -66.41 -26.55 67.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.925 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -79.68 -34.65 40.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.524 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 211' ' ' LEU . 42.9 mm -71.82 -53.5 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.971 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.08 -38.38 70.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.452 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.72 76.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 214' ' ' ALA . 88.4 t -80.78 -38.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.255 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 239' ' ' ILE . 38.4 p -83.17 -35.83 25.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.88 -68.72 2.26 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.37 -140.92 4.01 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.15 171.67 13.38 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.714 2.276 . . . . 0.0 112.244 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.02 124.49 44.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.545 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.28 25.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.574 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.13 164.85 13.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.12 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.7 -160.84 18.94 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.255 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.1 m120 56.96 -107.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.982 0.513 . . . . 0.0 111.61 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.09 -14.54 61.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 98.27 -32.48 6.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.476 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -103.47 16.8 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.733 0.778 . . . . 0.0 109.107 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -124.61 144.3 50.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.99 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -82.49 161.57 22.34 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 236' ' ' ALA . 28.4 pt -73.08 151.54 90.43 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.29 -38.08 41.36 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.269 2.646 . . . . 0.0 113.442 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -76.09 -23.81 54.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -69.61 -39.48 77.19 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.267 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -56.01 -40.77 73.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.259 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.4 -48.9 79.89 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.187 0.518 . . . . 0.0 109.887 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 243' ' ' VAL . 53.1 mt -63.57 -47.41 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.757 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.49 -41.18 93.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.502 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -39.81 78.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 59.5 mtt180 -73.04 -26.82 61.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.524 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 239' ' ' ILE . 70.0 t -68.09 -47.94 76.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.61 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -64.26 -30.87 71.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.205 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 32.4 t70 -58.18 -41.09 83.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.298 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 54.9 mmtt -73.03 -32.39 65.06 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.1 mt -67.93 -33.24 74.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.5 mtpm? -65.24 -34.78 79.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 0.0 110.09 174.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.44 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 38.0 t -138.06 76.91 38.21 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 204' ' ' ALA . 61.3 Cg_endo -73.75 -0.48 9.45 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.913 2.408 . . . . 0.0 113.394 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -99.64 -3.12 33.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -82.09 150.31 27.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.822 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -115.88 137.82 51.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.31 137.21 57.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 51.6 m -98.61 114.5 26.97 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.172 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.58 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.7 p-10 -103.36 119.48 38.96 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.542 0.687 . . . . 0.0 109.897 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -89.2 148.6 20.23 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.435 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 302' ' ' SER . 20.6 t80 -134.32 147.16 50.53 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -140.69 172.83 12.15 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 264' ' ' THR . 26.6 t70 -85.0 157.29 20.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.498 HD21 ' ND2' ' A' ' 309' ' ' ASN . 4.3 p-10 -74.65 33.21 0.09 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.029 0.442 . . . . 0.0 111.137 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 262' ' ' ASP . 3.3 m -70.18 -55.41 9.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.194 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -97.69 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 114.128 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.505 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 28.9 m -155.68 154.77 32.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -52.37 -57.17 10.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.343 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.92 -5.25 64.45 Favored Glycine 0 C--O 1.226 -0.397 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.514 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.505 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 6.8 mt -102.91 -41.84 7.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.571 0.7 . . . . 0.0 111.523 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -35.03 74.6 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.665 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 299' ' ' GLY . 74.1 mt -61.76 -59.42 13.36 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.73 -33.95 96.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.245 1.296 . . . . 0.0 111.521 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -31.41 70.06 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.9 p -78.32 -33.49 49.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.784 0.802 . . . . 0.0 109.324 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.96 65.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.107 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -63.75 -54.0 42.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.773 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.5 98.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.583 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.28 -38.17 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.161 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.02 -41.54 86.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 0.0 110.202 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 321' ' ' VAL . 72.8 t -67.04 -43.38 88.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.31 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.8 -44.14 86.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.83 -44.25 94.15 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.592 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.8 -40.59 97.03 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.351 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 87.8 mt -63.63 -42.21 98.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 72.0 t -58.27 -32.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.154 0.502 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.84 61.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.045 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -95.85 -3.37 45.62 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.98 28.09 5.42 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.62 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.3 t -109.09 130.62 61.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.593 0.235 . . . . 0.0 110.375 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.49 119.58 10.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.72 -35.05 88.98 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.884 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.39 -8.06 57.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.196 0.498 . . . . 0.0 111.238 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -95.62 2.42 54.13 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.97 119.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.618 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.7 129.78 49.42 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.2 p -107.98 125.34 51.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 98.9 t -131.07 138.87 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -110.74 122.25 6.15 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.07 -8.47 23.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.096 0.448 . . . . 0.0 111.617 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.15 -118.31 14.1 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 260' ' ' TYR . 23.3 t -133.35 88.37 2.48 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.146 0.498 . . . . 0.0 109.936 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.39 -36.42 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.498 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.16 84.17 37.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-O 121.475 0.655 . . . . 0.0 111.952 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.6 158.26 56.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.612 2.208 . . . . 0.0 111.496 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 37.5 pt -123.28 -8.93 7.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.211 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.36 29.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.3 t -81.44 139.59 35.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.072 0.463 . . . . 0.0 112.201 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.498 ' ND2' HD21 ' A' ' 263' ' ' ASN . 27.9 p-10 -81.39 -7.87 59.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.444 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.85 -24.63 60.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.825 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 72.8 p -109.44 141.07 22.77 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.86 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.55 -33.75 35.46 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.061 1.841 . . . . 0.0 111.097 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.2 -46.09 74.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.471 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.11 -43.67 95.27 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.508 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -54.88 -36.8 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.786 0.327 . . . . 0.0 111.06 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.13 -20.22 65.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.761 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -87.08 -28.02 22.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.544 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 95.5 m-20 -76.05 -14.36 60.21 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.306 0.574 . . . . 0.0 110.73 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -93.96 84.68 4.56 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -146.73 169.3 19.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.273 0.559 . . . . 0.0 111.845 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 281' ' ' VAL . 29.0 t -131.08 138.5 53.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.951 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -119.91 140.47 50.83 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.661 0.267 . . . . 0.0 110.378 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.7 mt -114.42 112.69 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 47.1 t -108.41 123.67 64.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.5 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' ' 211' ' ' LEU . 23.4 t -87.81 136.55 22.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.355 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.37 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -124.1 113.6 18.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.69 128.69 53.55 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.27 142.27 94.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.575 2.183 . . . . 0.0 112.415 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.31 172.85 13.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.555 2.17 . . . . 0.0 111.569 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.51 -177.52 38.54 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.058 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.58 154.81 40.1 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.591 2.194 . . . . 0.0 111.882 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.73 146.41 72.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.667 2.245 . . . . 0.0 111.571 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 57.57 77.76 0.26 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.8 m -79.87 110.33 15.14 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.95 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.11 171.74 25.18 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.87 150.26 30.17 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.32 2.013 . . . . 0.0 111.699 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.8 m -94.5 136.05 35.24 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 110.859 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.79 -2.83 4.71 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.282 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -120.91 9.99 10.76 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.734 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -63.1 -35.46 80.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.489 -177.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -68.04 -39.44 83.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 34.8 t -63.93 -25.87 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.719 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.25 -39.46 33.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.887 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.0 mm -70.69 -47.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -55.51 -39.92 71.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.93 0.395 . . . . 0.0 111.341 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.05 77.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.205 0.526 . . . . 0.0 110.884 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.08 -46.02 23.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.2 p -71.45 -45.94 61.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.811 0.339 . . . . 0.0 111.722 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.31 2.24 53.48 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.474 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.96 -158.58 31.17 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.33 166.57 12.38 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.834 2.356 . . . . 0.0 111.433 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -86.34 115.55 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.73 145.59 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.12 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.99 150.19 36.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 168.29 -152.27 20.16 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 29.9 t30 70.98 -46.83 0.65 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.158 0.479 . . . . 0.0 111.948 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.56 -52.19 0.81 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.32 1.17 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 111.83 -2.441 . . . . 0.0 110.367 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 18.33 3.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.501 0.667 . . . . 0.0 109.699 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.1 m -151.89 171.85 17.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.242 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 232' ' ' LEU . 4.2 mp -91.86 172.85 8.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.945 0.402 . . . . 0.0 110.695 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.4 pt -79.43 152.81 76.13 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.801 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.87 -40.19 24.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.35 2.7 . . . . 0.0 114.009 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.91 -24.12 52.5 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.408 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -67.05 -41.88 85.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.771 0.319 . . . . 0.0 110.511 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -58.63 -37.75 76.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.05 -46.27 88.66 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 243' ' ' VAL . 69.1 mt -60.95 -47.5 93.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.411 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.7 -42.84 89.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.708 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -38.33 73.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.069 0.462 . . . . 0.0 110.82 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 81.2 mtp180 -73.8 -35.0 64.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.3 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 109.877 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.72 73.36 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.303 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 29.6 t70 -61.19 -45.53 94.23 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.75 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.78 -38.51 89.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 64.4 mt -62.57 -40.83 98.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.83 -35.48 78.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 110.614 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.7 -17.72 64.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.332 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 252' ' ' ASP . 41.3 t -146.25 82.84 8.8 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-O 121.1 0.476 . . . . 0.0 110.518 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 19.88 0.26 Allowed 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 123.259 2.64 . . . . 0.0 111.759 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 250' ' ' CYS . 5.8 t70 -103.38 -18.86 14.65 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.375 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.32 135.76 36.52 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.347 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 12.9 mmt180 -107.48 147.35 30.59 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 175.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.8 m -123.56 147.36 27.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 324' ' ' VAL . 66.9 m -111.09 117.83 34.35 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.448 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -104.54 101.12 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -106.99 120.52 42.28 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.26 155.34 20.62 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.093 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.88 155.11 50.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.394 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 9.1 t -162.75 141.57 8.74 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.32 128.07 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.703 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.485 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 14.0 t30 -87.68 22.59 2.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.392 0.615 . . . . 0.0 110.694 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -59.52 -27.6 66.32 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.002 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -104.88 -145.6 14.05 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.629 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 75.5 m -66.92 114.93 6.13 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.72 74.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.696 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.13 -7.0 29.06 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.084 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.97 -28.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.265 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 83.1 m-20 -73.54 -54.87 7.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.5 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 4.5 mp -59.21 -51.54 80.9 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -57.77 -28.68 83.08 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.5 1.467 . . . . 0.0 111.536 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.15 -49.18 24.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.38 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.38 -40.53 65.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.193 0.521 . . . . 0.0 110.778 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.61 96.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.243 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.436 ' O ' HG13 ' A' ' 280' ' ' ILE . 32.5 tt0 -61.38 -48.12 82.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.993 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 277' ' ' ARG . 26.9 mmt180 -55.03 -42.91 73.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.67 98.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.371 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -62.27 -34.99 77.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 276' ' ' GLN . 69.2 mt -60.79 -43.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.046 0.45 . . . . 0.0 110.325 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 77.1 t -64.58 -45.14 96.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.276 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.83 -38.11 86.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.444 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -44.41 95.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.441 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 74.0 t80 -63.54 -38.87 92.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.231 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 89.9 mt -65.51 -41.55 93.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.157 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.5 t -64.46 -34.9 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.81 -28.83 69.83 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.43 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.74 -2.98 45.5 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.934 176.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.14 5.31 54.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.425 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.5 t -77.13 135.8 25.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.218 0.509 . . . . 0.0 110.426 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.02 113.84 4.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.809 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.88 51.14 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.237 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.46 -17.4 51.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.606 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -100.57 4.96 43.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.398 0.618 . . . . 0.0 109.429 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.4 mt -115.15 119.13 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.96 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -103.43 134.25 47.11 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -114.59 127.62 55.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.741 0.305 . . . . 0.0 111.373 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.0 t -130.4 137.52 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.25 118.22 4.47 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.41 1.2 15.0 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.29 -110.41 1.34 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.38 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 75.0 m -127.2 88.69 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.122 0.461 . . . . 0.0 110.718 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.1 m -102.12 -36.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.269 0.557 . . . . 0.0 110.615 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.531 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.8 OUTLIER -140.21 87.99 11.81 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.666 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.27 157.1 57.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 111.997 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.01 -5.67 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.12 24.06 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.9 t -73.42 135.51 44.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 111.81 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -81.14 -6.56 58.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.795 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.06 -27.71 43.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.371 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.6 p -103.87 139.39 20.06 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 -33.68 97.68 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.626 2.218 . . . . 0.0 111.538 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.56 -48.64 63.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.985 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.65 -38.56 90.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.307 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -54.54 -39.07 67.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.709 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.19 -16.41 62.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.648 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.53 -30.49 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.013 0.435 . . . . 0.0 110.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.39 -6.08 50.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.375 0.607 . . . . 0.0 109.527 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 37.7 ttm180 -109.08 83.98 1.85 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.707 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -145.15 171.94 13.8 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.252 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.22 138.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 81.8 mt-10 -118.87 138.25 52.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.032 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 47.5 mt -117.87 106.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 256' ' ' THR . 22.9 m -113.49 145.81 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 211' ' ' LEU . 45.8 t -90.45 133.87 31.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.525 -179.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.34 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 139.49 46.7 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.04 62.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.123 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.73 141.53 5.49 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.717 2.278 . . . . 0.0 112.24 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.15 137.47 56.88 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.509 2.139 . . . . 0.0 111.057 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.15 179.19 22.43 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.801 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 54.0 Cg_endo -69.54 132.28 23.35 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 29.2 Cg_exo -62.95 159.7 37.04 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.329 2.019 . . . . 0.0 110.329 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -79.64 167.95 20.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.593 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.4 m -69.95 169.87 12.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -179.86 -70.72 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.9 179.99 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.549 2.166 . . . . 0.0 110.369 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 71.6 m -110.78 142.97 42.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.904 0.383 . . . . 0.0 111.373 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.73 -20.35 12.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.494 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.38 25.1 9.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.069 0.462 . . . . 0.0 111.269 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -60.39 -33.76 72.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.577 -178.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.44 -42.45 78.83 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.582 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.0 t -64.84 -18.1 64.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.65 -37.79 17.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.9 mm -72.27 -51.56 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.412 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -61.46 -27.1 68.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.177 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.17 72.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 0.0 110.449 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.5 t -77.9 -42.68 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.7 p -74.8 -43.35 55.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.13 6.16 67.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.274 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.68 -147.76 14.51 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -91.45 170.41 3.1 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.753 2.302 . . . . 0.0 110.787 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -87.28 116.04 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.65 145.67 25.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 111.349 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 36.7 m-85 -119.97 171.5 8.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.89 -152.37 21.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.784 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 t30 58.73 -109.44 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.403 0.681 . . . . 0.0 110.552 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.22 -18.96 64.09 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.621 0.724 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 100.88 -40.32 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.858 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.411 ' HA ' ' NH1' ' A' ' 277' ' ' ARG . . . -97.75 18.63 15.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.7 m -125.1 150.19 47.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.339 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.7 mp -84.28 165.97 17.87 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.6 pt -74.2 153.38 88.35 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.91 -44.66 31.43 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.2 2.6 . . . . 0.0 113.332 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.87 -26.21 64.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.08 -48.94 77.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.241 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -56.88 -42.68 80.25 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.98 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.9 -41.53 98.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.798 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 235' ' ' ALA . 74.9 mt -60.18 -45.14 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.831 176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 78.1 mt -59.05 -44.4 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.374 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -52.92 -46.56 68.12 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.227 0.537 . . . . 0.0 110.27 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 246' ' ' LYS . 68.5 mtp180 -67.58 -37.69 82.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.161 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 239' ' ' ILE . 79.2 t -65.32 -43.86 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.71 -34.85 78.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.445 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.74 -40.2 94.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.329 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 71.9 mmtt -67.21 -38.48 85.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.413 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.51 -32.42 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -60.77 -39.22 87.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.91 63.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.707 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.8 t -148.08 84.93 6.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.91 0.386 . . . . 0.0 110.768 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.27 -1.89 12.01 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.738 2.292 . . . . 0.0 112.555 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.67 -8.53 54.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.379 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.67 134.82 34.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.133 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.1 mpp_? -104.46 145.41 30.32 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.97 137.13 52.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.212 0.529 . . . . 0.0 111.965 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 85.1 m -103.22 114.06 28.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.089 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 52.7 mt -103.72 101.28 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 322' ' ' GLU . 0.9 OUTLIER -110.52 122.11 46.94 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.787 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.63 157.71 23.88 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.797 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -138.39 155.3 48.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.696 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 11.3 t -152.84 173.83 14.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.076 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.13 147.02 28.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.043 0.449 . . . . 0.0 110.663 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.29 5.25 20.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.314 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.2 m -64.67 -40.59 95.68 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.091 -0.38 . . . . 0.0 111.474 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.72 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.975 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 61.9 m -157.15 134.09 10.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.35 -61.92 1.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.51 -10.28 29.05 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.322 -0.465 . . . . 0.0 113.71 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.5 mm -102.9 -18.81 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.331 0.586 . . . . 0.0 110.48 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.426 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.5 m-20 -84.42 -35.67 22.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.792 -176.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -50.6 85.57 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.899 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.18 -35.47 95.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 121.777 1.651 . . . . 0.0 111.113 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 2.3 tm? -67.75 -46.88 70.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.068 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 p -64.12 -43.82 94.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.037 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.33 -38.66 90.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.607 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 280' ' ' ILE . 5.6 tp-100 -61.31 -51.18 69.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.145 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 17.2 mmt180 -53.91 -46.16 71.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.813 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.76 99.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.88 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -61.92 -36.56 81.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.428 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 276' ' ' GLN . 76.8 mt -58.8 -43.92 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.467 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 86.8 t -67.99 -45.16 84.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.48 -50.13 74.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.421 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.48 -39.71 91.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 110.329 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.73 -38.84 89.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.2 mt -71.65 -39.1 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 282' ' ' ALA . 67.9 t -61.36 -31.19 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.174 0.512 . . . . 0.0 110.295 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.02 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.587 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -85.05 2.45 43.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.95 -0.32 60.55 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.414 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.5 t -69.95 127.32 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.16 115.79 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.81 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.17 43.54 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.575 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -18.04 61.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -105.72 6.42 31.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.115 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.81 119.35 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.978 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.13 141.21 41.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.318 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.0 p -124.47 125.7 44.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.3 133.68 68.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.091 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.68 106.65 2.22 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.75 -7.09 25.97 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.71 -114.15 6.39 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.56 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.8 m -121.53 89.76 3.18 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.623 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.487 HG23 ' OD1' ' A' ' 304' ' ' ASN . 12.8 m -107.35 -40.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.562 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.487 ' OD1' HG23 ' A' ' 303' ' ' VAL . 1.5 p-10 -147.3 98.47 3.98 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-O 121.607 0.718 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.66 164.96 23.01 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.125 2.55 . . . . 0.0 111.613 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.85 -13.01 11.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.41 167.23 22.96 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 44.6 t -78.44 145.08 35.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.019 0.438 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.36 -6.16 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.019 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.03 -19.08 63.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.283 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -116.22 139.92 25.81 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.878 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.62 -36.12 98.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.244 . . . . 0.0 111.445 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.94 -45.04 71.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.77 -40.15 89.88 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.358 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -56.93 -41.03 77.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.215 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.46 -12.01 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.417 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -86.27 -33.82 20.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -71.15 -14.25 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.061 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -95.0 91.43 6.37 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -150.91 174.36 13.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.824 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 39.7 t -129.37 139.57 51.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.749 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.562 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 37.0 tt0 -115.1 146.05 41.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.88 112.06 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.161 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 12.3 m -122.62 144.92 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 211' ' ' LEU . 44.5 t -88.79 142.4 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.295 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.007 179.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -131.73 173.76 10.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.85 141.41 22.73 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.556 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.41 158.59 39.89 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.517 2.144 . . . . 0.0 111.227 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.0 148.12 40.15 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.758 2.305 . . . . 0.0 111.83 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -106.65 -174.46 23.07 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.965 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.84 149.88 43.33 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.568 2.179 . . . . 0.0 111.917 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.47 169.81 21.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.652 2.234 . . . . 0.0 111.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.07 -31.53 70.09 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 110.814 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 46.8 t -84.28 139.29 32.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.946 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -138.4 -83.64 0.11 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.59 114.76 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.482 2.122 . . . . 0.0 110.533 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 211' ' ' LEU . 75.9 m -95.11 139.2 31.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.981 0.42 . . . . 0.0 111.414 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.64 -45.22 10.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -127.16 45.73 2.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 215' ' ' ILE . 34.1 tp -59.73 -31.15 69.36 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.287 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.6 tp60 -56.68 -43.14 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -66.46 -21.85 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.16 -29.79 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.006 0.432 . . . . 0.0 109.893 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 211' ' ' LEU . 52.1 mm -76.56 -54.43 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.683 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 33.2 p30 -63.79 -26.37 68.6 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.48 -33.95 77.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 214' ' ' ALA . 76.4 t -75.58 -43.2 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.666 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 28.8 p -75.95 -41.1 52.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.052 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.65 61.83 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.724 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.09 -154.34 25.28 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.11 171.73 5.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.561 2.174 . . . . 0.0 110.821 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.7 mm -88.06 115.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.99 24.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.123 0.487 . . . . 0.0 111.115 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.9 m-85 -117.91 179.45 4.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -154.11 -170.02 19.58 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.712 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.49 ' C ' ' H ' ' A' ' 229' ' ' GLY . 16.5 m120 59.03 -163.9 0.21 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.96 19.58 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.387 0.613 . . . . 0.0 111.927 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 227' ' ' ASN . . . 79.86 31.3 40.18 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 121.225 -0.512 . . . . 0.0 114.349 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.502 ' HA ' ' NH2' ' A' ' 277' ' ' ARG . . . -97.29 -17.28 19.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 61.0 m -155.2 175.36 13.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.5 OUTLIER -96.66 172.22 8.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.64 145.59 92.65 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.271 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.18 -33.7 55.53 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.024 2.483 . . . . 0.0 112.898 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.4 -20.68 62.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 240' ' ' LEU . . . -70.11 -36.73 75.05 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.164 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -48.83 -42.53 36.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.326 0.391 . . . . 0.0 111.533 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.34 -48.86 75.9 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.259 0.552 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 243' ' ' VAL . 40.2 mt -64.99 -46.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.236 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 281' ' ' VAL . 4.4 mm? -54.1 -51.28 64.68 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -49.66 -48.09 49.66 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.224 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -66.2 -42.35 88.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.332 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 239' ' ' ILE . 76.3 t -61.41 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.178 0.513 . . . . 0.0 110.582 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.04 82.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.14 -33.26 75.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.53 -36.78 83.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.712 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.32 -33.96 76.34 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.02 -46.19 71.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.663 0.744 . . . . 0.0 109.293 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.37 -15.27 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.227 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 4.6 t -132.57 79.85 63.73 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.09 -14.44 20.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.709 2.272 . . . . 0.0 113.071 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 -4.76 55.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.244 0.545 . . . . 0.0 110.731 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -93.05 147.44 22.85 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.656 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -114.32 143.59 44.64 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.11 140.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 324' ' ' VAL . 68.4 m -107.57 118.77 37.6 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.512 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.78 100.71 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.186 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.94 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.22 154.73 20.2 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.798 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -133.9 152.69 51.95 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.048 0.451 . . . . 0.0 110.823 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -143.04 174.62 10.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.406 ' OD2' ' HB ' ' A' ' 264' ' ' THR . 3.3 p-10 -89.29 157.32 18.26 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.647 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.46 ' HB3' HD22 ' A' ' 309' ' ' ASN . 5.1 t-20 -73.69 35.46 0.09 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.6 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.406 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 4.2 t -56.11 -52.77 63.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.72 -146.7 9.17 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.835 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 27.7 m -76.65 139.49 40.6 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 122.667 0.387 . . . . 0.0 110.7 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.32 -38.49 77.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.772 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.81 55.85 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.123 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.59 -42.63 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.388 0.613 . . . . 0.0 109.559 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.63 -41.71 86.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.678 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 55.2 mt -59.41 -55.68 43.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 73.3 Cg_exo -52.19 -33.99 56.91 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.041 1.827 . . . . 0.0 112.125 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.65 -54.62 11.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.442 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 p -51.2 -42.72 61.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.045 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.53 -39.77 94.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.987 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.91 -49.3 73.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.502 ' NH2' ' HA ' ' A' ' 230' ' ' ALA . 19.5 mmt180 -59.18 -39.91 84.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.914 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.13 97.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 297' ' ' THR . 63.5 tttp -61.73 -34.08 75.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.368 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.26 -40.04 76.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 52.2 t -67.65 -46.72 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.317 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.06 -43.34 86.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.61 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.55 -45.29 94.44 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.367 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.26 -38.21 90.28 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.576 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.9 mt -65.06 -41.75 94.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.743 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 59.0 t -61.63 -34.95 64.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.198 0.523 . . . . 0.0 110.399 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.4 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.729 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -82.43 -3.38 55.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.909 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.95 35.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.223 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.1 t -76.06 135.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.811 0.306 . . . . 0.0 110.755 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.38 117.38 10.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.24 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.4 -15.25 61.08 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.733 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.71 -24.12 60.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -101.54 11.4 39.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.142 0.496 . . . . 0.0 110.242 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.45 120.9 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.168 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.49 149.2 26.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.102 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 279' ' ' LYS . 12.4 p -130.58 125.23 33.65 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.786 0.327 . . . . 0.0 110.833 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.28 137.04 59.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -111.39 117.46 4.52 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 303' ' ' VAL . 91.1 mt -108.34 -0.8 20.5 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 57.93 -114.44 5.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.112 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 87.5 2.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 117.065 0.433 . . . . 0.0 111.07 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 300' ' ' LEU . 31.6 m -103.46 -38.39 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -142.04 96.14 6.67 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.586 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.31 159.27 23.02 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 123.118 2.545 . . . . 0.0 111.572 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.3 pt -118.96 -5.41 11.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.84 166.64 28.89 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.563 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 32.6 t -65.86 129.22 39.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.253 0.549 . . . . 0.0 112.045 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.46 HD22 ' HB3' ' A' ' 263' ' ' ASN . 2.9 m-20 -77.66 -8.16 57.5 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -89.39 -4.27 58.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.263 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 72.3 p -124.07 134.48 25.45 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.394 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -35.49 93.68 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.595 2.197 . . . . 0.0 110.842 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.09 -46.12 90.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.951 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.01 -39.95 73.58 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.256 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 311' ' ' THR . 87.6 mtt180 -54.24 -39.25 66.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.742 0.306 . . . . 0.0 110.741 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.62 -25.45 66.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.891 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.13 -37.87 16.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.146 0.498 . . . . 0.0 110.632 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.53 -14.34 62.85 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -93.72 86.05 5.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -142.84 163.75 31.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.775 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.48 135.17 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.331 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -121.74 121.83 38.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.48 111.1 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.468 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.458 HG23 ' HB ' ' A' ' 256' ' ' THR . 20.2 m -111.76 143.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.6 t -86.71 135.14 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 254' ' ' ARG . 63.4 m-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.611 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.153 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.31 151.09 33.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.93 0.395 . . . . 0.0 110.598 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -87.71 130.19 47.91 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.976 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 41.7 Cg_endo -70.5 132.25 21.77 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.21 1.94 . . . . 0.0 111.602 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 47.8 Cg_exo -56.88 145.61 83.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.779 2.319 . . . . 0.0 111.678 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.47 -151.11 9.35 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.207 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.29 126.02 8.86 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.246 1.964 . . . . 0.0 111.416 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.41 168.13 24.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.512 2.142 . . . . 0.0 112.199 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -117.98 144.83 45.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.0 t -120.55 136.4 54.8 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.288 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.89 2.49 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.62 124.58 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.374 2.05 . . . . 0.0 111.702 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.25 136.08 41.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.774 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.68 -59.24 2.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -158.59 98.89 1.55 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.199 0.523 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 tp -62.88 -32.47 73.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.828 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.2 tp60 -56.41 -41.77 76.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.484 0.183 . . . . 0.0 111.102 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -60.39 -21.93 62.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.416 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -94.23 -30.96 14.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.652 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 211' ' ' LEU . 45.4 mm -70.68 -55.11 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.698 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -60.33 -30.74 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.26 75.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.056 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 214' ' ' ALA . 55.1 t -76.7 -40.65 33.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -72.44 -37.63 68.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.657 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.05 3.56 56.64 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.43 -148.99 16.61 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.52 171.57 4.28 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.758 2.306 . . . . 0.0 111.002 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 46.7 mm -84.66 111.93 21.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.35 26.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.445 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 23.0 m-85 -103.6 -175.82 2.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.828 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -149.0 178.91 26.24 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.458 -1.354 . . . . 0.0 113.193 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -52.6 -27.59 17.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.835 0.854 . . . . 0.0 113.173 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' SER . 5.2 m-20 -50.84 -20.07 1.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.26 -87.32 0.53 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.512 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.2 13.86 28.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.253 0.549 . . . . 0.0 110.384 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 228' ' ' ASP . 15.4 m -105.77 122.39 45.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 3.2 mp -86.38 168.5 13.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.19 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.8 pt -71.93 150.2 92.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.4 -43.41 44.41 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.149 2.566 . . . . 0.0 114.115 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.87 -23.41 63.26 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -62.43 -44.43 96.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.058 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -56.43 -41.7 76.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.361 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 29.5 tt0 -61.61 -43.41 98.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.0 mt -63.17 -48.25 88.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.297 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 80.0 mt -56.17 -43.98 78.88 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.226 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.51 -42.53 70.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.975 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 238' ' ' GLU . 81.4 mtt180 -71.3 -39.65 71.34 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.773 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 78.1 t -59.06 -44.83 92.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.253 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.78 73.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.311 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.56 -37.64 77.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.509 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.42 -35.06 77.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 47.7 mt -59.03 -33.25 70.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.21 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -61.04 -31.26 70.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.497 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.79 64.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.751 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.5 t -141.5 72.49 25.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.83 0.348 . . . . 0.0 110.224 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.26 -2.13 9.28 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.968 2.445 . . . . 0.0 112.654 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 -14.69 53.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.538 0.685 . . . . 0.0 109.529 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.8 135.79 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.427 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.15 155.66 16.96 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 10.8 m -124.37 135.44 63.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.809 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 324' ' ' VAL . 48.9 m -103.66 117.96 35.61 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.319 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.58 103.78 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.9 OUTLIER -109.98 124.37 51.31 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.113 -177.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.95 161.38 23.54 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.825 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -134.68 154.26 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.82 0.343 . . . . 0.0 110.375 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 39.6 p -135.45 175.48 9.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.994 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -94.12 148.88 21.76 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.74 9.72 2.66 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.4 m -62.47 -45.31 93.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.875 0.369 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.64 -177.81 52.1 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.2 m -79.47 152.87 30.01 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 268' ' ' GLY . 10.1 pt-20 -57.29 -42.59 82.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.831 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 267' ' ' GLU . . . -71.78 -1.03 44.66 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.656 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 9.1 mt -113.39 -44.57 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.623 0.725 . . . . 0.0 110.11 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 77.8 m-20 -66.48 -52.62 44.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.457 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.443 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 82.0 mt -56.61 -53.27 66.24 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.1 Cg_endo -61.1 -29.06 86.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.691 1.594 . . . . 0.0 112.103 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.0 tt -76.78 -43.24 37.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.9 64.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.143 0.496 . . . . 0.0 110.186 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.7 75.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.66 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -64.87 -54.9 23.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 85.1 mtt180 -56.54 -37.9 71.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -43.04 99.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.384 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 88.0 tttt -61.49 -32.54 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.83 -44.15 93.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -63.38 -43.85 98.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.266 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.62 -44.2 89.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.752 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.78 -42.56 99.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.943 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 71.8 t80 -64.8 -37.08 86.4 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 81.8 mt -65.96 -41.94 90.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 109.989 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 282' ' ' ALA . 57.9 t -63.37 -33.44 61.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.315 0.578 . . . . 0.0 109.925 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.451 ' C ' ' HE ' ' A' ' 288' ' ' ARG . . . -68.61 -14.59 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.357 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 2.3 mmp_? -97.06 1.23 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.527 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.38 46.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.167 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 47.1 t -73.47 136.48 25.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.971 0.386 . . . . 0.0 110.431 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.58 112.61 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.577 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.24 60.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.897 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.97 -12.76 60.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.155 0.503 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -100.26 4.91 44.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 119.93 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.203 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.38 138.17 48.22 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.227 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.4 p -115.49 129.0 56.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.702 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 60.7 t -128.26 137.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.901 0.381 . . . . 0.0 110.854 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -106.22 123.3 7.39 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.86 -11.28 14.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 117.072 0.436 . . . . 0.0 111.29 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.0 -127.37 35.66 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -113.14 88.29 2.8 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.122 0.461 . . . . 0.0 110.814 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 23.3 m -105.82 -40.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.29 0.567 . . . . 0.0 111.393 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -135.62 97.43 12.84 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.63 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.05 144.35 29.96 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.852 2.368 . . . . 0.0 110.959 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -113.4 -8.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.905 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.22 167.09 26.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.852 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.6 m -75.17 131.17 40.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.252 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -81.57 -6.04 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.386 0.612 . . . . 0.0 110.76 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.01 -29.88 70.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.888 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -107.45 147.32 35.05 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.83 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.87 -26.19 59.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.322 2.015 . . . . 0.0 111.204 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.34 -48.7 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.413 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.67 92.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.074 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.1 -36.63 65.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 0.0 110.246 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.06 63.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.876 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -87.66 -31.64 19.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.244 0.545 . . . . 0.0 110.949 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.551 ' HA ' HH21 ' A' ' 320' ' ' ARG . 92.4 m-20 -73.51 -13.07 60.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 277' ' ' ARG . 5.1 ptp180 -101.93 92.22 4.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 318' ' ' ASN . 3.8 ptp85 -147.64 175.81 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 -172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 42.3 t -131.05 139.46 51.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 320' ' ' ARG . 58.5 mt-10 -128.09 139.42 52.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.28 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 30.2 mt -116.42 111.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.495 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 31.4 m -108.87 139.8 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.039 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.9 t -86.13 136.9 21.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.26 0.552 . . . . 0.0 112.146 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.046 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -92.01 112.88 24.99 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.27 117.15 59.47 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.592 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.1 159.93 23.66 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.167 . . . . 0.0 111.45 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.57 139.23 82.46 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.595 2.196 . . . . 0.0 111.35 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.65 11.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.183 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 147.77 85.96 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.389 2.059 . . . . 0.0 111.385 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.42 159.26 54.36 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.326 2.017 . . . . 0.0 111.412 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -94.75 71.07 3.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.2 m -65.67 100.22 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.7 73.91 0.56 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.446 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.54 94.28 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.377 2.051 . . . . 0.0 110.516 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 74.6 m -127.03 136.49 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.143 0.497 . . . . 0.0 111.742 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.99 26.4 0.63 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.99 12.79 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.721 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.631 ' HB3' HG11 ' A' ' 325' ' ' VAL . 19.2 tp -61.29 -23.46 65.71 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.019 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.3 tp60 -61.72 -40.18 94.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.4 t -65.91 -25.5 67.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.459 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -80.3 -38.89 29.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 243' ' ' VAL . 34.3 mm -69.79 -48.43 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.585 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.71 -36.04 73.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.968 0.413 . . . . 0.0 110.947 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.53 78.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.923 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 214' ' ' ALA . 96.2 t -82.46 -40.27 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.482 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.7 p -73.58 -47.92 36.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.596 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.41 4.21 64.04 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.264 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.19 -166.22 37.57 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.79 171.42 11.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.77 2.313 . . . . 0.0 112.031 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 44.0 mm -87.98 111.24 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.16 148.29 25.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -123.56 163.69 20.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -160.62 -170.2 24.9 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.537 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 59.8 -95.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.406 1.082 . . . . 0.0 112.007 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -93.79 0.83 56.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 111.01 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.9 83.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.661 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.2 6.5 10.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.1 t -110.88 130.17 55.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.1 mp -80.65 160.46 25.03 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 46.8 pt -67.88 148.03 98.47 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.52 -43.67 38.06 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.917 2.411 . . . . 0.0 112.964 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.13 -20.46 66.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -65.47 -39.85 92.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.499 0.19 . . . . 0.0 111.358 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -58.51 -45.14 89.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.18 -43.51 87.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.167 0.508 . . . . 0.0 109.76 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.2 mt -63.58 -52.32 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.544 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 85.8 mt -53.09 -46.17 68.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -56.72 -42.86 79.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 91.7 mtt180 -75.5 -26.55 58.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.011 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 215' ' ' ILE . 39.5 t -71.24 -46.86 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.6 -29.67 70.77 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.988 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 18.3 t70 -60.25 -45.62 92.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.242 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 242' ' ' ARG . 42.4 mmtm -69.17 -35.1 75.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.236 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 67.0 mt -65.9 -38.6 89.17 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.534 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 58.3 mtmt -66.11 -27.55 68.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.838 0.352 . . . . 0.0 110.847 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.89 65.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.496 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 28.7 t -135.6 75.23 57.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 7.17 3.15 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.062 2.508 . . . . 0.0 114.258 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.58 -4.68 16.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.44 0.638 . . . . 0.0 109.693 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -75.87 155.86 34.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.868 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.454 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.5 OUTLIER -117.64 135.33 54.06 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.35 137.38 54.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.35 0.595 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.7 m -106.14 116.04 31.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.062 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.01 102.13 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.67 123.04 47.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.117 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.03 159.61 17.22 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.974 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 320' ' ' ARG . 54.1 m-85 -135.13 151.74 50.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.042 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -143.29 170.01 16.57 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 264' ' ' THR . 29.6 t70 -81.71 159.75 23.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.102 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 0.1 OUTLIER -73.91 30.51 0.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.538 -178.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 262' ' ' ASP . 22.7 m -59.46 -56.25 24.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.859 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.58 -160.01 26.9 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.192 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 269' ' ' ILE . 31.9 m -72.69 149.68 43.6 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.361 0.265 . . . . 0.0 111.156 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.19 -46.39 75.83 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.234 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.95 -14.6 53.33 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 266' ' ' SER . 16.1 mt -101.8 -41.73 8.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.897 0.856 . . . . 0.0 110.473 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.66 -37.16 80.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.62 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 299' ' ' GLY . 59.1 mt -60.43 -57.58 25.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.579 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 10.9 Cg_endo -58.52 -35.42 98.69 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.366 1.377 . . . . 0.0 111.687 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -34.53 74.29 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.7 p -74.31 -35.03 63.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.866 0.841 . . . . 0.0 109.374 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.18 -33.72 76.68 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.124 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.4 mt-30 -60.17 -53.13 61.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.471 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -54.84 -40.47 69.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.851 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.2 85.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.771 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 69.6 tttt -60.46 -33.21 72.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.65 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.55 -43.9 88.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.247 0.546 . . . . 0.0 110.011 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 85.6 t -64.59 -45.66 94.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.081 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -59.06 -49.12 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.72 -38.48 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.533 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 60.0 t80 -66.19 -39.64 89.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 94.8 mt -66.77 -39.4 87.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.053 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 282' ' ' ALA . 73.0 t -61.4 -34.96 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 109.996 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.63 66.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.386 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.452 ' HE ' ' HA ' ' A' ' 288' ' ' ARG . 1.8 mmp_? -82.31 -1.3 49.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.76 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.8 -2.47 52.41 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.976 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.51 131.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.839 0.319 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -58.98 114.95 2.82 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.175 0.59 . . . . 0.0 112.101 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.55 -24.23 65.79 Favored Glycine 0 C--O 1.228 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.081 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -74.84 -8.42 56.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -109.59 1.13 19.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.782 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -109.07 116.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.697 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.35 132.78 53.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.665 0.269 . . . . 0.0 110.721 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 32.4 p -110.64 126.68 54.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.954 0.407 . . . . 0.0 110.721 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.97 136.11 60.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.06 104.83 1.31 Allowed Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.65 -1.46 56.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.876 0.338 . . . . 0.0 111.617 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.78 -118.85 16.33 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.31 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 4.3 m -116.65 106.8 13.93 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.02 -35.07 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.64 97.93 13.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.96 66.63 7.65 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.958 2.439 . . . . 0.0 111.855 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.553 HD13 HH21 ' A' ' 320' ' ' ARG . 44.8 pt -44.46 -25.11 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.511 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.402 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -137.67 164.19 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 19.4 m -66.79 122.42 17.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.151 0.5 . . . . 0.0 112.221 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -82.54 -6.45 59.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.907 0.861 . . . . 0.0 109.441 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.01 -22.23 61.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.805 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 75.3 p -115.58 152.63 47.39 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.867 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.63 -27.09 69.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.349 2.032 . . . . 0.0 111.168 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.52 -53.06 60.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.353 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -76.34 -40.17 29.14 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.742 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -56.0 -34.87 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.941 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -81.75 -17.79 46.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -81.35 -30.69 33.7 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.409 0.623 . . . . 0.0 109.51 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.82 -4.19 6.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.563 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -109.46 90.8 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.553 HH21 HD13 ' A' ' 306' ' ' ILE . 0.1 OUTLIER -147.31 154.85 41.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.079 -175.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 320' ' ' ARG . 64.4 t -123.46 144.37 33.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.478 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -126.56 147.13 49.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.4 mt -114.86 107.48 22.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 72.7 t -103.08 124.56 57.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.275 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 211' ' ' LEU . 3.6 t -99.51 150.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.838 177.246 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.17 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -138.58 143.07 39.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.81 158.17 84.14 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.25 141.1 32.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.554 2.169 . . . . 0.0 112.249 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.51 167.27 5.18 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.955 2.437 . . . . 0.0 112.186 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -116.17 139.46 15.32 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.585 -0.816 . . . . 0.0 111.874 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 149.61 43.34 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.298 1.999 . . . . 0.0 111.31 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.02 166.4 23.07 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.527 2.151 . . . . 0.0 111.963 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.52 -126.72 0.27 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 t -100.45 -155.73 0.52 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.29 -70.65 0.02 OUTLIER Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.5 156.74 40.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.326 2.017 . . . . 0.0 110.934 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -94.93 135.48 36.39 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.225 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.3 -176.79 5.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 67.5 7.56 5.68 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.542 0.737 . . . . 0.0 112.485 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 tp -59.98 -33.95 72.64 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.2 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.0 tp60 -61.4 -41.94 97.94 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -62.57 -28.38 69.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.928 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.4 -37.52 25.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.319 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.1 mm -67.27 -51.02 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.039 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.57 -35.02 73.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.165 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.51 84.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 214' ' ' ALA . 80.0 t -73.94 -49.71 32.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 25.3 p -68.21 -42.51 79.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.58 5.94 61.42 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.434 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.25 -150.57 19.5 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -91.8 171.35 2.79 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.939 2.426 . . . . 0.0 111.947 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.04 114.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.66 152.77 21.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.252 0.549 . . . . 0.0 112.083 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 231' ' ' SER . 7.4 m-85 -128.46 -178.49 4.59 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.44 -134.89 1.87 Allowed Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.349 -1.405 . . . . 0.0 113.437 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -84.94 47.09 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.194 0.997 . . . . 0.0 109.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.62 -49.21 3.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.997 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.82 -58.39 4.52 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.214 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -98.94 10.81 40.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 225' ' ' PHE . 24.4 t -159.67 -172.07 3.54 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 236' ' ' ALA . 0.4 OUTLIER -114.79 -174.28 2.46 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.892 0.477 . . . . 0.0 110.541 175.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 30.3 pt -73.65 149.68 88.44 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.87 -37.92 56.55 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.53 2.82 . . . . 0.0 113.923 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.45 -24.52 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 232' ' ' LEU . . . -68.67 -32.82 72.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.359 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -52.6 -47.57 66.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.425 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.85 -49.96 74.93 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 243' ' ' VAL . 57.3 mt -66.94 -42.8 89.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.039 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.87 -40.88 97.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -57.44 -37.93 73.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 3.8 mmp_? -71.66 -31.55 66.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.542 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 239' ' ' ILE . 85.6 t -65.66 -44.3 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.872 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -60.35 -32.97 71.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.151 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 31.6 t70 -61.05 -44.22 97.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.677 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.19 -34.65 76.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.998 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 58.5 mt -63.47 -37.07 85.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 66.9 mttm -60.17 -34.73 73.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 110.421 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.55 65.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.261 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.93 82.29 13.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.912 0.387 . . . . 0.0 110.481 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.03 -7.73 18.41 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.594 2.196 . . . . 0.0 112.736 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -88.92 -5.25 58.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 0.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -93.98 141.26 28.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.614 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.61 145.5 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.25 133.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.331 0.586 . . . . 0.0 112.138 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 324' ' ' VAL . 52.6 m -97.82 114.27 26.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.403 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.07 99.81 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 5.0 p-10 -105.4 120.82 42.55 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 110.373 -177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -97.79 155.76 20.49 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.184 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -125.48 -179.48 4.64 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.558 0.695 . . . . 0.0 110.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 15.3 t -172.67 179.17 2.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 13.2 t70 -100.08 139.98 34.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 23.3 t30 -80.51 28.34 0.33 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.899 0.38 . . . . 0.0 111.526 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -46.43 68.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.536 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.92 -156.91 30.9 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.469 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 75.3 m -67.27 143.34 56.51 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 122.654 0.382 . . . . 0.0 111.796 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -52.99 -55.7 21.58 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.66 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.67 1.63 44.16 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.537 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 50.3 mm -106.37 -18.79 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.774 0.797 . . . . 0.0 109.653 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.1 m-20 -89.33 -39.21 13.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.624 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.508 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 73.1 mt -59.07 -49.28 94.03 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 14.1 Cg_endo -58.97 -32.03 96.76 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.537 1.491 . . . . 0.0 111.417 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 277' ' ' ARG . 3.0 tm? -65.38 -54.15 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.515 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -41.7 61.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.329 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.89 95.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.919 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 79.9 mt-30 -58.17 -53.98 52.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 280' ' ' ILE . 78.9 mtt-85 -59.08 -39.24 81.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.232 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.88 94.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.252 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG21 ' A' ' 297' ' ' THR . 65.1 tttm -62.2 -30.92 71.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.491 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 277' ' ' ARG . 68.3 mt -59.42 -40.27 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.115 0.483 . . . . 0.0 109.736 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.441 HG21 HG11 ' A' ' 321' ' ' VAL . 93.5 t -67.59 -43.88 86.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.169 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.54 -52.68 64.43 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.297 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.18 -37.89 78.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 111.03 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.33 -40.22 89.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.672 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 97.4 mt -68.32 -39.48 81.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.476 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.0 t -62.54 -33.87 61.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.334 0.587 . . . . 0.0 109.85 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -73.11 -14.59 61.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.575 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -96.17 4.7 52.27 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.388 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.99 56.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.307 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.8 t -70.96 128.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 117.062 0.431 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.34 7.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.837 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.73 -20.15 51.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.037 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.06 -18.55 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.191 0.52 . . . . 0.0 110.706 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -105.82 6.15 31.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.3 115.57 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.493 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.98 138.93 44.56 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.231 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -117.62 132.08 56.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.573 0.225 . . . . 0.0 110.799 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 22.8 t -133.61 129.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.773 0.32 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.79 121.38 7.19 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.64 -4.98 15.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.259 0.529 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.95 -123.4 26.33 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.2 m -119.62 87.66 2.78 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 120.903 0.382 . . . . 0.0 110.747 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.17 -44.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.032 0.444 . . . . 0.0 110.404 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.15 97.44 6.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.905 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.91 164.35 35.99 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.4 2.734 . . . . 0.0 111.874 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.05 -13.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.016 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -144.81 167.24 23.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.935 0.398 . . . . 0.0 111.071 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.4 m -63.62 124.89 22.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.94 -8.16 58.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.732 0.777 . . . . 0.0 109.302 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.45 59.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.878 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -115.18 137.76 23.17 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.68 -37.18 98.28 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.899 2.4 . . . . 0.0 111.697 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.12 -45.18 70.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.805 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.48 -41.9 96.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.384 -0.913 . . . . 0.0 110.935 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 39.3 ttm180 -56.78 -32.5 65.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.656 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.63 -25.24 53.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.648 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -86.71 -29.19 22.61 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.915 0.388 . . . . 0.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.69 -11.39 25.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.058 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.441 HH21 ' HG2' ' A' ' 315' ' ' ARG . 30.1 mtt180 -99.22 96.95 8.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -148.26 175.06 11.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.601 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 281' ' ' VAL . 5.8 t -130.63 139.79 50.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.141 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -119.36 136.96 54.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.98 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.137 0.494 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.494 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 74.3 t -111.57 127.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.879 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 211' ' ' LEU . 59.2 t -84.18 133.49 29.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.609 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.55 153.97 41.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -89.07 147.33 38.35 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.914 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.75 121.38 9.92 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.75 156.79 59.61 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.727 2.285 . . . . 0.0 112.01 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 167.01 -151.03 18.64 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 32.6 Cg_exo -62.33 126.25 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.18 1.92 . . . . 0.0 110.345 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 17.3 Cg_exo -66.77 128.46 18.96 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.12 1.88 . . . . 0.0 112.443 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.77 27.95 8.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.597 . . . . 0.0 109.79 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 6.7 m -71.97 -175.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.126 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -130.84 69.16 0.54 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.637 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.28 162.68 39.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.724 2.283 . . . . 0.0 112.208 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.1 p -95.22 -179.57 4.84 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.11 160.35 34.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.032 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 68.03 4.09 3.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.239 0.616 . . . . 0.0 112.341 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 215' ' ' ILE . 26.4 tp -59.08 -33.64 71.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.967 0.413 . . . . 0.0 110.083 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.431 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.5 m -65.64 -26.31 67.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.034 0.445 . . . . 0.0 110.423 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -82.07 -37.39 26.48 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.479 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.7 mm -67.37 -49.42 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.565 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -55.98 -39.64 72.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.991 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.91 86.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.268 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 214' ' ' ALA . 94.0 t -78.32 -43.73 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.431 ' HA ' HG21 ' A' ' 239' ' ' ILE . 29.9 p -69.04 -43.87 73.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.703 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.02 3.47 44.35 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.105 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.51 -165.64 36.86 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.61 167.4 20.85 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.411 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 232' ' ' LEU . 48.1 mm -91.12 107.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.61 151.41 22.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.519 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 6.8 m-85 -109.58 142.37 40.78 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.263 0.554 . . . . 0.0 111.264 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -169.55 -122.8 0.64 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 33.2 t30 67.16 -58.43 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.329 0.652 . . . . 0.0 111.201 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.63 -45.28 0.98 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 155.86 -47.84 0.49 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.823 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.23 -61.68 1.89 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.847 -0.676 . . . . 0.0 112.062 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 1.4 m -66.91 -178.09 0.71 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 3.0 mp -83.64 167.87 16.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 236' ' ' ALA . 37.0 pt -74.19 148.69 86.59 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.85 -41.56 38.85 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.114 2.543 . . . . 0.0 113.367 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.689 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.37 -42.84 98.88 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.773 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -60.85 -42.88 98.69 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.33 -40.78 91.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.393 0.616 . . . . 0.0 109.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.9 mt -63.69 -49.15 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.898 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 84.1 mt -54.03 -41.59 68.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -51.69 -46.56 63.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.2 0.524 . . . . 0.0 110.808 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 88.9 mtt180 -75.65 -32.22 60.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.468 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.4 t -65.66 -45.13 92.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.51 -33.93 74.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 17.5 t70 -59.82 -43.66 94.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.065 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -69.54 -39.3 77.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.636 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 63.3 mt -63.67 -39.72 95.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -66.09 -29.15 69.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.976 0.417 . . . . 0.0 110.76 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.31 -23.63 64.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.66 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 37.5 t -134.33 78.72 56.99 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.73 -3.75 13.73 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.202 2.601 . . . . 0.0 114.206 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.97 7.34 25.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.17 0.509 . . . . 0.0 111.296 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -86.5 151.09 23.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.268 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -113.29 134.34 54.66 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.17 133.1 67.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.186 0.517 . . . . 0.0 111.915 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 80.0 m -99.26 113.86 26.37 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.21 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -100.98 100.71 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.0 p-10 -109.46 120.96 44.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.079 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.93 156.92 23.2 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.621 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -128.34 179.25 5.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.421 0.629 . . . . 0.0 110.64 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 13.3 t -170.25 177.24 4.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.202 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.01 158.34 27.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.494 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 8.4 p30 -90.64 -11.57 39.48 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 19.9 m -70.28 -36.23 74.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.27 177.76 35.56 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.197 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 49.3 m -65.88 127.98 34.2 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.469 0.176 . . . . 0.0 111.117 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.03 -39.55 75.04 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.26 62.09 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.144 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.94 -37.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.375 0.607 . . . . 0.0 109.6 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 97.3 m-20 -62.87 -49.86 73.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.314 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.556 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 70.9 mt -60.45 -52.06 75.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 44.0 Cg_exo -59.9 -33.49 95.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.648 1.565 . . . . 0.0 111.59 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.455 HD21 ' HE ' ' A' ' 277' ' ' ARG . 2.6 tp -67.19 -55.78 12.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.556 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.0 p -48.04 -42.37 28.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.419 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.27 -39.95 94.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.001 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.82 -49.34 71.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.69 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.455 ' HE ' HD21 ' A' ' 273' ' ' LEU . 65.4 mtt-85 -56.88 -41.53 78.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.776 177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.46 99.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 297' ' ' THR . 58.9 tttp -60.95 -28.27 68.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.606 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.43 -39.04 84.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.145 0.498 . . . . 0.0 109.87 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 78.9 t -66.14 -45.86 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.3 -49.31 74.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.765 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.48 -43.39 97.01 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.126 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 32.8 t80 -61.55 -39.75 92.22 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.88 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 90.8 mt -68.98 -42.0 77.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.562 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.8 t -62.97 -34.0 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 109.951 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.86 62.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.904 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 26.9 mmt180 -96.82 4.96 51.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.517 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.54 39.35 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.903 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 30.4 t -70.43 134.22 30.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.386 0.593 . . . . 0.0 110.977 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.15 118.2 10.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.39 -14.46 57.16 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.403 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.97 -22.55 65.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.245 0.618 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 253' ' ' ALA . 87.6 m-70 -110.72 12.29 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.99 116.92 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -111.03 140.01 45.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.507 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.3 p -116.6 133.0 56.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 38.9 t -132.49 137.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.388 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -108.21 121.25 6.26 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.2 -17.84 17.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.242 0.521 . . . . 0.0 111.394 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.85 -121.06 15.58 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.183 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 263' ' ' ASN . 3.8 m -106.96 96.68 6.61 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.415 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.7 m -123.45 -46.47 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 303' ' ' VAL . 2.4 p-10 -151.05 100.7 3.03 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.48 157.94 55.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.361 2.707 . . . . 0.0 111.495 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.2 pt -116.43 -13.3 11.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.503 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -142.9 167.58 21.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 28.4 t -76.49 126.94 31.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.628 ' HB2' ' NH1' ' A' ' 315' ' ' ARG . 9.0 p30 -72.34 -6.91 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.373 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -78.57 -14.76 59.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.916 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 68.1 p -111.84 144.24 30.27 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.22 -34.55 93.77 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.635 2.224 . . . . 0.0 111.022 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -64.02 -51.22 65.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.952 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -62.86 -40.08 98.8 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.777 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.628 ' NH1' ' HB2' ' A' ' 309' ' ' ASN . 20.1 tpp180 -57.18 -41.98 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.5 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.37 52.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.23 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -87.83 -34.57 18.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.625 0.25 . . . . 0.0 111.232 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.44 -16.01 52.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.497 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 34.4 mtm180 -99.7 98.46 9.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -150.3 175.75 11.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.222 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.7 t -131.04 141.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.039 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -120.71 127.62 52.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.99 115.19 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.178 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.99 127.27 70.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 211' ' ' LEU . 29.7 t -89.82 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.337 -178.126 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -140.6 153.0 45.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.684 0.278 . . . . 0.0 110.425 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.69 119.86 65.59 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.099 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.19 142.33 21.47 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.377 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 149.42 49.46 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.716 2.278 . . . . 0.0 111.686 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.81 -152.75 7.62 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.26 150.86 42.7 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.352 2.035 . . . . 0.0 112.035 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.53 163.22 34.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.591 2.194 . . . . 0.0 111.455 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.08 -54.48 42.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.187 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 252' ' ' ASP . 49.5 m -71.46 115.36 10.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.001 0.429 . . . . 0.0 110.867 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -148.99 175.04 28.42 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.836 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.02 129.97 29.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.839 2.36 . . . . 0.0 111.791 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 11.0 t -147.7 134.77 20.35 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -88.39 -71.46 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.77 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -160.83 99.01 1.23 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.609 ' O ' HG12 ' A' ' 215' ' ' ILE . 21.6 tp -60.39 -37.71 81.65 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.866 -178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 325' ' ' VAL . 26.9 tp60 -55.3 -42.18 73.31 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.2 m -59.78 -27.06 66.22 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.597 0.56 . . . . 0.0 111.307 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -91.2 -29.0 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 211' ' ' LEU . 47.7 mm -72.79 -55.66 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.012 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 32.6 p30 -61.17 -31.68 71.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.85 76.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.8 t -82.7 -40.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.166 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 22.1 p -68.89 -44.36 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.722 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.8 4.04 24.64 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.996 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.86 -163.45 36.37 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 1.2 Cg_endo -85.08 166.72 11.07 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.841 2.361 . . . . 0.0 111.58 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 50.7 mm -84.72 116.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.11 143.59 26.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.802 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -112.39 160.01 18.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.011 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.82 32.82 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.068 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 66.7 t30 56.89 -102.89 0.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.159 0.983 . . . . 0.0 111.591 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.11 -30.49 71.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.13 0.49 . . . . 0.0 111.176 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.71 -41.12 2.25 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -93.7 17.98 10.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.909 0.862 . . . . 0.0 108.986 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.7 p -126.79 143.41 51.26 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.3 mp -79.33 166.95 21.55 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 236' ' ' ALA . 29.6 pt -77.33 153.1 81.83 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.02 -41.6 33.02 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.103 2.535 . . . . 0.0 113.665 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -71.64 -32.0 67.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.479 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.5 -44.18 97.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.99 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -56.08 -44.44 78.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.618 0.247 . . . . 0.0 110.99 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -56.88 -51.88 67.34 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 61.1 mt -64.16 -41.07 91.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.758 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.78 -44.23 97.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -57.88 -35.47 71.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.1 -35.3 69.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.418 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 95.5 t -63.91 -44.36 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.76 76.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.751 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.99 -37.88 89.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.22 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -68.97 -36.83 78.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.562 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 44.1 mt -60.63 -32.73 71.87 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.466 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -58.62 -39.7 81.22 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.375 0.607 . . . . 0.0 110.264 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.87 -19.62 62.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.844 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 19.3 t -145.59 71.72 14.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.93 0.395 . . . . 0.0 110.358 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.15 -8.7 23.3 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.895 2.397 . . . . 0.0 111.946 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 205' ' ' SER . 33.4 t70 -85.86 -12.34 51.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.494 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -87.07 146.72 25.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.689 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.8 OUTLIER -105.54 138.97 40.86 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.07 135.19 62.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.196 0.522 . . . . 0.0 111.939 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 99.5 m -101.99 117.91 35.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.932 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.31 101.45 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 1.4 p-10 -107.84 121.39 44.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.958 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -95.74 160.13 22.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.385 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.04 158.48 44.35 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.071 0.462 . . . . 0.0 110.397 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.559 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 15.0 t -150.47 173.53 13.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.287 175.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 319' ' ' ARG . 16.9 t70 -86.48 152.74 22.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.787 0.327 . . . . 0.0 110.865 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.434 HD22 ' HB2' ' A' ' 302' ' ' SER . 14.2 t-20 -78.55 10.32 3.28 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.251 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 34.4 m -55.01 -44.46 74.57 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.482 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.77 -167.87 36.45 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.911 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.8 m -76.83 138.36 39.78 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.53 -49.54 64.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.627 0.251 . . . . 0.0 111.161 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.66 -17.29 62.33 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.076 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.9 -16.67 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.853 0.835 . . . . 0.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 86.8 m-20 -89.41 -33.82 16.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.213 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 74.7 mt -58.77 -47.9 97.83 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.697 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.1 Cg_endo -58.81 -32.08 96.45 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.734 1.623 . . . . 0.0 111.956 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.77 -44.93 54.58 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.843 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.417 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 1.6 p -56.75 -40.78 76.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.39 0.614 . . . . 0.0 109.953 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.41 80.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.224 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.422 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tt0 -59.11 -55.57 33.35 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-O 120.776 0.322 . . . . 0.0 110.789 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -55.47 -39.79 70.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.375 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.88 97.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.683 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 297' ' ' THR . 56.3 tttp -64.01 -36.18 83.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.257 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.2 mt -60.21 -41.31 86.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.158 0.504 . . . . 0.0 110.136 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 76.8 t -66.98 -45.22 87.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.35 -49.89 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.218 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.68 -40.96 89.58 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.456 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 47.5 t80 -63.39 -38.7 92.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 86.4 mt -66.62 -41.97 87.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.335 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 282' ' ' ALA . 58.9 t -62.13 -31.63 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.098 0.475 . . . . 0.0 110.02 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.79 70.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.533 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -79.0 -3.42 45.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.024 177.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.34 -1.68 43.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.804 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 43.1 t -69.9 135.87 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.81 0.305 . . . . 0.0 110.8 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.31 113.66 6.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.024 0.44 . . . . 0.0 111.382 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.61 -13.91 40.55 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.29 -23.76 62.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -103.19 9.12 38.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.02 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.3 115.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.706 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.27 135.97 48.69 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 279' ' ' LYS . 36.3 p -113.88 125.85 54.51 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.635 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 48.4 t -128.73 136.18 60.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.672 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.11 119.53 5.74 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.4 -4.21 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.937 0.368 . . . . 0.0 111.839 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.59 -117.62 11.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.408 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.434 ' HB2' HD22 ' A' ' 263' ' ' ASN . 3.6 m -121.19 88.78 3.0 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.927 0.364 . . . . 0.0 110.715 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.0 m -104.98 -37.73 4.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 0.0 111.482 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.64 97.72 4.61 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.448 0.642 . . . . 0.0 111.997 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.26 158.89 50.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.144 2.563 . . . . 0.0 111.523 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.33 -8.04 11.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.596 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.34 167.17 26.84 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.627 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.0 m -67.13 126.87 30.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.325 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -81.25 -6.87 59.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.682 0.754 . . . . 0.0 109.825 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.25 -25.19 54.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.925 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 58.4 p -99.53 146.57 32.02 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.358 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.29 -39.34 23.15 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.443 2.095 . . . . 0.0 112.193 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -73.56 -41.37 63.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.23 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.73 99.88 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.73 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 48.5 ttp180 -52.43 -41.11 62.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.608 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.04 -19.28 61.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.92 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -84.71 -34.08 23.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.459 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.92 -11.45 47.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.727 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 315' ' ' ARG . 41.7 mtp180 -109.5 91.94 3.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.437 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 35.2 ptt-85 -144.39 175.07 10.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.988 -175.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 58.4 t -127.18 139.01 53.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.44 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 97.4 mt-10 -123.41 144.86 49.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.57 115.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.951 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.53 133.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.866 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 211' ' ' LEU . 62.7 t -87.5 134.8 26.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--N 1.312 -1.046 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.125 179.677 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -150.35 170.77 18.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.35 137.38 19.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.057 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.95 135.31 65.84 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.452 2.102 . . . . 0.0 111.374 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.08 147.42 91.58 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.874 2.383 . . . . 0.0 112.593 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.67 -178.21 40.06 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.062 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.44 145.45 98.68 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.791 2.327 . . . . 0.0 111.936 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.12 161.13 9.27 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.727 2.285 . . . . 0.0 111.346 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -116.2 -4.24 11.94 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.952 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 p -161.66 157.47 24.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -78.01 129.64 9.59 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.243 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.86 -46.22 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.48 2.12 . . . . 0.0 113.096 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.94 136.79 38.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.35 -22.34 0.68 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.121 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.23 14.86 13.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.992 0.425 . . . . 0.0 110.457 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.6 tp -61.16 -28.14 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 26.9 tp60 -58.93 -41.31 87.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.065 178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.4 m -64.25 -20.89 66.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -88.28 -35.44 17.26 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.009 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.4 mm -70.98 -53.79 20.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.952 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -63.29 -26.62 68.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.08 -34.39 68.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.804 0.335 . . . . 0.0 110.982 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 214' ' ' ALA . 79.7 t -73.08 -40.07 58.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.272 0.558 . . . . 0.0 109.904 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 41.1 p -74.19 -37.45 63.93 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.323 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.12 8.28 73.8 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.8 -142.04 7.71 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.587 ' HB3' ' OE2' ' A' ' 322' ' ' GLU . 78.2 Cg_endo -91.3 171.73 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.92 2.413 . . . . 0.0 111.533 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 48.3 mm -84.94 106.38 14.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 233' ' ' ILE . . . -86.52 130.57 34.45 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.168 0.509 . . . . 0.0 112.171 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 13.7 m-85 -96.65 176.93 5.83 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.048 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.34 -145.5 13.19 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.348 -1.406 . . . . 0.0 113.011 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 228' ' ' ASP . 4.6 t30 58.03 -101.06 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 227' ' ' ASN . 12.7 t70 -67.08 -46.29 74.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.105 0.479 . . . . 0.0 110.679 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 126.41 -39.9 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.293 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.6 15.37 14.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.353 0.596 . . . . 0.0 110.675 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.8 p -144.56 167.28 22.89 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 232' ' ' LEU . 2.7 mp -83.73 161.22 21.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 224' ' ' ALA . 26.9 pt -76.73 152.11 82.8 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.898 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.25 -44.9 15.59 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.464 2.776 . . . . 0.0 113.235 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.7 69.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.418 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -61.39 -43.98 97.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.089 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.34 -44.02 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.166 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.19 -43.62 87.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.959 0.409 . . . . 0.0 110.67 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.1 mt -67.82 -45.39 84.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.51 -42.78 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.341 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -55.79 -39.98 72.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 99.8 mtt180 -72.05 -22.12 61.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 96.9 t -74.83 -43.5 46.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.79 73.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.743 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 13.4 t70 -57.19 -44.12 83.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.266 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -71.16 -33.23 69.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 72.6 mt -66.12 -37.74 86.46 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.105 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -62.33 -35.52 79.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.341 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.63 64.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.271 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 35.1 t -135.83 80.69 42.38 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.238 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -8.44 23.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.75 2.3 . . . . 0.0 112.722 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -95.22 5.71 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.519 ' C ' ' HD3' ' A' ' 254' ' ' ARG . . . -95.16 145.54 24.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.519 ' HD3' ' C ' ' A' ' 253' ' ' ALA . 15.7 mmt180 -115.56 143.09 45.83 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.39 141.98 43.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 324' ' ' VAL . 28.5 m -113.95 125.37 53.96 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.336 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 321' ' ' VAL . 72.1 mt -109.76 111.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.672 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.461 ' OD1' ' HB ' ' A' ' 298' ' ' VAL . 39.9 m-20 -103.89 135.67 44.98 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.73 145.77 17.59 Favored Glycine 0 C--N 1.293 -1.841 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.892 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -129.19 143.98 51.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.454 0.301 . . . . 0.0 110.295 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 65.1 p -132.34 -174.9 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.956 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.14 156.95 17.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.39 9.52 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.5 m -74.32 -40.37 62.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.227 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.26 -112.78 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 24.4 m -157.56 162.95 38.81 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.491 -0.417 . . . . 0.0 109.98 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.51 -52.12 65.81 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.6 11.67 12.98 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.995 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 266' ' ' SER . 44.8 mm -120.66 -51.28 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.166 0.507 . . . . 0.0 109.938 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.553 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 72.7 m-20 -68.32 -49.2 61.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.71 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.3 mt -58.27 -51.81 79.09 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 31.7 Cg_exo -61.17 -35.78 84.05 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.227 1.285 . . . . 0.0 111.425 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 277' ' ' ARG . 0.6 OUTLIER -69.15 -49.22 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.555 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 261' ' ' THR . 3.6 p -52.02 -43.37 63.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.0 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.01 93.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.695 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 75.6 mt-30 -65.03 -49.51 69.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.267 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 273' ' ' LEU . 6.5 mpt_? -55.41 -42.76 74.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.523 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.6 99.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.556 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.533 ' HA ' HG21 ' A' ' 297' ' ' THR . 17.2 tppt? -63.62 -34.65 78.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 276' ' ' GLN . 68.8 mt -59.91 -42.87 90.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.066 0.46 . . . . 0.0 109.926 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.51 -45.7 94.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.062 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.39 -47.21 84.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.052 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.51 -42.45 98.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.619 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -63.08 -37.56 87.69 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.965 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -41.26 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.444 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 282' ' ' ALA . 47.1 t -62.53 -33.42 59.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 110.308 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.83 -24.72 66.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.452 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.07 2.98 50.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.374 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.8 -0.9 48.53 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.48 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.46 132.87 32.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 117.009 0.404 . . . . 0.0 110.052 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.11 108.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.435 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.13 -23.74 62.26 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.053 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.89 -19.75 61.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 254' ' ' ARG . 47.4 m170 -101.99 10.55 39.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.417 0.627 . . . . 0.0 109.488 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.5 mt -114.96 115.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.088 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -101.61 138.78 38.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.5 p -117.66 124.1 47.74 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 258' ' ' ASN . 61.1 t -123.67 138.77 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.522 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.77 115.16 3.52 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 88.1 mt -103.76 -2.74 25.95 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.818 0.309 . . . . 0.0 111.13 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -120.68 21.91 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.832 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.0 t -124.09 95.19 4.46 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.66 -32.97 3.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.762 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -154.49 99.47 2.46 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.325 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.52 166.51 29.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.922 2.415 . . . . 0.0 111.785 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.5 pt -116.63 -9.69 12.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.18 27.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.13 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 16.9 m -77.72 138.32 38.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.08 -5.96 58.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.139 0.495 . . . . 0.0 110.125 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.54 69.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.243 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -112.51 143.99 30.03 Favored Pre-proline 0 N--CA 1.431 -1.407 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.366 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.37 -27.26 84.52 Favored 'Trans proline' 0 N--CA 1.47 0.106 0 C-N-CA 122.382 2.055 . . . . 0.0 110.708 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -67.98 -56.3 9.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.543 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.28 97.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.42 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -55.88 -35.32 66.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.022 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.16 64.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.074 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -86.58 -30.56 21.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.037 0.446 . . . . 0.0 110.245 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -59.11 -20.93 57.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.705 177.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -98.42 97.55 8.88 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.827 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.48 172.7 17.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.781 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 2.1 t -125.7 142.13 43.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.738 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 222' ' ' PRO . 66.2 mm-40 -110.11 136.42 49.38 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.618 177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.6 mt -120.86 110.89 29.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.204 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 256' ' ' THR . 15.8 m -113.29 137.6 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.288 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.61 136.2 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.392 . . . . 0.0 110.849 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.208 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.262 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -79.33 138.67 37.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.831 0.316 . . . . 0.0 110.271 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.07 136.86 46.65 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 12.3 Cg_endo -56.28 111.46 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.787 2.325 . . . . 0.0 111.772 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 23.5 Cg_exo -64.65 145.04 86.19 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.013 2.476 . . . . 0.0 112.464 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.41 172.16 50.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.408 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.23 162.06 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.087 2.525 . . . . 0.0 112.105 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.52 171.5 9.35 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.964 2.443 . . . . 0.0 111.925 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -128.79 92.12 3.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.5 m -152.57 102.0 2.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.997 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.486 ' H ' ' HD3' ' A' ' 207' ' ' PRO . . . 144.44 62.85 0.02 OUTLIER Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.655 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.486 ' HD3' ' H ' ' A' ' 206' ' ' GLY . 94.5 Cg_endo -82.06 -29.09 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.197 1.931 . . . . 0.0 111.75 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.7 t -147.83 135.24 20.66 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -169.06 149.07 4.18 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.999 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.84 30.13 19.7 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -59.4 -36.69 76.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 HE21 HG23 ' A' ' 325' ' ' VAL . 7.1 tp-100 -75.61 -35.41 60.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.468 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.1 m -62.19 -28.48 69.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.31 0.576 . . . . 0.0 109.61 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.12 -36.21 55.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.66 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 211' ' ' LEU . 38.8 mm -69.0 -47.57 74.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -49.91 -46.07 51.52 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.781 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.23 77.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.023 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.6 -48.73 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.884 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 239' ' ' ILE . 30.7 p -71.27 -47.93 53.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.759 0.314 . . . . 0.0 111.693 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.85 3.03 41.0 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.219 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.24 37.1 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.14 169.4 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.884 2.39 . . . . 0.0 111.497 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mm -79.1 112.34 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.71 121.13 30.77 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 17.9 m-85 -91.76 169.52 10.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.521 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -156.39 -131.17 1.34 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.302 -1.427 . . . . 0.0 114.285 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -46.19 -67.01 0.32 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.117 0.967 . . . . 0.0 112.738 -175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 231' ' ' SER . 3.6 m-20 -47.58 -18.2 0.13 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.21 -68.18 1.14 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.364 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.53 19.64 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.948 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 228' ' ' ASP . 60.4 m -148.65 160.47 43.11 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -95.92 178.16 5.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.882 -176.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.6 pt -71.59 140.95 84.67 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.73 -36.38 25.67 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.451 2.768 . . . . 0.0 113.451 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.37 -19.55 60.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -79.33 -35.7 40.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.374 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 95.0 m-85 -54.0 -37.18 63.75 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.732 0.301 . . . . 0.0 111.248 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.32 -45.01 88.88 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.502 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 243' ' ' VAL . 80.1 mt -61.58 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.17 -51.48 61.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -52.96 -40.83 64.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.278 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 80.2 mtp180 -69.73 -35.12 74.74 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.713 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 97.3 t -63.73 -44.14 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.9 76.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.071 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 19.9 t70 -61.32 -44.43 97.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.419 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.32 -39.66 92.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.772 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 75.9 mt -62.82 -33.51 75.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.932 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.12 -35.4 75.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.196 0.522 . . . . 0.0 110.584 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.36 -24.22 64.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.33 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.5 t -153.76 83.39 4.38 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 2.16 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.504 2.136 . . . . 0.0 111.691 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.47 -13.2 40.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.414 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.96 138.99 30.97 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.153 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -99.84 146.3 26.77 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.064 0.459 . . . . 0.0 111.856 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 53.0 m -97.24 116.46 29.5 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.219 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.01 103.16 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 322' ' ' GLU . 0.5 OUTLIER -104.74 122.16 45.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -178.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.76 148.36 18.97 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.543 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -129.04 147.0 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.179 0.514 . . . . 0.0 110.536 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.493 HG21 HD23 ' A' ' 273' ' ' LEU . 10.0 t -158.13 139.57 13.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.44 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 1.5 t70 -40.41 120.28 1.2 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.577 0.548 . . . . 0.0 111.709 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.662 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 64.2 t30 -90.46 13.61 15.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.718 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 30.8 m -75.2 -34.51 61.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.321 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.3 -83.8 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.297 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.7 m -146.43 113.67 6.24 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 122.513 -0.404 . . . . 0.0 109.924 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 263' ' ' ASN . 38.4 mt-10 -52.72 -45.49 66.98 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.49 -2.85 56.5 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.854 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.57 -35.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.211 0.529 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.662 ' ND2' ' HA ' ' A' ' 263' ' ' ASN . 91.7 m-20 -66.96 -47.96 70.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.965 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 79.3 mt -59.44 -51.46 81.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 34.9 Cg_exo -59.76 -29.06 88.75 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.389 1.392 . . . . 0.0 111.007 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 261' ' ' THR . 2.7 tp -73.01 -49.84 26.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.395 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.31 -39.77 57.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 111.404 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.18 95.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.273 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.462 ' O ' HG13 ' A' ' 280' ' ' ILE . 79.9 mt-30 -66.38 -42.54 87.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.988 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.479 HH21 HD21 ' A' ' 273' ' ' LEU . 17.3 mmt180 -52.71 -46.71 67.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.021 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.694 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 297' ' ' THR . 83.7 tttt -62.44 -34.99 77.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.215 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 276' ' ' GLN . 75.0 mt -58.39 -42.95 85.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 110.0 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 79.2 t -67.97 -45.32 83.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.551 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.44 -46.27 80.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.415 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.43 -45.66 90.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 38.0 t80 -58.76 -38.88 79.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.973 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 83.7 mt -70.54 -42.92 70.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.585 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 282' ' ' ALA . 96.6 t -62.35 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 110.242 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.18 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 6.3 mpt_? -80.49 1.73 28.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.259 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.93 -1.6 48.1 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.353 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.1 t -70.89 135.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 117.123 0.461 . . . . 0.0 110.456 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.43 109.8 3.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.712 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.1 -15.72 56.7 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.51 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.44 -23.89 63.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.174 0.512 . . . . 0.0 110.699 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -105.4 13.42 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 110.062 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.7 mt -115.22 118.28 58.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.883 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.22 139.17 41.15 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.235 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 279' ' ' LYS . 41.1 p -118.6 126.48 52.06 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.957 0.408 . . . . 0.0 110.904 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.1 t -125.45 133.7 68.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.7 120.34 5.53 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 303' ' ' VAL . 80.9 mt -120.19 -1.01 10.37 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.72 -108.22 1.89 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.066 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 56.2 m -129.26 87.68 2.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.988 0.394 . . . . 0.0 110.847 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.486 HG23 ' OD1' ' A' ' 304' ' ' ASN . 4.7 m -95.4 -34.97 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.215 0.531 . . . . 0.0 110.736 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.486 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.6 OUTLIER -141.55 89.4 9.28 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.381 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 162.99 33.87 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.1 2.533 . . . . 0.0 112.347 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.492 HG23 ' NH2' ' A' ' 320' ' ' ARG . 27.0 pt -116.22 -8.35 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.117 0.484 . . . . 0.0 110.458 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.45 39.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.058 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.6 m -73.02 140.22 47.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 111.798 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.98 -8.37 59.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.538 0.685 . . . . 0.0 109.73 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.88 -6.87 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.845 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 52.6 p -121.57 134.17 24.48 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.602 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.76 -41.47 77.1 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.849 2.366 . . . . 0.0 111.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -62.76 -41.46 99.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.49 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.28 -43.5 95.13 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' THR . 81.9 mtp180 -57.81 -40.96 81.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.57 69.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.478 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -75.26 -29.83 60.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.08 0.24 22.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.512 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 55.3 ttp180 -102.03 92.03 4.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.492 ' NH2' HG23 ' A' ' 306' ' ' ILE . 14.3 ptt85 -155.14 175.3 14.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.1 t -131.86 142.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.554 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 67.3 mt-10 -124.06 144.39 49.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.5 mt -122.71 119.11 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.492 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 256' ' ' THR . 10.4 p -123.84 142.55 40.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.596 0.236 . . . . 0.0 110.408 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.555 HG23 HE21 ' A' ' 212' ' ' GLN . 90.7 t -89.64 133.93 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.118 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.814 -179.588 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -125.61 -162.53 1.12 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.13 142.23 35.84 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.62 141.52 80.05 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.271 1.981 . . . . 0.0 111.124 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.75 131.3 16.18 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.833 2.356 . . . . 0.0 112.081 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.75 -151.26 19.19 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 93.2 Cg_endo -82.94 137.65 8.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.68 2.253 . . . . 0.0 111.889 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 32.3 Cg_exo -59.9 146.99 94.42 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.858 2.372 . . . . 0.0 111.911 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.18 154.14 20.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.761 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.1 m -69.4 145.74 52.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.428 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.72 162.07 28.03 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.13 -29.53 81.09 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.648 2.232 . . . . 0.0 112.639 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.0 t -97.42 142.93 28.68 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.768 0.318 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 -178.65 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 61.52 7.68 1.92 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -59.57 -26.49 65.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.625 0.25 . . . . 0.0 110.606 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.4 tp60 -56.04 -38.2 70.26 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.732 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.3 m -62.63 -27.86 69.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -89.85 -32.24 16.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.5 mm -70.69 -52.39 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.465 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 5.8 p30 -61.43 -30.24 70.45 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.397 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.74 68.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.768 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.88 -36.98 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 27.8 p -75.4 -41.81 55.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.741 0.305 . . . . 0.0 111.541 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.19 1.68 35.95 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.207 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -158.78 31.11 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.63 170.79 13.99 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.842 2.361 . . . . 0.0 111.274 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -96.17 118.95 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.13 144.82 25.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.629 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 5.8 m-85 -115.0 162.13 17.4 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.254 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 157.43 102.26 0.19 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.559 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.41 ' HB3' ' OG ' ' A' ' 231' ' ' SER . 5.7 t-20 -162.57 -138.54 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.28 -50.45 62.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 109.676 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.25 -107.96 0.24 Allowed Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.117 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.72 54.12 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 227' ' ' ASN . 5.2 p -54.37 167.86 0.29 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.7 mp -89.8 172.81 8.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.047 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.0 pt -78.25 155.47 79.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.291 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.82 -35.65 59.89 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.843 2.362 . . . . 0.0 113.242 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -75.4 -20.86 58.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.396 . . . . 0.0 112.054 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -72.62 -38.21 67.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.672 0.272 . . . . 0.0 111.276 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -60.14 -37.51 80.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -58.04 -41.11 82.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.988 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 243' ' ' VAL . 30.6 mt -70.94 -48.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.8 mt -52.97 -45.1 67.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.895 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -56.91 -37.63 71.72 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 0.0 111.327 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 242' ' ' ARG . 9.6 mmp_? -79.08 -29.94 43.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.048 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 239' ' ' ILE . 99.0 t -68.41 -44.7 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 109.882 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.83 -29.97 71.13 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.239 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.66 -44.72 90.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.113 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -68.8 -37.21 79.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.385 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.04 -39.51 93.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.728 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 8.1 mtpm? -66.28 -31.36 72.12 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.27 0.557 . . . . 0.0 110.541 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.36 -22.26 65.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.447 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.9 t -152.99 78.08 6.06 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.053 0.454 . . . . 0.0 110.014 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.55 -0.36 4.34 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 123.688 2.926 . . . . 0.0 113.508 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 254' ' ' ARG . 29.4 t70 -82.94 -21.97 33.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.17 145.6 53.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.111 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -109.12 134.64 51.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 325' ' ' VAL . 9.8 m -122.35 132.44 71.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.283 0.563 . . . . 0.0 112.504 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 63.3 m -100.65 115.77 30.98 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.545 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 102.01 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 0.8 OUTLIER -106.86 123.21 47.83 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.883 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 321' ' ' VAL . . . -98.42 159.1 20.48 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.941 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.25 153.5 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 122.664 0.386 . . . . 0.0 110.435 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.0 t -143.46 -178.98 6.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.8 152.16 29.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.655 0.264 . . . . 0.0 110.374 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -79.55 9.05 5.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.364 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.8 t -57.93 -40.64 80.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.918 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.97 -171.44 34.05 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.55 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 269' ' ' ILE . 12.2 m -82.17 147.7 28.87 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.63 -0.285 . . . . 0.0 110.302 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -37.95 76.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -62.85 -13.65 48.17 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.466 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 266' ' ' SER . 14.3 mt -108.15 -46.35 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.009 0.909 . . . . 0.0 109.719 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.37 -40.6 82.7 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.336 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 53.2 mt -59.4 -55.17 48.8 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 59.5 Cg_exo -54.2 -37.77 87.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.598 1.532 . . . . 0.0 112.123 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.84 -40.8 72.17 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.5 p -65.75 -40.88 92.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.457 0.646 . . . . 0.0 110.022 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.827 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.7 tt0 -63.56 -54.66 32.59 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.778 0.323 . . . . 0.0 110.224 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -57.47 -39.03 75.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.229 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.55 91.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' HG21 ' A' ' 297' ' ' THR . 59.4 tttp -63.57 -34.25 77.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.376 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 276' ' ' GLN . 66.3 mt -58.57 -42.81 85.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.01 0.434 . . . . 0.0 110.002 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.4 t -65.64 -46.61 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.227 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.7 -46.44 84.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.11 -42.04 98.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.277 0.56 . . . . 0.0 110.759 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -62.43 -38.71 90.79 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.068 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.0 mt -67.81 -41.65 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.515 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.1 t -61.54 -31.49 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 110.316 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.91 70.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 288' ' ' ARG . 5.4 mpt_? -82.53 -0.49 46.9 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.269 177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.37 -2.43 43.21 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.179 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 39.7 t -69.33 129.15 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.525 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 115.53 5.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.851 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.07 -14.81 59.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.667 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.09 -20.33 60.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.058 0.456 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -104.48 9.37 35.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.288 0.566 . . . . 0.0 109.679 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 52.4 mt -114.64 113.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.697 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.13 133.22 51.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.765 0.317 . . . . 0.0 110.407 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 279' ' ' LYS . 21.1 p -110.02 126.66 54.2 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 46.4 t -124.79 138.17 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 271' ' ' ILE . . . -116.02 107.51 1.69 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.31 -2.09 50.01 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.74 0.27 . . . . 0.0 111.472 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.94 -117.12 10.16 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.902 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.3 p -121.48 88.5 2.95 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.031 0.443 . . . . 0.0 110.677 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.95 -32.46 2.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.093 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.14 88.78 43.96 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-O 121.499 0.666 . . . . 0.0 112.509 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 148.73 46.95 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.018 1.812 . . . . 0.0 110.748 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.9 pt -124.14 -13.72 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.055 0.455 . . . . 0.0 110.927 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -141.29 166.84 23.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.8 m -82.84 140.89 32.66 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.61 -7.22 52.48 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.776 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.83 60.04 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.3 p -128.27 135.68 27.9 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.81 -26.17 81.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.635 2.224 . . . . 0.0 110.846 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -68.19 -47.69 67.24 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.199 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -59.71 -45.82 95.07 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.011 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -54.04 -34.21 59.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.009 0.433 . . . . 0.0 111.223 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.12 -21.28 59.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 306' ' ' ILE . 87.6 mttt -87.42 -38.59 16.01 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.44 -2.49 1.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -109.56 102.07 10.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.508 ' NH1' HD13 ' A' ' 306' ' ' ILE . 19.0 ptt180 -153.83 169.13 24.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.372 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 259' ' ' GLY . 15.7 t -125.68 140.78 47.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.797 177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.61 145.46 50.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.2 120.81 64.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.952 0.406 . . . . 0.0 110.807 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.475 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 79.1 t -117.41 130.13 72.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 255' ' ' VAL . 52.6 t -94.24 137.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--N 1.314 -0.972 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.552 -179.604 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -83.4 147.49 27.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.775 0.322 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -81.43 126.76 75.55 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.321 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 37.0 Cg_exo -61.7 123.02 11.88 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.63 2.22 . . . . 0.0 111.535 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 34.2 Cg_exo -60.94 139.72 86.42 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.687 2.258 . . . . 0.0 111.516 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.13 -150.28 9.18 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 126.32 21.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.423 2.082 . . . . 0.0 111.189 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.5 139.07 74.29 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.359 2.04 . . . . 0.0 112.041 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.39 -27.65 56.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.15 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.2 p -58.58 124.23 18.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.947 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -81.17 178.96 53.79 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.732 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.13 150.68 72.0 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.004 2.469 . . . . 0.0 112.155 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 0.1 OUTLIER -98.03 161.26 13.81 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.28 140.8 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 53.94 19.86 2.16 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.531 ' HB3' HG11 ' A' ' 325' ' ' VAL . 31.0 tp -62.08 -28.98 69.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.96 0.409 . . . . 0.0 110.155 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 28.7 tp60 -57.09 -40.09 76.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.421 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.0 t -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.764 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.34 -32.5 17.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.852 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 211' ' ' LEU . 49.0 mm -75.51 -51.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.178 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -63.81 -23.34 67.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.63 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.14 65.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 0.0 110.439 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.502 HG13 ' HE ' ' A' ' 242' ' ' ARG . 72.5 t -78.81 -41.81 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.9 p -75.98 -45.48 34.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.375 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.43 7.24 63.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.468 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.56 26.95 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.13 169.12 7.54 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.033 2.489 . . . . 0.0 111.229 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.7 mm -91.63 120.86 41.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.4 24.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -115.61 153.16 31.76 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -179.18 -169.59 39.91 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t30 71.82 -38.23 0.41 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.441 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.3 -50.75 0.75 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 123.023 1.392 . . . . 0.0 108.038 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 128.27 -42.04 1.5 Allowed Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 112.131 -2.304 . . . . 0.0 109.211 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.5 21.22 10.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 28.9 m -125.91 143.55 51.03 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 232' ' ' LEU . 3.4 mp -83.37 169.94 15.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 236' ' ' ALA . 40.8 pt -75.07 151.79 86.21 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.31 -45.43 22.29 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.179 2.586 . . . . 0.0 113.296 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 239' ' ' ILE . . . -69.09 -26.3 64.86 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.403 ' H ' HG13 ' A' ' 233' ' ' ILE . . . -65.66 -40.99 93.03 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.63 0.253 . . . . 0.0 110.86 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -59.23 -42.01 90.01 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.79 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.34 -42.42 99.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 218' ' ' VAL . 70.9 mt -57.78 -52.88 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.441 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.6 mt -56.64 -40.5 75.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.857 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -41.06 64.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HE ' HG13 ' A' ' 218' ' ' VAL . 71.9 mtm-85 -79.84 -34.69 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.3 t -62.79 -48.33 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.017 0.436 . . . . 0.0 110.472 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 248' ' ' LYS . . . -62.4 -32.61 73.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.483 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.11 -44.04 97.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.208 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -65.81 -37.1 85.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.829 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 73.8 mt -67.45 -39.12 85.33 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 244' ' ' ALA . 7.9 mtpm? -63.6 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 0.0 110.199 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.43 64.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.271 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.7 t -143.06 81.81 12.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.953 0.406 . . . . 0.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.99 -2.28 12.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.962 2.441 . . . . 0.0 113.512 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.41 -5.55 51.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -90.46 143.59 26.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.37 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.3 OUTLIER -108.0 146.25 32.76 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.07 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -122.82 135.47 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.236 0.541 . . . . 0.0 112.094 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.2 m -100.62 113.18 25.8 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.28 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.551 HG22 ' HB1' ' A' ' 278' ' ' ALA . 62.9 mt -101.79 100.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 1.3 p-10 -107.02 122.4 46.38 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.805 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -96.54 158.52 21.54 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.787 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 87.8 m-85 -133.13 151.42 51.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.979 0.512 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.5 t -156.8 150.36 24.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.61 ' HA ' ' ND2' ' A' ' 318' ' ' ASN . 7.0 p-10 -64.56 133.11 51.65 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.957 0.408 . . . . 0.0 110.891 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.451 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 27.8 p-10 -81.5 22.49 0.7 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.1 m -57.66 -31.71 66.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.857 0.36 . . . . 0.0 111.685 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.58 -153.88 28.67 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.386 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 67.5 m -70.62 127.36 32.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.41 -32.83 71.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 110.675 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -70.18 -7.75 60.54 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.998 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.37 -37.27 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.388 0.613 . . . . 0.0 109.356 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 263' ' ' ASN . 20.2 m120 -64.7 -52.69 55.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.418 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 79.9 mt -55.53 -53.18 65.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 276' ' ' GLN . 17.8 Cg_endo -60.1 -29.76 89.91 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.66 1.573 . . . . 0.0 111.831 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.62 -46.3 59.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -39.37 64.43 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.365 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.31 84.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.046 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 47.8 mt-30 -66.06 -45.06 82.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -55.59 -38.49 69.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.922 0.392 . . . . 0.0 110.594 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.551 ' HB1' HG22 ' A' ' 257' ' ' ILE . . . -68.57 -36.69 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.419 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 297' ' ' THR . 42.9 tptt -59.11 -31.64 69.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.917 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.97 -40.6 86.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 321' ' ' VAL . 90.9 t -67.59 -44.38 86.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.88 -40.37 80.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.36 -47.42 86.13 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 38.0 t80 -62.19 -39.63 93.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.186 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 88.4 mt -66.25 -42.79 88.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 85.4 t -61.32 -34.32 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 110.328 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.29 63.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.685 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 15.9 mmm180 -90.67 -3.79 57.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.588 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.76 -3.31 36.22 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.687 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 29.7 t -74.11 130.31 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 0.0 110.252 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.54 123.84 22.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.436 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.1 -14.25 45.64 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.466 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.93 -23.91 65.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.693 0.397 . . . . 0.0 110.912 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.05 10.77 26.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.782 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.5 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.149 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.29 43.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 279' ' ' LYS . 7.9 p -117.24 127.59 54.24 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 58.5 t -126.69 142.44 43.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.455 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -113.63 121.91 5.62 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 94.9 mt -110.1 -4.25 15.93 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.111 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 56.42 -113.62 4.35 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' ASN . 70.2 m -122.85 88.46 2.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.126 0.463 . . . . 0.0 111.011 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.32 -31.71 4.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.139 0.971 . . . . 0.0 108.934 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -143.33 92.87 6.56 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.077 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 1.3 Cg_endo -82.75 85.51 1.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.768 2.312 . . . . 0.0 112.982 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 35.3 pt -48.61 -22.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.313 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -137.22 159.35 42.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.245 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.9 m -71.02 130.62 42.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.78 -177.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.41 -7.42 59.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.105 0.955 . . . . 0.0 108.517 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.12 52.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.049 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 76.1 p -130.28 144.92 55.16 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.132 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.47 -33.48 57.19 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.359 2.04 . . . . 0.0 111.191 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.66 -41.83 78.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.308 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -64.09 -43.27 97.49 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.057 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 18.2 ttm180 -49.78 -40.3 41.0 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.97 -27.1 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.601 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -89.83 -40.94 12.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 110.75 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 262' ' ' ASP . 43.0 t30 -66.45 -10.45 44.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.788 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 58.2 ttp180 -104.12 92.33 4.32 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.1 ptp85 -146.25 168.49 20.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 55.6 t -124.46 136.24 61.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.29 131.78 53.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.71 119.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 55.5 t -117.14 131.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.453 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 211' ' ' LEU . 21.4 t -89.44 134.29 29.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.99 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.264 -178.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -114.77 175.9 5.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 142.7 92.25 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.619 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.18 136.35 51.33 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.742 2.295 . . . . 0.0 112.102 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.9 154.78 43.27 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.542 2.161 . . . . 0.0 111.518 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.16 -150.36 16.19 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.717 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.52 164.37 29.01 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.772 2.315 . . . . 0.0 111.396 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.74 156.87 8.42 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.764 2.31 . . . . 0.0 111.951 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.437 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -112.82 -104.47 0.4 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.305 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.0 m -56.79 98.46 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.991 0.424 . . . . 0.0 111.06 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -110.77 -85.18 1.57 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.182 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 -7.47 19.91 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.741 2.294 . . . . 0.0 111.7 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.2 t -147.69 139.16 23.77 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.62 -177.94 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.366 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.22 12.41 7.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.636 0.775 . . . . 0.0 112.232 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -56.84 -39.27 73.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.907 178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -56.82 -41.95 78.73 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.182 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.0 m -61.89 -25.55 67.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -89.15 -29.47 19.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.362 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.1 mm -71.66 -55.34 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.743 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 26.2 p30 -63.37 -26.94 68.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.89 -36.96 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.799 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 214' ' ' ALA . 69.3 t -77.79 -38.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.984 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 41.5 p -74.89 -42.85 57.06 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.435 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.63 60.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.353 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.52 -160.12 32.4 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.55 170.06 9.23 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.365 2.043 . . . . 0.0 111.091 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 41.6 mm -85.88 115.72 27.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -87.53 147.14 25.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 232' ' ' LEU . 24.6 m-85 -122.56 169.77 10.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.761 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 173.01 -119.8 0.78 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 55.51 -132.82 1.67 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.556 0.342 . . . . 0.0 110.102 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -78.24 -32.76 49.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.16 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.27 -60.66 0.27 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.938 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.77 33.6 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 m -139.57 154.55 47.64 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.872 0.368 . . . . 0.0 110.458 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -97.94 172.72 7.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.182 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 pt -69.46 147.54 96.88 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.9 -38.34 57.79 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.327 2.685 . . . . 0.0 113.504 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.82 61.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.926 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 232' ' ' LEU . . . -70.73 -36.2 73.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.197 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 232' ' ' LEU . 91.3 m-85 -56.21 -41.39 75.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.455 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 40.0 tt0 -56.34 -49.72 73.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.197 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.5 mt -56.8 -52.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.994 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 51.8 mt -55.46 -44.2 76.18 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.685 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.0 -42.2 84.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.145 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 39.0 mmt180 -68.48 -38.03 80.66 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 215' ' ' ILE . 65.0 t -62.5 -40.65 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.718 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.92 75.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.477 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 27.6 t70 -57.64 -45.07 85.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.636 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -69.63 -35.45 75.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.767 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.8 mt -66.6 -41.73 88.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -61.16 -34.61 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.18 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.66 -20.36 62.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.708 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.0 t -140.28 79.32 21.53 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 -6.43 16.14 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.634 2.223 . . . . 0.0 113.138 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.63 -13.91 47.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.004 0.43 . . . . 0.0 110.531 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -92.43 142.16 27.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.9 OUTLIER -103.37 145.51 29.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.84 133.48 67.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.157 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 55.7 m -97.17 113.52 25.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.39 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.427 HG21 ' HB ' ' A' ' 281' ' ' VAL . 55.6 mt -102.26 100.27 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.7 p-10 -107.59 122.29 46.39 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.962 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.73 158.93 20.29 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.876 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -132.69 178.91 6.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.402 0.62 . . . . 0.0 110.472 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 8.9 t -171.61 172.18 5.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.082 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.467 ' CG ' ' HG3' ' A' ' 315' ' ' ARG . 16.0 t70 -88.06 147.88 24.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.73 25.3 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.652 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 262' ' ' ASP . 35.2 m -53.7 -44.6 69.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.014 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -110.46 -150.16 12.41 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.787 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 269' ' ' ILE . 57.6 m -80.6 135.24 36.03 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.327 0.251 . . . . 0.0 110.585 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.06 -34.45 73.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.25 -20.52 65.29 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.199 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 266' ' ' SER . 13.5 mt -95.66 -39.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.195 0.998 . . . . 0.0 109.197 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 95.7 m-20 -60.05 -39.18 85.07 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.038 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 59.3 mt -57.35 -55.32 45.55 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.5 Cg_exo -56.7 -33.72 94.43 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.685 1.59 . . . . 0.0 111.707 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.6 tp -68.8 -54.52 15.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.487 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.4 p -52.27 -41.9 63.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.096 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.02 79.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.095 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 45.5 mt-30 -70.2 -43.79 69.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -55.66 -42.95 75.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.406 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.56 82.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.281 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -58.16 -37.11 74.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.2 -41.93 88.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.085 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 98.4 t -65.71 -48.25 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.645 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.51 -44.2 80.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.82 -45.62 93.05 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.25 -38.36 86.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.921 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 79.1 mt -68.37 -43.98 76.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.751 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 282' ' ' ALA . 98.2 t -60.99 -33.77 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.22 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.44 -31.7 72.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.821 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -82.89 -0.25 47.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.54 3.69 43.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.561 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 41.8 t -74.9 130.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.713 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.44 116.21 5.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.959 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.8 -16.34 56.31 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -70.64 -22.35 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.49 . . . . 0.0 110.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.63 11.36 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.04 118.7 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.368 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.23 142.86 35.22 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 4.4 p -126.3 126.09 43.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 55.9 t -127.94 134.95 64.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.592 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -110.56 111.91 3.14 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 97.4 mt -97.02 -4.73 39.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.949 0.375 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.68 -119.5 18.92 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.479 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.0 m -126.79 88.19 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.58 -47.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.224 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.73 98.95 8.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 121.391 0.615 . . . . 0.0 111.851 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.21 161.17 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.979 2.452 . . . . 0.0 111.187 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.07 -6.51 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.8 161.45 42.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.832 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.3 m -67.24 133.5 49.83 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.857 0.36 . . . . 0.0 111.084 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -81.46 -6.1 58.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.867 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.441 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 75.5 p -117.77 144.18 33.93 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.825 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 31.6 Cg_exo -58.54 -35.96 97.98 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.652 2.235 . . . . 0.0 111.514 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.9 -46.87 76.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.57 -40.96 96.34 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.192 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 262' ' ' ASP . 24.5 ttm180 -58.49 -41.4 85.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.158 -0.521 . . . . 0.0 110.464 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.88 67.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.777 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.13 -27.53 32.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 110.616 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.525 ' HA ' HH21 ' A' ' 320' ' ' ARG . 94.9 m-20 -66.89 -17.82 65.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.433 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 319' ' ' ARG . 18.1 mtm180 -96.54 93.76 6.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.525 HH21 ' HA ' ' A' ' 318' ' ' ASN . 1.6 ptp85 -146.36 163.34 35.9 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.426 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 62.4 t -129.19 141.82 45.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -120.4 144.74 47.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.61 106.64 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.151 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.86 128.86 62.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.52 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 211' ' ' LEU . 56.5 t -87.91 138.69 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.85 0.357 . . . . 0.0 110.296 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.437 ' C ' ' HB1' ' A' ' 204' ' ' ALA . 21.9 m120 . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.165 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.241 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 110.601 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.78 149.93 97.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.514 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.92 143.2 99.64 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.68 164.28 29.76 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.551 2.168 . . . . 0.0 111.486 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.17 167.66 36.23 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.209 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 126.67 23.06 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.553 2.168 . . . . 0.0 111.575 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.86 129.28 17.52 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.147 2.565 . . . . 0.0 112.113 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 66.27 111.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.038 0.836 . . . . 0.0 111.341 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.7 m -67.87 119.68 12.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.996 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 207' ' ' PRO . . . -92.57 133.1 11.57 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.349 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 206' ' ' GLY . 13.6 Cg_exo -70.14 159.0 54.68 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 86.2 m -128.05 154.73 45.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.175 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.96 6.21 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.39 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -115.74 21.98 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.2 tp -60.23 -36.71 78.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.039 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.3 tp60 -61.09 -38.04 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.789 0.328 . . . . 0.0 110.155 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.5 m -65.25 -23.62 67.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.525 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -86.34 -34.4 20.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.292 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 211' ' ' LEU . 43.2 mm -72.23 -54.48 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 36.1 p30 -61.69 -30.54 70.81 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.07 -34.88 78.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 214' ' ' ALA . 73.6 t -78.9 -40.65 23.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.696 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 216' ' ' ASN . 35.2 p -73.73 -42.53 61.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.446 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.07 75.05 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.576 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 161.74 -144.84 10.14 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 95.3 Cg_endo -91.29 172.31 2.91 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.145 2.563 . . . . 0.0 110.596 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 321' ' ' VAL . 49.2 mm -73.49 113.65 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -79.68 141.44 36.44 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.694 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 47.1 m-85 -125.58 163.85 21.84 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.779 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . 174.39 101.69 0.15 Allowed Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.76 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 4.1 t-20 172.04 -106.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.403 0.681 . . . . 0.0 109.644 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -98.05 -4.18 36.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.742 0.305 . . . . 0.0 111.288 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 106.35 -19.74 36.42 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.906 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.08 -0.09 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.311 0.577 . . . . 0.0 110.282 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.5 m -116.3 136.5 52.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.688 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -94.47 165.1 12.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.63 150.28 81.78 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.722 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.57 -33.46 48.31 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.173 2.582 . . . . 0.0 113.278 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.9 -24.05 59.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 111.419 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.7 77.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.348 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.25 -40.56 77.89 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 242' ' ' ARG . 7.8 tp10 -57.12 -48.46 78.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 74.8 mt -58.14 -50.73 77.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.367 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.5 -44.86 73.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.939 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.45 -46.9 80.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.704 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 238' ' ' GLU . 24.7 mmm-85 -70.09 -28.79 65.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 239' ' ' ILE . 65.4 t -73.88 -43.35 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.28 -33.36 70.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.465 0.65 . . . . 0.0 109.851 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 22.8 t70 -57.81 -44.23 86.24 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.625 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -68.18 -36.88 80.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.423 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.9 mt -64.52 -41.1 96.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.304 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -64.06 -34.5 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.143 0.496 . . . . 0.0 110.284 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.15 64.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.5 79.21 20.73 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.6 -2.24 12.33 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.795 2.33 . . . . 0.0 113.392 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.64 -6.74 39.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.549 0.69 . . . . 0.0 110.4 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.46 149.95 22.7 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.077 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -110.63 137.88 47.73 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 15.1 m -120.51 139.6 47.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.251 0.548 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 324' ' ' VAL . 96.7 m -106.71 115.68 30.62 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.7 mt -105.12 100.24 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 4.4 p-10 -110.54 122.2 47.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.789 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -83.36 150.39 27.15 Favored Glycine 0 N--CA 1.422 -2.257 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.633 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.473 ' HD2' ' O ' ' A' ' 318' ' ' ASN . 4.3 t80 -136.93 158.03 45.39 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 14.9 t -160.51 -175.92 5.28 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.685 ' OD2' HG22 ' A' ' 264' ' ' THR . 8.4 p-10 -82.58 179.27 7.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 31.2 p-10 -118.71 2.46 11.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.685 HG22 ' OD2' ' A' ' 262' ' ' ASP . 14.5 t -72.65 -32.13 65.63 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.103 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.72 -175.04 43.12 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.557 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -67.29 122.94 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.918 0.389 . . . . 0.0 111.253 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -55.34 -40.37 71.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.462 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -72.86 -5.45 64.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.577 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 48.7 mm -106.76 -36.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.66 -45.28 93.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.318 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 81.2 mt -59.11 -52.43 74.73 Favored Pre-proline 0 CA--C 1.553 1.079 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.2 Cg_exo -58.45 -33.63 98.08 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.452 1.434 . . . . 0.0 111.131 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 2.8 tm? -69.15 -44.5 72.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.253 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.563 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.0 p -60.06 -43.84 95.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.624 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.38 85.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.927 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -56.04 -59.06 5.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.067 0.547 . . . . 0.0 111.274 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 25.7 mtm180 -59.24 -39.63 83.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.79 80.8 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HA ' HG21 ' A' ' 297' ' ' THR . 55.6 tttm -59.61 -34.71 73.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.411 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.3 -38.09 72.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.094 0.473 . . . . 0.0 109.916 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 83.6 t -68.6 -46.06 80.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.349 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.25 -46.69 82.79 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.09 -38.07 84.97 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.07 -42.98 96.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 74.7 mt -65.23 -42.27 93.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 90.6 t -61.34 -35.04 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.448 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -70.2 -15.27 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -92.0 -0.74 57.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.77 -3.8 39.2 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.179 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 40.0 t -72.28 134.86 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.42 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.59 123.31 22.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.114 0.483 . . . . 0.0 111.542 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.41 -14.32 53.69 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.732 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.57 -24.86 64.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.706 0.288 . . . . 0.0 111.137 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -106.03 10.05 32.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.663 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.93 113.33 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.572 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -106.66 140.12 40.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 279' ' ' LYS . 5.0 p -121.74 126.75 49.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.963 0.411 . . . . 0.0 111.362 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 23.8 t -128.86 146.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -118.69 110.57 1.95 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.04 -9.77 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.93 -111.18 3.72 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 10.7 t -140.35 116.76 10.7 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.44 HG23 ' OD1' ' A' ' 304' ' ' ASN . 15.3 m -125.67 -27.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.146 0.498 . . . . 0.0 111.976 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 303' ' ' VAL . 34.9 p-10 -155.1 79.28 4.6 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.283 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.18 158.88 6.34 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.166 2.577 . . . . 0.0 113.489 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 317' ' ' LYS . 48.8 pt -113.87 -8.58 12.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.531 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.1 31.76 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.786 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 42.2 t -66.38 142.39 57.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.195 0.521 . . . . 0.0 111.679 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -78.13 -7.12 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.709 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.19 63.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.507 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -116.04 141.15 27.25 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.288 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.23 -33.98 29.13 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 111.195 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -69.67 -36.76 76.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.222 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -60.94 -42.84 99.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.024 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -57.3 -40.54 78.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.949 0.405 . . . . 0.0 110.305 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.35 -20.49 64.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.761 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' A' ' 306' ' ' ILE . 57.9 mttm -82.55 -34.19 27.88 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.473 ' O ' ' HD2' ' A' ' 260' ' ' TYR . 91.2 m-20 -73.11 -25.66 60.95 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 31.5 ttm180 -83.55 81.64 8.65 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.704 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.443 ' N ' HH22 ' A' ' 277' ' ' ARG . 38.1 ptt-85 -147.31 175.27 10.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.587 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 223' ' ' ILE . 70.6 t -127.64 135.95 61.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.45 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 8.5 mm-40 -110.17 136.76 48.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 256' ' ' THR . 52.5 mt -124.04 109.92 24.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.13 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 256' ' ' THR . 14.5 m -119.03 146.74 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.27 135.62 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 120.889 0.376 . . . . 0.0 110.639 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.434 -1.263 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.648 179.668 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -88.48 160.78 17.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.622 0.248 . . . . 0.0 110.523 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.71 153.72 39.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.73 157.94 58.71 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.46 165.04 18.71 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.636 2.224 . . . . 0.0 111.356 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.01 177.61 21.82 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.084 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 36.8 Cg_endo -65.97 131.93 28.66 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.715 2.277 . . . . 0.0 111.666 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 50.6 Cg_exo -54.62 128.44 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.664 2.242 . . . . 0.0 111.841 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.52 140.46 29.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.4 m -116.95 160.61 20.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.565 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.19 161.24 14.85 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.37 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.3 2.0 . . . . 0.0 111.639 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 79.7 m -145.82 174.2 11.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.48 145.61 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.05 26.24 13.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.31 -36.5 73.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 27.7 tp60 -62.72 -38.76 91.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.2 m -62.94 -24.19 67.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.51 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -87.73 -36.31 17.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.345 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 211' ' ' LEU . 50.6 mm -67.26 -54.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.082 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -65.1 -24.51 67.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.2 -37.5 72.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.973 0.416 . . . . 0.0 110.583 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 214' ' ' ALA . 70.9 t -74.54 -43.24 48.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.442 ' HA ' HG21 ' A' ' 239' ' ' ILE . 46.0 p -78.1 -26.36 48.0 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.47 -67.31 3.63 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.76 -139.38 3.29 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 163.73 38.17 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.212 1.941 . . . . 0.0 111.248 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.08 119.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.46 152.23 21.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.999 0.428 . . . . 0.0 111.556 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 3.7 m-85 -109.21 157.03 19.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 227' ' ' ASN . . . -178.75 110.3 0.29 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.719 -176.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 226' ' ' GLY . 60.3 t30 170.39 -108.32 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -91.93 4.36 53.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.65 -18.39 57.5 Favored Glycine 0 CA--C 1.495 -1.18 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.956 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.74 -76.46 0.09 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.58 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 6.2 p -91.67 -169.6 2.34 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 2.5 mp -91.98 172.53 8.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.9 -174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 236' ' ' ALA . 31.4 pt -75.54 148.45 82.96 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.295 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.73 -36.06 40.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.27 2.647 . . . . 0.0 113.467 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.66 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -63.56 -42.53 98.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -59.75 -38.06 80.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.28 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -58.97 -41.65 88.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.4 mt -70.45 -38.24 73.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.444 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 77.7 mt -59.36 -41.82 90.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -55.44 -36.39 66.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.092 0.472 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 56.9 mtt180 -75.66 -23.39 56.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.72 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 67.2 t -77.5 -42.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.339 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.779 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.7 t70 -56.16 -47.42 78.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.625 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.1 -37.05 78.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.806 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 51.6 mt -63.68 -42.95 97.95 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.1 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 248' ' ' LYS . 9.1 mtpm? -63.68 -30.43 71.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.6 64.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.339 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.5 78.25 8.51 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -6.11 17.86 Favored 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.911 2.408 . . . . 0.0 112.231 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.0 -6.15 58.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.68 154.7 17.13 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.045 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 0.6 OUTLIER -119.63 137.91 53.58 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.52 142.18 38.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.154 0.502 . . . . 0.0 111.639 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.8 m -106.0 119.28 38.78 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.85 106.78 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 3.3 p30 -104.15 124.2 48.67 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.505 0.669 . . . . 0.0 110.727 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -97.7 148.53 18.96 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.266 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.52 -179.45 3.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.621 0.724 . . . . 0.0 110.83 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.439 ' CG2' ' HB3' ' A' ' 270' ' ' ASN . 12.5 t -173.46 176.05 2.9 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.074 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.2 162.97 18.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.88 12.25 32.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.186 0.517 . . . . 0.0 111.31 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.1 m -57.11 -40.42 77.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.1 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.21 -166.56 35.48 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.316 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.402 ' HB2' ' CG1' ' A' ' 269' ' ' ILE . 70.0 m -70.2 140.18 52.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.855 0.36 . . . . 0.0 111.805 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.37 -47.24 82.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.207 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.57 -9.37 69.08 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.532 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 272' ' ' PRO . 46.8 mm -96.89 -41.3 11.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.469 0.652 . . . . 0.0 109.713 177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' THR . 94.5 m-20 -59.57 -39.18 83.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.19 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 272' ' ' PRO . 77.0 mt -62.03 -54.04 53.95 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 51.4 Cg_exo -55.47 -34.66 90.17 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.704 1.603 . . . . 0.0 111.633 176.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.35 -54.0 16.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 3.0 p -51.03 -42.23 60.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.495 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 299' ' ' GLY . . . -64.6 -35.91 82.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.675 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.73 -48.91 75.15 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.828 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 225' ' ' PHE . 69.7 mtt180 -56.76 -40.58 76.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.101 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.39 -41.24 96.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.427 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' A' ' 297' ' ' THR . 39.6 ttmt -61.09 -32.7 72.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.512 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.85 -40.32 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.195 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 73.4 t -66.98 -46.23 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.221 178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -57.23 -42.92 82.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.546 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.79 -46.87 86.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.962 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -63.39 -39.02 93.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.39 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 69.4 mt -67.05 -43.37 82.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.1 t -61.91 -32.45 54.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.329 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.75 66.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -85.14 1.1 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.52 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.66 45.73 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.409 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.87 140.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.764 0.282 . . . . 0.0 110.763 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.27 112.19 6.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 111.306 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -64.14 -19.08 63.44 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.997 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.55 -14.85 60.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 110.488 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -104.65 5.77 33.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.354 0.597 . . . . 0.0 109.636 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.92 125.79 69.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.45 138.76 45.33 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.314 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 279' ' ' LYS . 19.2 p -118.92 124.62 47.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.648 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -131.11 136.1 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.651 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 275' ' ' ALA . . . -104.25 125.46 8.4 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.4 -4.71 19.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.078 0.439 . . . . 0.0 110.42 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -122.37 28.66 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.2 p -126.78 86.62 2.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.231 0.538 . . . . 0.0 109.942 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.22 -46.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.692 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.52 94.08 9.56 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-O 121.414 0.626 . . . . 0.0 110.371 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.61 172.55 12.29 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.182 2.588 . . . . 0.0 112.268 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.19 -8.7 12.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.296 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.435 ' CB ' ' HA2' ' A' ' 314' ' ' GLY . . . -149.28 164.56 34.49 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.027 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.441 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 45.1 t -66.73 131.67 46.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.147 0.498 . . . . 0.0 111.628 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -78.23 -7.94 57.75 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.783 0.801 . . . . 0.0 109.259 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.26 -2.36 55.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.435 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 74.2 p -125.47 149.26 64.15 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.61 -41.01 34.03 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.598 2.198 . . . . 0.0 110.937 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -63.38 -44.19 95.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.346 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -63.49 -41.55 99.23 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.39 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -54.52 -44.06 72.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.443 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.16 62.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.475 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.13 -38.43 24.78 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.031 0.443 . . . . 0.0 111.288 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.28 -8.73 19.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.972 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.99 93.17 8.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -147.49 167.99 23.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 281' ' ' VAL . 2.5 t -130.88 139.38 51.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.457 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -124.52 131.26 53.49 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.2 mt -106.11 122.3 59.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 8.9 p -124.04 138.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.03 127.87 40.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.988 -176.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.25 119.48 8.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.45 55.98 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.465 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.23 153.78 50.72 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.6 2.2 . . . . 0.0 110.956 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.37 172.32 11.43 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 170.5 32.46 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.39 155.78 36.72 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.401 2.067 . . . . 0.0 111.932 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.03 170.61 12.68 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 122.86 2.374 . . . . 0.0 111.777 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.67 65.78 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.287 0.565 . . . . 0.0 111.718 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -157.49 163.98 37.89 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 165.23 -150.93 19.38 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.489 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.87 177.92 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.845 2.363 . . . . 0.0 112.169 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.66 134.99 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.814 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.16 173.52 16.59 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 59.67 24.06 12.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.441 0.696 . . . . 0.0 112.509 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.3 tp -60.23 -37.77 81.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 29.2 tp60 -61.65 -42.02 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -64.1 -28.6 69.88 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.23 40.43 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 211' ' ' LEU . 41.6 mm -67.44 -46.88 82.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -55.84 -46.0 78.26 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.93 83.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.564 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.3 t -75.92 -45.21 37.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.538 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.0 p -68.53 -40.4 80.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.409 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.19 4.4 36.07 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.211 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.88 -156.85 28.74 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -88.13 168.89 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.493 2.129 . . . . 0.0 111.391 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -84.43 115.86 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.16 24.6 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.064 0.459 . . . . 0.0 111.504 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -123.25 167.09 14.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.968 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -175.54 -159.05 20.83 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.58 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 55.51 -102.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.446 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.33 -28.04 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 111.44 -31.14 7.36 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.26 14.42 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.7 t -111.44 137.25 49.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.193 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 232' ' ' LEU . 3.6 mp -83.46 161.49 21.26 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.047 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 236' ' ' ALA . 34.3 pt -79.15 154.48 77.3 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.188 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.17 -43.9 30.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.169 2.579 . . . . 0.0 113.568 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.58 65.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 240' ' ' LEU . . . -59.94 -47.45 85.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.69 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -56.98 -41.37 78.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.44 -47.51 85.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.0 mt -59.79 -41.74 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 236' ' ' ALA . 73.6 mt -59.35 -45.92 90.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.474 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -56.8 -37.54 71.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -71.87 -41.25 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 73.5 t -62.2 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.97 79.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.413 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.71 -41.17 94.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.356 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.39 -41.96 88.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.147 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 65.0 mt -62.96 -37.94 89.11 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -62.36 -34.7 77.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.354 0.597 . . . . 0.0 110.661 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.94 62.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.389 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.7 t -148.37 68.16 10.05 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.82 2.96 6.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.983 2.456 . . . . 0.0 113.505 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -100.82 -3.87 29.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.411 0.624 . . . . 0.0 109.973 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -91.4 144.64 25.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.185 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 254' ' ' ARG . 1.0 OUTLIER -106.97 142.08 37.17 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.0 m -123.08 136.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.293 0.568 . . . . 0.0 112.033 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 72.8 m -97.35 116.39 29.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.518 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.6 mt -101.2 102.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' VAL . 2.8 p-10 -107.66 121.91 45.64 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.296 0.57 . . . . 0.0 110.498 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 274' ' ' SER . . . -86.66 155.8 28.34 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.325 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -134.41 169.86 16.62 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 120.959 0.409 . . . . 0.0 111.139 -177.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.453 HG22 ' HA2' ' A' ' 301' ' ' GLY . 5.4 t -173.74 170.72 3.93 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.935 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.75 147.99 26.07 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.88 0.371 . . . . 0.0 110.559 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 25.4 p30 -84.2 13.51 5.16 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 43.5 m -56.36 -41.16 75.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -96.03 -155.2 30.85 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.551 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 43.6 m -74.13 124.77 26.95 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 122.896 -0.179 . . . . 0.0 111.085 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.675 ' O ' HG12 ' A' ' 271' ' ' ILE . 8.0 mm-40 -60.35 -34.56 74.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.85 0.357 . . . . 0.0 110.346 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.04 -12.46 54.94 Favored Glycine 0 C--O 1.222 -0.622 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.02 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 272' ' ' PRO . 49.5 mm -105.97 -37.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.326 0.584 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.11 -48.37 80.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.078 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 267' ' ' GLU . 10.6 mm -58.8 -52.11 77.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 271' ' ' ILE . 42.7 Cg_exo -59.38 -34.96 97.57 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.529 1.486 . . . . 0.0 112.233 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.27 -44.1 54.19 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.936 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.545 ' O ' ' HA3' ' A' ' 259' ' ' GLY . 2.2 p -52.43 -39.39 60.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.404 0.621 . . . . 0.0 110.384 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.88 -37.68 88.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.958 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' PRO . 28.7 mt-30 -61.37 -50.87 71.14 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 110.384 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -54.84 -39.56 68.72 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.002 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.78 -43.52 92.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.736 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -59.51 -37.67 78.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.457 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 276' ' ' GLN . 74.0 mt -57.83 -45.82 87.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.437 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 94.3 t -65.92 -46.11 89.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.74 -51.87 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.357 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -35.53 78.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 59.3 t80 -66.82 -42.29 86.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.437 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 96.0 mt -62.6 -40.04 95.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.832 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 282' ' ' ALA . 62.2 t -61.94 -34.7 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.478 0.656 . . . . 0.0 109.811 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -72.02 -21.87 61.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.174 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 3.6 mmp_? -82.61 -3.93 56.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.238 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.96 -2.85 41.15 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.921 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 38.4 t -74.26 137.73 22.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.383 . . . . 0.0 111.196 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.71 113.67 7.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.84 -19.01 58.12 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.367 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.45 -9.9 59.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.069 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -110.94 8.99 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.746 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 58.5 mt -113.74 117.62 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.835 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -109.18 134.91 51.12 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.258 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 11.5 p -112.05 126.32 55.03 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.991 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 258' ' ' ASN . 47.8 t -130.14 135.54 60.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -104.7 122.73 7.42 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.39 -8.9 12.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 117.298 0.549 . . . . 0.0 111.748 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.58 ' HA3' HD13 ' A' ' 271' ' ' ILE . . . 55.88 -106.89 0.69 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 263' ' ' ASN . 27.3 t -131.93 95.07 3.61 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 304' ' ' ASN . 6.9 m -99.05 -31.63 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.278 0.561 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 303' ' ' VAL . 0.9 OUTLIER -152.48 87.33 4.18 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.009 178.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.39 47.93 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 111.946 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.28 -11.38 11.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.596 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.47 165.93 31.7 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 30.7 m -71.74 124.61 25.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.194 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.74 -6.1 58.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.449 0.642 . . . . 0.0 109.961 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.83 -27.45 61.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.676 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 81.8 p -107.58 149.29 38.69 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.113 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.84 -38.32 89.14 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.628 2.219 . . . . 0.0 111.601 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.53 -51.24 66.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.215 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -68.77 -36.48 82.46 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.772 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.57 -45.37 89.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.1 -22.98 67.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.965 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.66 -33.77 40.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 110.652 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 94.2 m-20 -73.79 -23.76 59.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -87.01 90.58 8.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -151.92 174.65 13.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.855 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.21 136.14 58.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.93 136.81 55.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.71 0.29 . . . . 0.0 111.197 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.63 118.55 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.088 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 70.1 t -120.91 132.16 71.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.648 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.77 137.26 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.386 . . . . . . . . 0 0 . 1 stop_ save_